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 Natural products have long stood as a rich source of biologically relevant molecules 
bearing highly functionalized and complex architectures. On one hand, they are a focal 
point for the development of new therapeutic agents owing to their inherent biological 
activities. On the other, they serve as an exciting testing ground for existing synthetic 
methodologies and provide opportunities for the development of new reactions. 
Herein, we describe a modular strategy that was employed for the total synthesis of 
the antibiotic (+)-pleuromutilin. Key features of our synthesis include (1) the development 
of a highly stereoselective SmI2-mediated ketyl radical cyclization to establish the central 
eight-membered ring and (2) a modular crotylation reaction to install the eight-membered 
ring’s backbone that permits full control over the stereochemistry at C12 as desired. During 
our synthetic studies, a transannular [1,5]-hydrogen atom transfer reaction that affects a 
stereospecific redox relay to set the C10 stereocenter was serendipitously uncovered. This 
strategy enabled the completion of a concise total synthesis of (+)-pleuromutilin, 
proceeding in 18 steps. To demonstrate the modularity of our synthetic approach, the same 
strategy was readily applied to the synthesis of (+)-12-epi-pleuromutilin with no 
reoptimization, providing a new platform for the preparation of fully synthetic derivatives 
that may hold promise as broad-spectrum antibiotics. 
This report also highlights the work we have conducted in the development of a 
synthetic strategy towards (–)-merrilactone A. We detail our investigation of a Pd-
catalyzed  asymmetric allylic alkylation reaction that rapidly constructs the D ring bearing 
the C5 and C6 vicinal quaternary centers. Potential paths forward to complete the synthesis 
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BBN  9-borabicyclo[3.3.1]nonane 
BINAP  2,2’-bis(diphenylphosphino)-1,1’-binaphthyl 
BINOL  1,1’-binaphthalene-2,2’-diol 
Bn   benzyl 
Boc  tert-butoxycarbonyl 
bp   boiling point 
bpy  2,2'-bipyridine 
br   broad 
brsm  based on recovered starting material 
Bu   butyl 
iBu  iso-butyl 
nBu  butyl or norm-butyl 
tBu  tert-butyl 
 xxii 
c   concentration of sample for measurement of optical rotation 
13C   carbon-13 isotope 
/C   supported on activated carbon charcoal 
°C   degrees Celsius 
calc’d  calculated 
cis   on the same side  
cm–1  wavenumber(s) 
CO   carbon monoxide 
cod  1,5-cyclooctadiene 
conv.  conversion 
COSY  homonuclear correlation spectroscopy 
D   heat or difference 
d   chemical shift in ppm 
d   doublet 
d   deutero or dextrorotatory 
D   deuterium 
DACH  diaminocyclohexyl 
dba  dibenzylideneacetone 
DCC  N,N'-dicyclohexylcarbodiimide 
DCE  1,2-dichloroethane 
DDQ  2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
de novo  starting from the beginning; anew 
DIBAL  diisobutylaluminum hydride 
 xxiii 
DMAP  4-(dimethylamino)pyridine 
DMDO  dimethyldioxirane 
DME  1,2-dimethoxyethane 
DMF  N,N-dimethylformamide 
DMP  Dess-Martin periodinane 
DMSO  dimethylsulfoxide 
dpm  dipivaloylmethanato 
dr   diastereomeric ratio 
ee   enantiomeric excess 
E+   electrophile 
E   trans (entgegen) olefin geometry 
EDCI  N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride 
e.g.  for example (Latin: exempli gratia) 
EI   electron impact 
ent   enantiomer of 
epi   epimeric 
equiv  equivalent(s) 
ESI  electrospray ionization 
Et   ethyl 
et al.  and others (Latin: et alii) 
FAB  fast atom bombardment 
FTIR  fourier transform infrared spectroscopy 
g   gram(s) 
 xxiv 
h   hour(s) 
1H   proton 
HG-II  Hoveyda–Grubbs’ catalyst™ 2nd generation 
HMBC  heteronuclear multiple-bond correlation spectroscopy 
HMDS  hexamethyldisilazide 
HMPA  hexamethylphosphoramide 
HMPT  hexamethylphosphorous triamide 
hu   irradiation with light 
HPLC  high performance liquid chromatography 
HRMS  high resolution mass spectrometry 
HSQC  heteronuclear single quantum coherence spectroscopy 
Hz   hertz 
i.e.   that is (Latin: id est) 
iso   isomeric 
in situ  in the reaction mixture 
J   coupling constant in Hz 
k   rate constant 
kcal  kilocalorie(s) 
kg   kilogram(s) 
L   liter 
Ln   ligand 
l   levorotatory 
LCMS  liquid chromatography–mass spectrometry 
 xxv 
LDA  lithium diisopropylamide 
m   multiplet or meter(s) 
M   molar or molecular ion 
m   meta 
µ   micro 
mCPBA  meta-chloroperbenzoic acid 
Me   methyl 
MeOH  methanol 
MeCN  acetonitrile 
mg   milligram(s) 
MHz  megahertz 
min  minute(s) 
mL   milliliter(s) 
mol  mole(s) 
MOM  methoxymethyl 
Ms   methanesulfonyl (mesyl) 
MS  molecular sieves 
m/z   mass-to-charge ratio 
Np   naphthyl 
NBS  N-bromosuccinimide 
NCS  N-chlorosuccinimide 
ND  not determined 
nm   nanometer(s) 
 xxvi 
nM   nanomolar 
NMI  1-methylimidazole 
NMR  nuclear magnetic resonance 
nOe  nuclear Overhauser effect 
NOESY  nuclear Overhauser enhancement spectroscopy 
Nu—  nucleophile 
o   ortho 
p   para 
PCC  pyridinium chlorochromate 
Ph   phenyl 
pH   hydrogen ion concentration in aqueous solution 
PhH  benzene 
PhMe  toluene 
pKa  acid dissociation constant 
pm   picometer(s) 
PMB  para-methoxybenzyl 
ppm  parts per million 
PPTS  pyridinium para-toluenesulfonate 
Pr   propyl 
iPr   isopropyl 
nPr   propyl or norm-propyl 
psi   pounds per square inch 
Pyr   pyridine 
 xxvii 
q   quartet 
quant.  quantitative 
R   generic (alkyl) group 
RL   large group 
R   rectus 
RCM  ring-closing metathesis 
recry.  recrystallization 
ref   reference 
Rf   retention factor 
rgt.   Reagent 
rr   regioisomeric ratio 
rt   room temperature 
s   singlet or seconds 
S   sinister 
SAR  structure-activity relationship 
sat.   saturated 
SFC  supercritical fluid chromatography 
t   triplet 
TBABr   tetra-n-butylammonium bromide 
TBACl   tetra-n-butylammonium chloride 
TBAF  tetra-n-butylammonium fluoride 
TBAI   tetra-n-butylammonium iodide 
TBDPS  tert-butyldiphenylsilyl 
 xxviii 
TBHP  tert-butyl hydroperoxide 
TBS  tert-butyldimethylsilyl 
temp  temperature 
Tf   trifluoromethanesulfonyl 
TFA  trifluoroacetic acid 
THF  tetrahydrofuran 
TLC  thin layer chromatography 
TMS  trimethylsilyl 
TOF  time-of-flight 
Tol   tolyl 
trans  on the opposite side 
Ts   para-toluenesulfonyl (tosyl) 
UV  ultraviolet 
vide infra  see below 
w/v  weight per volume 
X   anionic ligand or halide 
xs   excess 
Z   cis (zusammen) olefin geometry 
 
















“One sometimes finds what one is not looking for. When I woke up just after dawn 
on Sept. 28, 1928, I certainly didn’t plan to revolutionize all medicine by discovering the 
world’s first antibiotic, or bacteria killer. But I suppose that was exactly what I did.” In 
1928, Alexander Fleming serendipitously discovered penicillin after finding that a 
staphylococcus culture plate had been contaminated with mold.1 Upon closer examination, 
he realized that the bacteria in close proximity to the mold colonies had stopped 
proliferating. He then isolated the mold and identified it as a member of the Penicillium 
genus, which he found to be effective against all Gram-positive pathogens. He noted that 
it was not the mold itself but rather the mold juice, or penicillin, that possessed antibiotic 
properties. Despite this breakthrough, there were still significant challenges in  
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implementing these findings for widespread use against bacteria, most notably the isolation 
and purification of penicillin. Fortunately, in 1940, Howard Florey and Ernst Chain 
reported a purification technique, leading to the mass production and distribution of 
penicillin in 1945. 
The discovery of penicillin, as well as Ehrlich’s sulfonamide antibiotics,2 set up the 
paradigms for future drug discovery and small molecule research where a number of new 
antibiotics closely followed. The period between the 1950s and the 1970s is now 
considered the golden age of discovery of novel antibiotics classes; however, few have 
been discovered since then.3 With the rapid emergence of pathogenic antibiotic resistance 
and the decline of discovery rate of new antibiotics, there has been a renaissance in the 
scientific community toward discovering new antibiotics. 
1.2 PLEUROMUTILIN 
In 1951, Kavanagh and coworkers4,5 reported that Pleurotus mutilus and P. 
Passeckerianus of the genus Pleurotus were found to produce substances that inhibit 
Staphylococcus aureus. At the time of isolation, the full structure of (+)-pleuromutilin (1, 
Figure 1) had not yet been elucidated; however, the authors found that its antibiotic 
characteristics were lost by boiling the metabolite in a 0.1 N solution of sodium hydroxide, 
presumably removing the glycolic ester residue. This functionality was later determined to 
be critical for its biological activity. The antibacterial substance was isolated as a 
crystalline solid from culture liquids and named pleuromutilin, whose structure and 
biosynthetic pathway6,7 were elucidated by Birch and Arigoni independently in the 1960s. 
 




Figure 1. (+)-Pleuromutilin (1) and mutilin antibiotics. 
1.3 PROPOSED BIOSYNTHESIS 
The biosynthesis of pleuromutilin is suspected to occur through a pathway similar 
to other cyclic terpenes, beginning with pyrophosphate ester 3.6,7 Cyclization of the 
pyrophosphate of all-trans geranylgeraniol (3, Scheme 1) commences with protonation, 
which leads to a cationic polyene cyclization cascade to generate cationic trans-decalin 4. 
A subsequent 1,2-hydride shift, 1,2-methyl shift, and second 1,2-hydride shift migrates the 
positive charge, resulting in a hydride induced ring contraction to afford the hydrindane 
framework 6. Transannular cyclization of the isopropenyl unit in an SN2’ fashion 
eliminates the phosphate moiety with concomitant formation of the C11–C12 bond, forging 
the medium-sized ring in pleuromutilin. Addition of water and simultaneous hydride 
migration installs the C14 hydroxyl. 
Studies done by Oikawa and coworkers8 have shown that 8 is an intermediate in 
the biosynthesis of pleuromutilin. After studying the later oxidation steps of the 
biosynthetic pathway, it was postulated that C11 is first oxidized before introduction of the 
C3 carbonyl to forge mutilin (2). This hypothesis was later confirmed by Foster and 
coworkers,9 who used stepwise heterologous expression to elucidate the full biosynthetic 
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oxidation (9). Further addition of pl-p450-1 and pl-p450-2 led to subsequent C3 oxidation 
(10). Addition of dehydrogenase/reductase pl-sdr resulted in formation of the C3 ketone 
(2), where then acetylation of the C14 hydroxyl with acetyl transferase pl-atf and final 
oxidation of C22 with cytochrome P450 monooxygenase pl-p450-3 provided pleuromutilin 
(1). 
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1.4 BIOLOGICAL ACTIVITY 
The ribosome is an organelle comprised of ribosomal proteins and ribosomal rRNA 
that polymerizes amino acids into proteins using information encoded in mRNA. During 
the elongation stage of protein synthesis, amino acid monomers are transported to the 
initiation complex where there are three binding sites for tRNA: the acceptor site (A site), 
peptidyl site (P site), and the exit site (E site). The first peptidyl tRNA binds to the P site, 
and the tRNA carrying the amino acid to be added enters the A site. Within the PTC, the 
peptide bond is formed, and the newly formed protein chain grows in the E site of the 50S 
subunit. The ribosome then moves down the mRNA, freeing the A site, and enabling the 
continuation of this process. Although many characteristics of the ribosome are conserved 
across all organisms, the differences that exist in rRNA sequence allow pleuromutilin 
antibiotics to be selective for bacterial ribosomes. 
Initial studies on pleuromutilin’s mode of action were carried out throughout the 
1970s and 1980s first by Högenauerd10–12 and then Cheney,13 revealing that pleuromutilins 
selectively bind to the PTC within the 50S ribosomal subunit and inhibit bacterial protein 
synthesis.14 Later in 2004,15 the crystal structure of tiamulin (19) complexed with the 50S 
ribosome subunit of Deinococcus radiodurans was solved, providing a detailed picture of 
its interactions with the 23S rRNA and explaining the molecular mechanism of its 
antibiotic activity. The molecule’s tricyclic core is situated in the A site; the peptidyl tRNA 
has already bound to the P site therefore disrupting the correct positioning of the second 
tRNA. This prevents formation of the first peptide bond, and thus protein synthesis cannot 
begin.16 This discovery is further supported by previous findings that tiamulin competes 
with chloramaphenicol, puromycin, and carbomycin A, which also bind to the A site.12  
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 Due to their mode of action in binding to functionally important nucleotides, the 
pleuromutilin class of antibiotics has experienced less cross-resistance than many other 
antibiotics, making it an exciting family of compounds to target for human use. However, 
these molecules suffer from low in vivo efficacy due to poor pharmacokinetics and rapid 
metabolism.17 To combat these issues, many pleuromutilin derivatives have been 
synthesized in academic and industrial labs through modification of the natural product.  
1.5 SYNTHETIC MODIFICATIONS OF PLEUROMUTILIN 
Due to the emergence of multi-drug resistant bacteria, scientists are now focusing 
their research efforts on developing new antibiotics with novel modes of action and activity 
against resistant organisms.18 With this goal in mind, derivatives of (+)-pleuromutilin (1), 
of which several analogs were successfully developed for veterinary medicine, have 
regained interest in the past few years as promising antibiotics with potential for human 
application. Herein, a selection of previously reported synthetic strategies toward accessing 
various derivatives will be discussed. 
1.5.1 Glycolic Ester (C14 and C22) Modifications 
Perhaps the most extensively derivatized position on pleuromutilin is the C22 
hydroxyl due to its ease of functionalization.19–21 Acyloxy derivatives are typically 
prepared through activation of the C22 hydroxyl group as a tosylate 13 or mesylate 12, 
followed by substitution with a thiol, amine, or alcohol to forge the corresponding 
derivatives (Scheme 2). In an effort to rapidly investigate various pleuromutilin nucleoside 
conjugates, Nielsen and coworkers22,23 substituted tosylpleuromutilin 13 with sodium azide 
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and introduced purine rings on the side chain using click chemistry and alkynyl 
nucleotides. However, the in vitro potencies of these compounds against E. coli were only 
modest.  
 
Scheme 2. C22 functionalization of (+)-pleuromutilin (1).  
 While C22-modification of pleuromutilin is facile, selective functionalization of 
the C14 hydroxyl of mutilin has proven to be more challenging due to the more reactive 
C11 hydroxyl group. Berner and coworkers24 demonstrated that stereochemical inversion 
of C4 can be accomplished with a concomitant 1,5-hydride shift from C11 to C3 to forge 
resultant ketone 16 (Scheme 3). Because this compound now has only one hydroxyl 
functionality at C14, it can be selectively functionalized with the desired acid chloride to 
form C14 mutilin derivatives 17. Subsequent treatment with ZnCl2 and HCl restores the 
C4 stereochemistry, and a concomitant 1,5-hydride shift from C3 to C11 reestablishes the 
desired C3 carbonyl and C11 hydroxyl functionalities. Although not discussed herein, 
numerous alternative approaches to access C14 derivatives, specifically carbamates, have 
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Scheme 3. C14 functionalization of (+)-pleuromutilin (1). 
Due to the wide availability of (+)-pleuromutilin (1) through fermentation and ease 
of rapid late-stage derivatization, thousands of C14 pleuromutilin derivatives have been 
prepared through the methods described above. However, only sulfanylacetyl derivatives 
have advanced into or beyond Phase I clinical studies (Figure 2).17,19,20  
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On the other hand, the lack of general methods to functionalize the tricyclic core still 
remains an obstacle; as a result, the number of structural and core-modified derivatives 
remains relatively low. 
1.5.2 Structural Modifications 
As shown in the work described earlier by Berner and coworkers,24 as well as that 
of many other groups,24,27–30 the unique molecular structure of pleuromutilin is susceptible 
to alkyl and hydride shifts under forcing conditions. This can lead to stereochemical 
inversion, as well as ring expansion or contraction. Such structural rearrangements are 
often reported as undesired reaction side products.  
One interesting and important finding by Berner and coworkers31 is that the C12 
quaternary center can be epimerized to a 1:1 mixture of C12 epimers through a zinc-
mediated retroallylation-allylation reaction (Scheme 4). This strategy was later employed 
by Herzon and coworkers32 in 2017 for the completion of their total synthesis; the only 
difference in the Herzon system is that C22 hydroxyl group was protected as a trityl ether.  
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Birch and coworkers6 reported a ring contraction reaction that generates a novel 5-
6-7 tricyclic skeleton (33) through treatment with PCl5. It is suspected that this shift occurs 
through activation of the C11 hydroxyl as a leaving group, leading to C11–C13 bond 
formation. This finding has industrial relevance: as previously discussed, many 
pleuromutilin derivatives are accessed through activation of C22 through mesylation, 
followed by nucleophilic displacement (vide supra, Scheme 2), and it has been noted that 
if any competing C11-mesylation occurs, this side product readily undergoes ring 
contraction in the manufacturing process.33 
 
Scheme 5. PCl5-medidated ring contraction from Birch and coworkers. 
Alternatively, Springer and coworkers27,28 reported that prolonged conditions used 
for methoxymethyl (MOM) protection led to formation of a tricyclic 5-6-9 ring system 
(36), where dimethoxymethane acts as a single carbon linchpin that facilitates the ring 
expansion reaction (Scheme 6). Furthermore, it was also reported that pleuromutilin readily 
undergoes oxidative cleavage of the cyclopentanone ring through a Kornblum-DeLaMare 
type fragmentation. Although this fragmented product no longer contains the central 
tricyclic core, the bicyclic system, such as that shown in 37, has shown promising activity 
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Scheme 6. Ring expansion and oxidative cleavage reports from Springer. 
 Currently, the vast majority of pleuromutilin derivatives are synthesized through 
modification of the natural product itself, primarily at C14 and C22. As a result, access to 
more complex structural derivatives and alternatively functionalized tricyclic cores has 
remained a challenge that can only be addressed with de novo synthesis.   
1.6 PREVIOUS SYNTHESES OF PLEUROMUTILIN 
The development of de novo syntheses of (+)-pleuromutilin (1) has been the focus 
of intense effort by the synthetic community over the past four decades.30,34–40 Because 
synthetic work in this area has been extensively reviewed by Procter and coworkers in 
2014,21 this section is focused on completed total syntheses. Thus far, there have been five 
completed syntheses of (+)-pleuromutilin (1), each utilizing distinct strategies in 
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1.6.1 Gibbons’ Total Synthesis of (±)-Pleuromutilin 
Gibbons’ strategy commences with construction of tricyclic intermediate 41 by a 
double Michael addition of cyclohexenone 39 to cyclopentene 40 (Scheme 7). Elaboration 
of 41 through an eleven-step procedure affords key tetracyclic intermediate 42. The initial 
ring expansion reaction was envisioned to proceed through a retro-aldol fragmentation; 
however, those efforts were unsuccessful. Ultimately, this transformation was 
accomplished through a bromination-induced Grob fragmentation to construct the central 
eight-membered ring (43).  
In five steps, diketone 44 was reduced to the correct oxidation states present in the 
natural product (1) and MOM protection of the C14 hydroxyl, followed by ozonolysis of 
the C12 exocyclic olefin afforded ketone 45. At this stage, elaboration of the ketone to the 
C12 quaternary center was investigated. Gibbons reported that carbanion formation at C12 
resulted in elimination of the C11 hydroxyl group, and methods that relied on a carbocation 
at C12 also proved unsuccessful. Alternatively, a four-step route from ketone 45 to the 
C12-functionalized tricycle 47 was developed. Enal formation, followed by reduction 
afforded allylic alcohol 46, which upon g-alkylation with Murahashi’s conditions45 
afforded 47. Benzyl deprotection of 47, oxidation, and MOM cleavage completed the first 
racemic total synthesis of mutilin (2), which was converted to pleuromutilin (1) through 
bis-glycolic ester formation and hydrolysis.  





Reagents and conditions: a) LDA, 62%; b) CH2CHLi, 67%; c) PCC, 79%; d) MeLi, 88%; e) MnO2, 88%; f) 
H2, 10% Pd/Al2O3, MgO, 61%; g) K2CO3, 92%; h) POCl3, DMAP, py; i) TFA, 80% (2 steps); j) tBuOOH, 
VO(acac)2, 97%; k) tBuOK, tBuOH; l) KH, MOMCl, 71% (2 steps); m) N-bromoacetamide, NaOAc; n) Zn, 
AcOH, 81% (2 steps); o) DIBAL; p) MsCl, py; q) LiAlH4, 68% (3 steps); r) PCC; s) Na, Na/Hg, 88% (2 steps); 
t) MOMBr, iPr2NEt; u) O3; v) P(OMe)3, 95% (3 steps); w) (Z)-[2-ethoxyvinyl]lithium; x) H2SO4, 50% (2 steps); 
y) DIBAL, 95%; z) CuI, MeLi, [Bu3PN(Me)Ph]+I–, 50%; aa) Li, NH3; bb) PCC; cc) HCl, 80% (3 steps); dd) 
AcOCH2COOH, MsCl, DMAP, py; ee) KOH, MeOH. 
 
Scheme 7. Gibbons’ total synthesis of (±)-pleuromutilin (1).  
 
1.6.2 Boeckman’s Total Synthesis of (±)-Pleuromutilin 
Boeckman’s synthetic route42 towards pleuromutilin (1) involved early 
construction of the tricyclic framework devoid of functionalities with the intention of 
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hypotheses that were based on MM2 calculations: 1) all substituents on the eight-
membered rings resided in equatorial-like environments in the most stable conformation. 
2) The few accessible conformations available to the eight-membered ring by the bicyclic 
ring fusion greatly reduce the conformational complexity to only two unique low-energy 
conformations.  
First efforts were focused on construction of vinyl carbinol 52 for investigation of 
the key anion oxy-Cope that would afford tricycle 53 (Scheme 8). Two-step Robinson 
annulation of cyclohexenone 48 and pentanone 49, followed by deprotection and tosylation 
afforded dienone tosylate 50. This intermediate was now primed for their key conjugate 
addition–alkylation sequence to install the C6 methyl substituent. Methyl cuprate addition 
resulted in complete axial selectivity, delivering methylated bicycle 51; however, vinyl 
addition resulted in a 1:1 mixture of diastereomers. Resubjection of the undesired 
diastereomer could be performed to obtain a 70% overall yield of rearrangement precursor 
52 after two cycles of equilibration. Key anionic oxy-Cope rearrangement proceeded 
smoothly to afford tricycle 53.  
Following construction of the carbon skeleton, investigations toward installing the 
functionalities on the eight-membered ring commenced. Formation of functionalized 
tricycle 54 occurred through a four-step procedure that involved epoxidation and 
rearrangement at C3, selective ketalization, C3 ketone reduction, and benzyl protection. 
Subsequent treatment with Py+HBr3– forged the equatorial bromo-ketal and syn-
elimination delivered E-alkene 55. Hydration to install the C14 hydroxyl, ketal hydrolysis, 
and MOM protection afforded methoxymethyl ether 56. Initial attempts at installing the 
C11 hydroxyl were focused on selective silyl enol ether formation; however this strategy 
Chapter 1 – An Introduction to Pleuromutilin 
 
15 
always resulted in mixtures that led to a mixture of silyloxy products upon oxidation. 
Fortunately, Rubottom-type oxidation selectively installed the C11 hydroxyl as a single 
epimer, and MOM protection afforded Gibbons’ intermediate 57 (vide supra, Scheme 7). 
 
Reagents and conditions: a) LDA, 61%; b) pyrrolidine; AcOH, NaOH, 98%; c) AcOH; d) pTsCl, DMAP, py, 
74% (2 steps); e) (Me)2CuLi, HMPA, 93%; f) CH2CHMgBr, 43%, minor epimer recycled, PhSCl, MeOH, 
P(OEt)3, 70% after 2 cycles); g) KH, 18-crown-6, 99%; h) mCPBA; i) BF3·OEt2 (CH2OH)2, 89% (2 steps); j) Li, 
NH3; k) KH, BnBr, 69% (2 steps); l) pyH+Br3–; m) tBuOK, DMSO, 67% (2 steps); n) pTsOH, H2O, 67%; o) 
MOMCl, iPr2NEt; p) TMSI, HMDS; q) mCPBA, NaHCO3; r) TBAF, 62% (4 steps); s) MOMCl, iPr2NEt, 90%; t) 
CH2CHMgBr; u) SOCl2; v) MeCuB(Me)3, 50% (3 steps); w) Li, NH3; x) PCC; y) HCl/EtOH, 80% (3 steps); z) 
AcOCH2COOMs, DMAP; aa) KOH, MeOH, 39% (2 steps). 
 
































































































At this stage, attention was turned towards installing the C12 quaternary center. 
Using a strategy similar to Gibbons’, vinyl addition followed by treatment of the resulting 
mixture of allylic alcohols with thionyl chloride and triethylamine furnished allylic 
chloride 58 (Scheme 8). SN2’ methyl addition afforded the C12 quaternary center as a 5:1 
mixture of diastereomers, favoring the correct stereochemistry, intercepting Gibbons’ 
intermediate 59. Despite constructing differentially protected analogues of 59, Boeckman 
ultimately found Gibbons’ final steps to be the most concise, and therefore both syntheses 
were completed in the same manner. 
1.6.3  Procter’s Total Synthesis of (+)-Pleuromutilin 
Similar to the previous two syntheses discussed, Procter’s strategy towards 
pleuromutilin centers on early construction of the tricyclic core and late stage 
functionalization of the eight-membered ring. At the heart of their approach is a SmI2-
mediated cyclization cascade to construct the tricyclic core in a single step, forming both 
the five- and eight-membered rings and four stereocenters. Their synthesis also features the 
first efficient conversion of mutilin (2) to pleuromutilin (1) in 75% yield over two steps, 
whereas prior unselective methods gave 39% yield. 
Construction of the SmI2-cyclization precursor commenced with synthesis of 
dialdehyde 64 through a nine-step protocol from (+)-trans-dihydrocarvone (60), Scheme 
9).46–48 Oxidative fragmentation of the isopropenyl unit, conjugate addition, and Saegusa–
Ito oxidation49 afforded enone 61. Conjugate addition with silylisopropenyl nucleophile 
installed the C9 quaternary center and proceeded to give an inseparable 2.5:1 mixture of 
diastereomers; subsequent trapping with Comin’s reagent forged the vinyl triflate. 
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Palladium-catalyzed methoxycarbonylation then furnished the a,b-unsaturated ester 62  
that is critical for their cascade. Cyclization precursor 64 was formed through Hosomi–
Sakurai allylation of allyl silane 62 and the corresponding aldehyde to afford homo-allylic 
alcohol 63. Subsequent pivalate protection, bis-desilylation, and bis-oxidation then set the 
stage for the key SmI2-mediated cyclization cascade.  
 
Reagents and conditions: a) O3, MeOH, then FeSO4·7H2O, CuOAc2, 57%; b) TBSO(CH2)3MgBr, 
CuCN·2LiCl, THF, –45 ºC, 20 min; TMSCl, 10 min, 23 ºC; c) Pd(OAc)2 (10 mol %), DMSO, O2, 3 days, 85% 
(2 steps), 95% ee by HPLC; d) CuI, TMSCH2C(MgBr)CH2, THF, –78 ºC to 0 ºC, 10 min; 61, –78 ºC, 1.5 h, 
Comins’ reagent, –78 ºC to 23 ºC, 60 h, 85%, 2.5:1 dr; e) Pd(OAc)2, PPh3, Et3N, MeOH, DMF, CO, 40 ºC, 24 
h, 85%, 2.5:1 dr; f) TBSOO(CH2)2CHO, BF3·OEt2, TBAT, 4 Å MS, –78 ºC, 18 h, –20 ºC, 4 h, 73%, 2.5:2.5:1:1 
dr; g) PivCl, Py., DMAP, CH2Cl2, 18 h; h) HF, Pt. MeCN, 0 ºC to 23 ºC, 16h; i) DMP, CH2Cl2, 3 h, 88% (3 
steps).  
 
Scheme 9. Procter’s synthesis of SmI2-mediated cyclization cascade precursor 64. 
 
 Dialdehyde 64 underwent smooth cascade cyclization to give 65 upon treatment 
with 2.5 equiv SmI2 (Scheme 10). Procter proposed that the cascade commences with 
single-electron ketone reduction to form radical anion 66. A 5-exo-trig cyclization50 then 
forges the C3–C4 bond and selectively forms the (Z)-SmIII-enolate 6751 due to SmIII 
chelation of the radical anion with the ester carbonyl. The stereochemistry is consistent 
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transition state 68. It is proposed that the high diastereocontrol was achieved due to pre-
coordination of samarium to the carbonyl group and unsaturated ester.52 
 
Scheme 10. Procter’s key SmI2-mediated cyclization cascade. 
 After validation of the key SmI2-mediated cyclization cascade, bis-silylation, 
pivalate deprotection, and oxidation of the C12 hydroxyl gave a separable 2.5:1 mixture of 
diastereomers (69) that arose from conjugate addition to forge C9 (vide supra, Scheme 9). 
Subsequent Pd-catalyzed hydrogenation of alkene 70 furnished a separable 3:1 
diastereomeric mixture at C10. The next key challenge of their synthesis involved 
reduction of the methyl ester to the C5 methyl substituent present in pleuromutilin. Initial 
attempts at reduction involved treatment with lithium aluminum hydride that ultimately led 
to an additional five steps of protecting group manipulations and reduction to access diol 
71. However, improved efforts later shortened the sequence to two steps through ketal 
protection with concomitant C3 desilylation, followed by methyl ester reduction with 
conditions utilizing SmI2.53–55 Final reduction of the primary hydroxyl to the desired methyl 
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p-methyl benzoate (MBz), 2) conversion of the primary hydroxyl to the thioimidazolide, 
and 3) deoxygenation under radical conditions. 
 
Reagents and conditions: a) Et3N, TBSOTf, CH2Cl2, 0 ºC, 5 min, 23 ºC, 30 min, 76%; b) LiAlH4, Et2O, 30 
min; c) DMP, CH2Cl2, 16 h, 63% (2 steps); d) H2, 10 % Pd/C, EtOH, 12 h, 3:1 dr, 75%; e) 1,2-ethanediol, 
HC(OCH3)3, Amberlyst® 15, PhMe, MeCN, 23 ºC, 40 h, 96%; f) SmI2, pyrrolidine, H2O, THF, 23 ºC, 18 h, 95%; 
g) LDA, –78 ºC, 30 min; MBzCl, THF, –78 ºC, 30 min, 97%; h) TCDI, THF, 60 ºC, 5 days; i) nBu3SnH, AIBN, 
PhMe, 80 ºC, 4 h, 66% (2 steps); j) FeCl3·SiO2, acetone, 23 ºC, 24 h, 99%; k) HMDS, TMSI, CH2Cl2, –20 ºC 
to 10 ºC, 3 h; l) NaHCO3, mCPBA, CH2Cl2, 0 ºC, 10 min; m) TBAF, THF, 23 ºC, 3 min, 94%; n) HF(aq), MeCN, 
23 ºC, 18 h, 78%; o) MOMCl, DIPEA (3 additions), CH2Cl2, 23 ºC, 2 days, 75%; p) EtOCHCHSnBu3, nBuLi, 
THF, –78 ºC, 1 h, 73, THF, –78 ºC, 15 min; q) FeCl3·SiO2, acetone, 23 ºC, 5 min; r) NaBH4, THF/H2O, 23 ºC, 
30 min, 63% (3 steps); s) NCS, DMS, CH2Cl2, 0 ºC, 10 min, –20 ºC to 23 ºC, 16 h, 97%; t) CuCN, DMF, 23 
ºC, 30 min, Me2Zn, –20 ºC, 24 h, 71%; u) LiAlH4, THF, 23 ºC, 90 min; v) DMP, CH2Cl2, 23 ºC, 1 h; w) AcCl, 
EtOH, 23 ºC, 3 h, 69% (3 steps); x) trifluoroacetylimidazole, EtOAc, –45 ºC, 30 min; y) 2-(2,2,2-
trifluoroacetoxy)acetic acid, EDCI, DMAP, CH2Cl2, 23 ºC, 30 min; MeOH, Et3N, 24 h, 75% (2 steps). 
 
Scheme 11. Procter’s completion of (+)-pleuromutilin (1). 
 
Now that the final oxidation state of the C5 methyl substituent was installed, 
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revealed the C12 ketone and use of Boeckman’s procedure for selective a-hydroxylation 
(vide supra, Scheme 8) followed by desilylation and MOM protection furnished ketone 
intermediate 73. Building off the work of Gibbons and Boeckman, conversion of the C12 
ketone to the desired quaternary center was accomplished through a similar sequence. 
Ketone 73 was treated with a lithiated enol ether. The addition product was hydrolyzed and 
the intermediate enal was reduced and subjected to Corey-Kim chlorination56 conditions to 
give allylic chloride 74. SN2’ displacement of the chloride with Me2Zn and CuCN in DMF 
afforded a single diastereomer at C12. Thus, benzoate deprotection, Dess-Martin oxidation, 
and MOM cleavage furnished (+)-mutilin (2) in 69% overall yield.  
 After identifying that existing methods for the conversion of mutilin to 
pleuromutilin suffered from poor yields and selectivity, Procter and coworkers turned 
towards methods developed in industry57 for the conversion of mutilin to C14 analogues 
of pleuromutilin. Protection of (+)-mutilin (2) as the C10 trifluoroacetate, followed by 
coupling with 2-(2,2,2-trifluoroacetoxy) acetic acid and subsequent deprotection furnished 
(+)-pleuromutilin (1) in 75% overall yield, concluding the first enantiospecific total 
synthesis of 1.  
1.6.4 Herzon’s Total Synthesis of (+)-Pleuromutilin 
Herzon and coworkers developed a modular route to access (+)-pleuromutilin (1) 
and its stereochemical derivatives, specifically at C11 and C12. Proceeding through the 
intermediates that are epimeric at C12, their synthesis was made possible through known 
diastereomer equilibration conditions developed by Berner and coworkers in 1986 (vide 
supra, Scheme 4). 
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The Herzon synthesis commences with a Cu-catalyzed enantioselective conjugate 
addition-acylation reaction into cyclohexenone 75, followed by methylation that proceeds 
in high enantio- and diastereoselectivity, respectively, to afford b-keto ester 76 (Scheme 
12).58 Deprotonation and trapping of the resultant enolate with N-phenyltriflimide 
furnished vinyl triflate 77, which was then converted to dienone 78 via a Pd-catalyzed 
carbonylative coupling.59 Cu-catalyzed Nazarov cyclization delivered hydrindanone 79 as 
a single olefin isomer. A Nagata hydrocyanation60 was next performed on hydrindanone 
79 to afford the C9 addition product in 3:1 dr; however, because this reaction forged the 
undesired trans-ring junction, subsequent epimerization with sodium hydroxide was 
necessary to access 80. Ketal protection of ketone 80 provided 81.  
 
Reagents and conditions: a) Zn(Me)3, Cu(OTf)2 (0.5 mol %), ligand (1.0 mol %), PhMe, 0 ºC, then MeLi, –
78 ºC, then methylcyanoformate, –78 ºC; b) MeI, NaOtBu, MeOH, 0 ºC, 71%; c) KHMDS, PhNTf2, THF, –78 
ºC, 88%; d) CO, tetravinyltin, LiCl, Pd(PPh3)4 (5 mol %), DMF, 40 ºC e) Cu(OTf)2 (5 mol %), (CH2Cl)2, 70 ºC; 
f) Et2AlCN, THF, 0 ºC, then DIBAL, –78 ºC; g) 0.01 M NaOH, MeOH/H2O (5:1), 0 ºC, 65%; h) TMSOTf, 
(TMSOCH2)2, CH2Cl2, 30 ºC; i) MeLi, PhMe, 0 ºC, then Boc2O, 0 ºC, 80%. 
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It was reported that selective functionalization of the C9 nitrile was challenging due 
to steric congestion; however, it was ultimately found that treatment with excess 
methyllithium, followed by di-tert-butyl dicarbonate, provided cyclic enimide 84. This 
cascade is likely to occur through methyllithium addition to the nitrile, followed by 
intramolecular cyclization onto the C5 methyl ester and deprotonation to form intermediate 
83. Final N-acylation would forge their key enamide intermediate 84, setting the stage for 
the key two-fold neopentyl fragment coupling.  
In the key sequence to form the eight-membered ring, addition of the organolithium 
derived from iodoether 85 to enimide 84 resulted in addition at C14; in situ hydrolysis of 
the resulting lithioenamine provided methyl ketone 86 (Scheme 13). It was noted that 
electronic activation of the C14 carbonyl group and minimization of nearby nonbonded 
interactions via the cyclic enimide was critical for the success of the reaction.  
 
Reagents and conditions: a) tBuLi, 85, Et2O, –45 ºC, then 84, –45 ºC, then HCl, THF, 0 ºC, 48%; b) KHMDS, 
Comin’s reagent, THF, –78 ºC, 81%; c) DDQ, CH2Cl2, pH 7 buffer, 20 ºC; d) DMP, CH2Cl2, 20 ºC, 83% (2 
steps) 
 
Scheme 13. Herzon’s synthesis of reductive cyclization precursor 88. 
Formal dehydration of methyl ketone 86 through base-induced elimination of a transiently-
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furnished aldehyde 88, setting the stage for an exo-selective reductive cyclization for the 
construction of the central eight-membered ring.  
The authors envisioned that the limited number of rotatable bonds along the nascent 
macrocycle would lower the entropic penalty of ring closure while enhancing regio- and 
stereocontrol. Furthermore, it was proposed that the presence of the sp2-hybridized carbon 
atoms at C10 and C14 of 88 would alleviate transannular nonbonding interactions in the 
eight-membered ring. Using a nickel-based catalyst, a single diastereomer of an allylic silyl 
ether was formed and desilylated to provide tricycle 89 in high diastereo- and 
regioselectivity (Scheme 14). Interestingly, their attempts to perform the Ni-catalyzed 
reductive cyclization on the substrate bearing the correct C12 stereochemistry resulted in 
tetracycle 91 formation. Thus, their strategy for accessing (+)-pleuromutilin (1) with the 
correct stereochemistry in place at C12 was thwarted, forcing them to proceed through the 
12-epi cyclization substrate 89. 
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Completion of their synthesis required five subsequent transformations. Dess-
Martin oxidation of the C11 alcohol to the enone and conjugate reduction with SmI2 
afforded the C10 methyl with complete site- and stereoselectivity. (+)-12-epi-mutilin (94) 
and (+)-11,12-di-epi-mutilin (95) were then formed as a thermodynamic 3:1 mixture of 
diastereomers upon single-electron reduction with excess sodium; the two mutilin 
diastereomers were brought forward to form several stereochemical pleuromutilin 
derivatives (Scheme 15). 
 
Reagents and conditions: a) DMP, CH2Cl2, 20 ºC; b) SmI2, THF, MeOH, 20 ºC, 98% (2 steps); c) Na, EtOH, 
20 ºC, then HCl, H2O, MeOH, THF, 20 ºC, 52%; d) HCl, H2O, MeOH, THF, 20 ºC, 96% for 94, 81% for 95. 
Scheme 15. Herzon’s synthesis of (+)-12-epi-mutilin (94) and (+)-11,12-di-epi-
mutilin (95).  
 Pressing forward, Herzon and coworkers found that the isolated mutilin 
diastereomers 94 and 95 could be elaborated to their respective pleuromutilin derivatives. 
It was also found that (+)-12-epi-mutilin (94) could be epimerized at C12 and advanced to 
(+)-pleuromutilin (1) through a three-step procedure (Scheme 16). Following Procter’s 
protocol (vide supra, Scheme 11), trifluoroacetyl protection of C11 and O-acylation of C14 
with trifluoroacetylglycolic acid, followed by in situ methanolysis of the trifluoroacetyl 
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(+)-11,12-di-epi-mutilin (95) for the synthesis of (+)-11,12-di-epi-pleuromutilin. Because 
(+)-12-epi-mutilin (94) is en route to (+)-pleuromutilin (1), their synthesis of the natural 
product was made possible by epimerization conditions developed by Berner and 
coworkers (vide supra, Scheme 4). Trifluoroacetyl protection of C11, followed by trityl-
protected glycolic ester installation and methanolysis furnished trityl-protected (+)-12-epi-
pleuromutilin derivative 97, where treatment with zinc-mediated conditions to effect 
equilibration at C12 via a retro-allylation/allylation sequence afforded (+)-pleuromutilin 
(1) in 33% yield, with the major isomer formed being (+)-12-epi-pleuromutilin (96) in 56% 
yield. They were also able to synthesize (+)-11,12-di-epi-pleuromutilin through a similar 
reaction sequence.  
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1.7 CONCLUDING REMARKS 
The mutilins are a class of antibiotics that bind to the peptidyl transferase center of 
the bacterial ribosome. To date, the C14 glycolic ester has served as the focal point of 
optimization of the antibacterial activity, with thousands of C14 analogs having been 
prepared through semisynthesis. However, evidence suggests that the tricyclic core has 
potential for further optimization. For example, epimerization of the C12 quaternary center, 
followed by functionalization of the primary olefin can provide extended spectrum 
antibiotics with activity against Gram-negative and drug-resistant pathogens.61 Ultimately, 
these structural derivatives can only been accessed through development of a de novo 
synthesis of (+)-pleuromutilin. In the following chapter, we will discuss our development 
of a modular and enantiospecific route towards (+)-pleuromutilin (1) and (+)-12-epi-
pleuromutilin.  
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At the outset of our studies towards developing a synthetic route to access (+)-
pleuromutilin (1) and its derivatives, there had only been three prior syntheses reported: 
those of Gibbons,1 Boeckman,2 and Procter.3,4 While these three prior synthetic routes were 
unique in their construction of the tricyclic core, they shared two common features: 1) early 
construction of the central eight-membered ring led to numerous functional group and 
redox manipulations, and 2) all were linear in fashion. In contrast, we initiated a synthetic 
campaign towards developing a modular and convergent total synthesis of (+)-
pleuromutilin (1) that would feature late-stage construction of the eight-membered ring. 
This chapter will outline the synthetic strategies attempted that ultimately enabled an 18-
step total synthesis of (+)-pleuromutilin and (+)-12-epi-pleuromutilin.  
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2.2 RETROSYNTHETIC ANALYSIS 
In considering a design plan for a synthesis of (+)-pleuromutilin (1), we envisioned 
a modular approach in which a hydrindane fragment (e.g., 2 and 4) would be annulated to 
form the eight-membered ring through two sequential C–C bond-forming steps. This 
proposed annulation could occur through two different approaches: 1) C5–C14 and C10–
C11, or 2) C5–C14 and C11–C12. Either disconnection links vicinal stereogenic centers 
which were identified as strategic points of disconnection. 
 
Scheme 1. Conceptual retrosynthetic analysis. 
With this modular annulation strategy in mind, (+)-pleuromutilin (1) was first 
simplified to 6 via disconnecting the C14 glycolic ester (Scheme 2). Considering that the 
previously reported syntheses construct the tricyclic core at a very early stage, it was 
envisioned that C5–C14 could be forged through a diastereoselective samarium diiodide 
mediated cyclization reaction of aldehyde 7 to construct the eight-membered ring of 
pleuromutilin (1) at a late stage in the synthesis. This strategy would minimize the number 
of redox manipulations upon construction of the core, as well as leverage the constrained 
molecular geometry of the cyclization precursor to dictate the stereoselectivity of the 
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Scheme 2. Construction of eight-membered ring. 
 Preparation of cyclization precursor was envisioned to arise through a fragment 
coupling reaction between a hydrindanone fragment (e.g., 8 and 10, Scheme 3) with its 
respective coupling partner (e.g., 9 and 11). At the outset of the retrosynthetic design, two 
different disconnections were identified: 1) C10 and C11 could be joined through the use 
of hydrindanone 8 as a nucleophile (e.g. Nozaki-Hiyama-Kishi reaction)5–7 and 2) C11 and 
C12 could be joined through the use of hydrindanone 10 as an electrophile (e.g. crotylation 
reaction)8–10. Both strategies would allow for diversification of the eight-membered 
backbone through variation of the coupling partner. As a means to investigate the 
feasibility of both coupling strategies, both hydrindanones could be prepared from alkyne 
12.  
 
Scheme 3. Two fragment coupling approaches. 
 The oxidation pattern of alkyne 12 (Scheme 4) could be obtained through a methyl 












































































Chapter 2 – Total Synthesis of (+)-Pleuromutilin and (+)-12-epi-Pleuromutilin 38 
envisioned to arise through a conjugate alkynylation and aldol cyclization from 
cyclohexenone 14, which, in turn, would be accessible from chiral methyl cyclohexenone 
15. 
 
Scheme 4. Hydrindenone alkyne 12 retrosynthesis. 
2.3 CYCLOOCTANE FORMATION 
Medium-ring construction is a centerpiece of prior art towards (+)-pleuromutilin, 
perhaps best exemplified by the highly stereoselective anionic oxy-Cope rearrangement 
employed by Boeckman and the chelation-controlled aldol cyclization key to Proctor’s Sm-
ketyl radical cyclization cascade (16, Figure 1).3,4 Both strategies employ minimally-
functionalized cyclization substrates and subsequently leverage the resulting tricyclic 
architecture to install remaining stereocenters in laborious 18 to 25-step sequences. An 
important difference, however, lies in the constrained nature of Boeckman’s vinyl carbinol 
precursor, critical for dictating the stereochemical outcome of the key anionic oxy-Cope 
cyclization. Proctor’s cyclization substrate lacks this rigidity and instead relies on chelation 
control to dictate cyclization. We envisioned a hybrid, convergent strategy leveraging both 
the innate functionality of a highly decorated, geometrically constrained cyclization 
precursor to guide medium-ring formation as well as the propensity of ketyl radicals 
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In accordance with this logic, SmI2 cyclization of 17 was expected to provide 
tricycle 6 with C3, C14, and C15 in the correct oxidation states for advancement to 1. 
 
Figure 1. Comparison of SmI2 approaches to pleuromutilin (1) framework.  
2.4 FORWARD SYNTHETIC EFFORTS 
2.4.1 First Generation Approach Towards Hydrindanone 
Fragment 
Synthetic efforts towards (+)-pleuromutilin (1) commenced with preparation of 
hydrindanone alkyne 12. Recognizing that (+)-dihydrocarvone (18) may serve to provide 
the C6 methyl stereocenter present in (+)-pleuromutilin (1), this material was subjected to 
a one-pot ozonolysis-oxidation procedure developed by Schreiber and coworkers.11,12 
Ozonolysis of the terminal alkene in methanol generated methoxy hydroperoxide 19 
(Scheme 5). Single-electron transfer of an electron from iron(II) sulfate to the peroxide 
produced oxy radical 20. Collapse of this tetrahedral intermediate led to formation of a 
carbon radical that undergoes radical combination with copper(II) acetate to yield alkyl 
copper intermediate 21. Oxidative elimination from this intermediate affords a 3:1 mixture 
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Scheme 5. Chiral enone 15 from fragmentation of (+)-trans-dihydrocarvone 18. 
 With enone 15 in hand, investigations toward setting the C9 quaternary center 
commenced. Conjugate addition of the cuprate derived from 23 followed by Pd-catalyzed 
Saegusa-Ito oxidation furnished the trisubstituted enone 14, setting the stage for installation 
of the C9 quaternary center through conjugate addition (Scheme 6).  
In 1974, Corey and coworkers13 developed a nucleophilic ethynyl group equivalent 
24 and were able to perform conjugate additions into a,b-enones; subsequent treatment 
with lead(IV) tetraacetate unmasked the alkyne. Our initial attempts at performing this 
transformation with hexamethylphosphoramide as an additive resulted in no product 
formation; however, use of hexamethylphosphorous triamide instead greatly improved the 
reactivity, affording 25 as a 2.6:1 mixture of separable diastereomers in 58%. According 
to Corey and coworkers,14 the insolubility of cuprous acetylides can often lead to reaction 
complications. This can be overcome through addition of superstoichiometric amounts of 
trialkyl- or triarylphosphines to the cuprate. However, tertiary phosphines are often 
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water-soluble phosphine, such as hexamethylphosphorus triamide. Pressing forward with 
vinyl stannane 25, treatment with lead(IV) tetraacetate afforded alkyne 26 in 88% yield. 
 
Scheme 6. Installation of the C9 quaternary center. 
 Alkyne 26 was elaborated to bicycle 13 through an acid-promoted intramolecular 
aldol condensation (Scheme 7). Treatment with 6 N HCl led to epimerization of the C6 
stereocenter, giving rise to a 4:1 mixture of inseparable methyl diastereomers that were 
separated at the vinyl iodide (8) stage in the synthesis. Advancing 13 as a diastereomeric 
mixture, cerium-promoted 1,2-methyl addition15 followed by Dauben oxidative 
transposition16 afforded key hydrindanone alkyne 12. Thus, fragment coupling 
investigations began. 
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2.4.2 Fragment Coupling Investigations 
Hydrindanone alkyne 12 was identified as an intermediate that would enable access 
to both vinyl iodide 8 and enal 10 for fragment coupling investigations. Iodoboration17,18 
followed by proto-deboration afforded vinyl iodide 8 in 94% yield. Subsequent palladium-
catalyzed reductive carbonylation afforded hydrindanone enal 10 (Scheme 8). With 
hydrindanone coupling partners 8 and 10 in hand, the first of two key C–C bond 
construction required to form the bridging eight-membered ring was investigated.  
 
Scheme 8. Hydrindanone alkyne 12 derivatization for fragment coupling. 
 Preliminary Nozaki-Hiyama-Kishi reaction investigations with pentanal 27 
produced none of the coupled product; instead, hydrodehalogenation 28, homocoupled 
hydrindanone 29, and starting material 8 were observed (Table 1). It appeared that vinyl 
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Table 1. Nozaki-Hiyama-Kishi addition investigations.  
 Precedent from Szabó and coworkers19 suggested that crotylation would be a 
reliable method for forming congested vicinal stereocenters. As such, attention was turned 
towards synthesis of crotylation fragment 35 (Scheme 9). Trityl protection of butynol 30 
afforded 31 in reasonable yield. Deprotonation and nucleophilic addition into ethyl 
chloroformate furnished ynoate 32, which upon conjugate addition with methyl cuprate 
and reduction with DIBAL-H provided allylic alcohol 34. Treatment with palladium- 
catalyzed conditions for allylicboronic acid synthesis20 afforded Z-allylic boronic acid 35, 


























1 4 0.2 – DMF (0.05 M) – 42% 42% –
2 4 0.02 – DMF (0.05 M) – 37% 35% –
3 9 1 – THF/DMF/4-tBuPy
(6:3:1, 0.05 M)
– 28% 30% –
4 3.4 0.2 3.4 THF (0.1 M)/
Et3N (3.4 equiv)
52% 23% – –
5 3 1 3 THF (0.05 M)/
Et3N (3 equiv)
91% 6% – –
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Scheme 9. Crotylation fragment 35 prepapration. 
 With enal 10 and Z-allylic boronic acid 35 in hand, use of conditions developed by 
Szabó and coworkers provided a mixture of separable diastereomers 36 and 37 (Scheme 
10).  
 
Scheme 10. Crotylation reaction and rationale for poor facial selectivity. 
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While the reaction proceeded with excellent selectivity for syn crotylation–consistent with 
a closed transition state, the catalyst did not discriminate between the faces of the aldehyde 
during the nucleophilic attack (Scheme 10). A brief investigation of alternative catalytic 
asymmetric crotylation conditions proved unfruitful (Table 2, Entries 2–4), and thus 
prompted further catalyst investigations. An initial survey of chiral phosphoric acids and 
PyBOX ligands yielded no product, and thus our efforts were focused on BINOL ligands. 
Use of the S catalyst (Table 2, Entry 5) provided a 1:1.4 mixture of 36 and 37. It was 
ultimately determined that 3,3’-(CF3)2-(R)-BINOL (Table 2, entry 7) provided a yield 
comparable to that of 3,3’-Br2-(R)-BINOL with slightly improved diastereoselectivity. 
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 In the first generation retrosynthesis, the initial motive for targeting hydrindanone 
alkyne 12 was to access both vinyl iodide 8 and enal 10. Therefore, the route was optimized 
for hydrindanone alkyne 12, not the desired coupling partner 10. After determining that the 
key fragment coupling to forge the C11–C12 bond would proceed through a crotylation 
reaction between boronic acid 35 and enal 10, attention was turned towards the 
development of a streamlined second generation synthesis of enal 10.  The reasons  the 
first generation route needed to be redesigned were three-fold: 1) Conjugate addition using 
mixed cuprate 24 proceeded in poor 2:1 dr and necessitated the use of toxic tin reagents 
that were not amenable to large-scale material throughput (Scheme 11). 2) Acid-promoted 
aldol cyclization of 26 furnished 13 in reasonable yield; however, the reaction conditions 
also resulted in C6 epimerization to a mixture of inseparable diastereomers. 3) The reagent 
used for iodoboration (B-I-9-BBN) was not reliably available for purchase and attempts to 
freshly prepare the reagent led to irreproducible results. With these targeted issues in mind, 
attention was shifted toward developing a new route towards hydrindanone enal 10. 
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Scheme 11. Reasons for route redesign. 
2.4.3 Second Generation Approach Towards Hydrindanone 
Fragment 
After evaluating the first generation ten-step route towards hydrindanone enal 10, 
it was realized that many of the issues stemmed from installation of an alkyne at C9. In the 
initial substrate design, it was envisioned that targeting hydrindanone alkyne 12 would give 
access to both vinyl iodide 8 and enal 10 for fragment coupling investigations. However, 
validation of the crotylation reaction with enal 10 led to designing a more efficient 
synthetic route towards hydrindanone enal 10. 
Beginning from trisubstituted enone 14, conjugate addition of in situ generated 
vinylcuprate afforded 41 in 73% yield and 6:1 dr, a three-fold improvement from the 2:1 
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dr observed from vinylstannane 24 (vide supra, Scheme 12). This diastereoselectivity 
presumably arises from trans-diaxial effects to minimize the twist-boat conformation that 
would arise from formation of the undesired diastereomer. With this significant 
improvement in diastereoselectivity, a two-step procedure to elaborate 41 to alkyne 26 was 
developed, obviating the need to proceed through the previous route. Ozonolytic cleavage 
of the installed olefin furnished aldehyde 42.  
Initial attempts to convert the aldehyde to alkyne 26 resulted in a more rapid 
intramolecular aldol cyclization to forge [2.2.1]-bicycle 43. It was suspected that the high 
concentration of methoxide in solution led to unselective reactivity for a-deprotonation. 
This was further supported by solvent investigations; in exchanging methanol for less 
acidic solvents such as ethanol and isopropanol (Scheme 12, entries 2 and 3), decreased 
formation of aldol product 43 was observed; however, the reaction rate also slowed 
considerably where the use of isopropanol as the solvent led to no formation of the desired 
product. Solvent mixture investigations ultimately proved fruitful, where tetrahydrofuran-
methanol mixtures (Scheme 12, entries 5 and 6) significantly improved yields of the 
desired alkyne 26 while minimizing bicycle 43 formation. 
Chapter 2 – Total Synthesis of (+)-Pleuromutilin and (+)-12-epi-Pleuromutilin 49 
 
Scheme 12. Intercepting alkyne 26 through vinyl conjugate addition. 
 Despite improving the diastereoselectivity of the conjugate addition reaction from 
2:1 to 6:1 and eliminating the use of vinyl stannane 24, the new route was unsatisfactory 
for three reasons: 1) obtaining the alkyne prior to cyclization would still furnish an 
inseparable mixture of diastereomers, 2) proceeding through the alkyne still necessitated 
the use of B-I-9-BBN, whose commercial availability was unreliable, and 3) utilizing the 
new route was one step longer than the first generation route (Scheme 13). Due to these 
shortcomings, additional conjugate addition investigations were pursued.  
 It was later envisioned that addition of an isopropenyl unit would obviate the need 
for homologation at a later stage by incorporating all the carbons present within the enal 
fragment. Initial attempts to add a hydroxyisopropenyl fragment were unfruitful. However, 
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2 EtOH 26% 30% 16%
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5 MeOH/THF (1:1) 46% 31% 0%
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Scheme 13. Isopropenyl conjugate addition. 
 At this stage, acid-promoted aldol cyclization from conjugate addition product 45 
was attempted but unsuccessfully due to the formation of a halo-Prins product 47 (Scheme 
14). It is hypothesized that the electron-rich nature of the isopropenyl unit was the source 
of this undesired reactivity.  
 
Scheme 14. Undesired halo-Prins cyclization. 
 Efforts were then steered towards installing an electron-withdrawing substituent at 
the allylic position; however, attempts to perform an allylic oxidation yielded starting 
material. Although hydroxyl group installation was unsuccessful, allylic chlorination with 
trichloroisocyanuric acid21 proceeded smoothly, setting the stage for the previously 
unsuccessful acid-promoted aldol cyclization with 45 (Scheme 15). Indeed, installation of 
the allylic electron-withdrawing substituent deactivated the previously electron-rich olefin,  
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unit did not minimize the amount of C6 epimerization or influence the diastereomeric ratio; 
however, the previously inseparable diastereomers were now separable at this stage, 
affording a 52% yield of the desired diastereomer 49. Elaboration to 51 proceeded via 
similar conditions to those established for the first generation route.  
 
Scheme 15. Successful aldol cyclization with allylic chloride 48. 
 Pressing forward, a 1,2-methyl addition assisted by the use of CeCl3·2LiCl15 was 
performed to furnish tertiary allylic alcohol 50, followed by treatment with pyridinium 
chlorochromate to affect a Dauben oxidative transposition16 to reveal the desired 
hydrindanone oxidation pattern 51, setting the stage for investigations of the final key 
oxidation to deliver hydrindanone enal 10 (Scheme 16). 
 
Scheme 16. Synthesis of final hydrindanone enal precursor. 
 Preliminary attempts to oxidize allylic chloride 51 to enal 10 via Ganem and 
Kornblum oxidation22–25 conditions gave low yields. While reactions performed under 
microwave irradiation in the presence of silver carbonate afforded moderate yields, scaling 
to decagram quantities proved impractical. Further exploring Kornblum oxidation 
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salts gave modest yields (Scheme 17). It is suspected that this reaction first undergoes a 
Finkelstein displacement of the allylic chloride with iodide. Subsequent iodide 
displacement by dimethylsulfoxide and deprotonation would unveil dimethylsulfide and 
product. Through these new conditions that were more amenable to scale, the key coupling 
fragment was obtained in 69% yield. This vastly improved nine-step synthesis delivered 
10 in 18% yield from commercial starting materials (compared to our first generation 10 
step, 11% yielding route). 
 
Scheme 17. Modified Kornblum oxidation. 
2.4.4 Elaboration to SmI2-Cyclization Precursor 
Once a streamlined second generation route to access hydrindanone enal 10 was 
established and the crotylation reaction had been validated for coupling fragments 10 and 
35 together, a three-step route that involved methoxymethyl protection, trityl deprotection, 
























Chapter 2 – Total Synthesis of (+)-Pleuromutilin and (+)-12-epi-Pleuromutilin 53 
 
Scheme 18. Synthesis of SmI2-cyclization precursor 56. 
2.4.5 SmI2-mediated Cyclization Investigations 
At this stage, attention was turned towards the second key C5–C14 bond 
construction step: a SmI2-mediated cyclization to forge the central eight-membered ring. It 
was envisioned that this reaction would occur through generation of ketyl radical 57, 
followed by cyclization onto the enone to generate samarium enolate 58, and protonation 
to reveal the tricyclic core of pleuromutilin (Scheme 19).  
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 Initial attempts in constructing the tricyclic core resulted in ketoacid 61 (Scheme 
20), the structure of which was confirmed by single-crystal X-ray diffraction. We 
hypothesized that this product arose from exposure of the SmIII-enolate to trace oxygen in 
solution, resulting in hydroperoxide 60 formation and subsequent oxidative ring scission 
to deliver the fragmented ketoacid product. Although the ring scission was deleterious, this 
was nonetheless the first indicator that the desired C5–C14 bond formation had occurred 
with high diastereoselectivity.  
 
Scheme 20. C5–C14 bond formation with undesired oxidative ring scission. 
To prevent unwanted formation of ketoacid 61, a variety of conditions were 
evaluated. Initial optimization studies involved rigorously deoxygenating all components 
of the reaction mixture. Because productive C5–C14 bond formation was occurring, 
attention was focused on investigating alternative quenches and found that TMSCl 
provided a 78% yield on first pass; however, this result was highly variable and contingent 
upon the humidity in the air (Scheme 21). When the reaction was performed under 
rigorously anhydrous conditions, trace amounts of desired tricycle 59 with fragmented 61 
and silylether 62 were isolated, all with 1:1 dr at C14. This observation led to the conclusion 
that water must be a crucial component of the reaction! Upon investigating equivalents of 
water, it was discovered that six equivalents were absolutely crucial for high yields and 
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additives in SmI2 reactions,28 it is postulated that in this particular case, water reacts with 
trimethylsilyl chloride to generate hydrochloride acid in situ, which can then quench the 
samarium enolate before it can react with residual oxygen in solution. Perhaps this is also 
the reason that upon addition of water, formation of silyl ether 62 was no longer observed. 
It is also possible that the water is necessary for an organized transition state to make this 
reaction highly diastereoselective.  
 
Scheme 21. Successful construction of the tricyclic core. 
2.4.6 C10 Olefin Reduction 
In the initial retrosynthetic analysis, it was envisioned that upon SmI2-mediated 
cyclization to construct the tricyclic core, completion of the synthesis would only require 
two further functional group manipulations: reduction of the C10 olefin and installation of 
the C14 glycolic side chain (Scheme 22). It was not until the tricyclic intermediate was 
obtained that we realized what a challenge selective C10 reduction in the presence of the 
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Scheme 22. Envisioned endgame for the synthesis of (+)-pleuromutilin (1). 
 Standard hydrogenation conditions employing cationic transition metal 
complexes29,30 gave rapid and exclusive reduction of the more sterically accessible C19 
olefin. Instead, attention was turned towards hydrogen atom transfer conditions,31,32 
seeking to leverage the thermodynamic preference for formation of a tertiary carbon-
centered radical over formation of a secondary radical if C19 reduction were to occur. 
Using conditions developed by Shenvi and coworkers,33 diastereoselective reduction of the 
C10 olefin (59) was observed; however, this was met with concomitant oxidation of the 
C14 alcohol to the undesired ketone (65) in a redox-relay type process (Scheme 23). Only 
trace products arising from competing C19–C20 vinyl reduction were observed.  
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To test whether this reaction proceeds through a transannular [1,5]-hydrogen atom 
transfer process, deuterium-labeled tricycle 68 was prepared through a four-step protocol 
(Scheme 24). First, Pinnick oxidation34,35 of aldehyde 56 to the carboxylic acid, followed 
by reduction with lithium aluminum deuteride afforded deuterated reduction product 66. 
Oxidation of the alcohol using conditions developed by Stahl and coworkers26 afforded 
deuterated aldehyde 67, which was smoothly converted to deuterated tricycle 68 using the 
previously optimized SmI2-mediated cyclization conditions. Exposure to the optimized 
1,5-hydrogen atom transfer conditions led to formation of diketone 69 as a single 
diastereomer with complete transfer of the deuterium label. The observation that substrates 
in which the C14 alcohol is protected perform poorly under hydrogen atom transfer 
conditions suggests that cleavage of the O–H bond to form the C14 ketone serves as a 
driving force for this transformation. 
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2.4.7 Completing the Synthesis of (+)-Pleuromutilin 
Although reduction of the C10 olefin using hydrogen atom transfer conditions was 
successful, the resulting C14 ketone presented a new set of challenges. Ultimately, 
selective reduction of the C14 ketone in the presence of the C3 ketone proved to be 
untenable due to the more sterically encumbered nature of the C14 ketone. To circumvent 
performing a selective reduction, triisopropylsilyl (TIPS) enol ether 70 was prepared and 
submitted to the previously optimized 1,5-hydrogen atom transfer conditions to obtain 
ketone 71 as a single diastereomer (Scheme 25). To complete the synthesis, 71 was exposed 
to excess lithium in ammonia to furnish alcohol 72 as a separable 14:1 mixture of 
diastereomers. This selectivity arises from the alcohol being placed in the pseudoequatorial 
position upon reduction. Subsequent one-pot acylation with 2-(2,2,2-trifluoroacetoxy)-
acetic acid4 followed by trifluoroacetate methanolysis and acidic hydrolysis affected global 
deprotection to deliver (+)-pleuromutilin (1). 
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2.5 EFFORTS TOWARD NOVEL ANALOGUES 
A key design aspect of the strategy described was the ability to easily vary the 
stereochemistry of the cyclization substrates at C11 and C12. Given the recent interest in 
derivatives of C12-epi-mutilin as broad spectrum antibiotics,36 it was envisioned that the 
12-epi-mutilin framework could be prepared using our synthetic route. 
When enal 10 was subjected to crotylation with Z-boronic acid 35, diastereomers 
36 and 37 (the 11,12-bis-epi variant) were observed as a 1.2:1 mixture. When enal 10 was 
subjected to crotylation with E-boronic acid 73,  diastereomers 74 (12-epi) and 75 (11-epi) 
were formed in 85% yield and 2:1 dr (Scheme 26).  
 
Scheme 26. Crotylation to access stereochemical analogues. 
Elaboration of 74 (12-epi) to  (+)-12-epi-pleuromutilin 82 was straightforward and 









































































a) Crotylation with Z-boronic acid
b) Crotylation with E-boronic acid
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diastereoselectivity as it did for the natural system and the 1,5-hydrogen atom transfer 
smoothly afforded the reduced product 81 (Scheme 27). Ketone reduction, glycolic ester 
installation, and global deprotection afforded (+)-12-epi-pleuromutilin (82). 
 
Scheme 27. Synthesis of (+)-12-epi-pleuromutilin. 
 However, attempts to cyclize any of the 11-epi-isomers revealed that the C11 
stereochemistry exerts a pronounced effect on the reactivity. Subjection of 37 to the SmI2-
mediated cyclization conditions provided tricycle 83 as the major product in 20% yield 
(Scheme 28). It is suspected that conformational gearing to minimize A1,2 strain at C11 
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84. Subsequent Dowd-Beckwith rearrangement proceeding through cyclopropane 85 
delivers the product bearing a bridgehead olefin. Attempts to cyclize 75 (11-epi) also led 
to an analogous product.  
 
Scheme 28. Cyclization of 7 (11,12-bis-epi). 
2.6 CONCLUDING REMARKS 
Herein, a modular synthesis of (+)-pleuromutilin and (+)-12-epi-pleuromutilin has 
been disclosed and each was completed in 18 steps (longest linear sequence) from (+)-
trans-dihydrocarvone. These syntheses were enabled by a modular approach that employed 
a highly diastereoselective SmI2-mediated radical cyclization to form the eight-membered 
ring. In addition, a transannular [1,5]-hydrogen atom transfer that affects a stereospecific 
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route will enable the design and synthesis of new fully synthetic variants of mutilin 
antibiotics. 
2.7 EXPERIMENTAL SECTION 
Materials and Methods 
Unless otherwise stated, reactions were performed under an inert atmosphere (Ar) 
with freshly dried solvents utilizing standard Schlenk techniques. Glassware was oven-
dried at 120 °C for a minimum of four hours, or flame-dried utilizing a Bunsen burner 
under high vacuum. Tetrahydrofuran (THF), methylene chloride (CH2Cl2), diethyl ether 
(Et2O), benzene (PhH), and toluene (PhMe) were dried by passing through activated 
alumina columns. Absolute ethanol (200 Proof) was purchased from Koptec. Methanol 
(HPLC grade) was purchased from Fisher Scientific. Anhydrous ammonia (NH3) was 
purchased from Matheson Tri-Gas. N,N-diisopropylethylamine (iPr2NEt), triethylamine 
(Et3N), methanol (MeOH), isopropanol (iPrOH), tert-butanol (tBuOH), and trimethylsilyl 
chloride (TMSCl) were distilled over calcium hydride prior to use. Unless otherwise stated, 
chemicals and reagents were used as received. All reactions were monitored by thin-layer 
chromatography using EMD/Merck silica gel 60 F254 pre-coated plates (0.25 mm) and 
were visualized by UV (254 nm), p-anisaldehyde, and/or KMnO4 staining. Flash column 
chromatography was performed using silica gel (SiliaFlash® P60, particle size 40-63 
microns [230 to 400 mesh]) purchased from Silicycle. 1H and 13C NMR spectra were 
recorded on a Bruker Avance III HD with Prodigy Cryoprobe (at 400 MHz and 101 MHz, 
respectively) or a Varian Inova 500 (at 500 MHz and 101 MHz respectively) and are 
reported relative to internal CHCl3 (1H, δ = 7.26) and CDCl3 (13C, δ = 77.0). Data for 1H 
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NMR spectra are reported as follows: chemical shift (δ ppm) (multiplicity, coupling 
constant (Hz), integration). Multiplicity and qualifier abbreviations are as follows: s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad, app = apparent. IR 
spectra were recorded on a Perkin Elmer Paragon 1000 spectrometer and are reported in 
frequency of absorption (cm–1). HRMS were acquired from the Caltech Mass Spectral 
Facility using fast-atom bombardment (FAB), electrospray ionization (ES+-TOF) or 
electron impact (EI). Optical rotations were measured on a Jasco P-2000 polarimeter using 
a 100 mm path-length cell at 589 nm.  
 Reagents were purchased from commercial vendors as follows: 2-(2-bromoethyl)-
1,3-dioxane was purchased from TCI America. Palladium(II) acetate (Pd(OAc)2, >99%), 
copper(I) iodide (CuI, 99.999%), and tetrakis(acetonitrile)palladium(II) tetrafluoroborate 
(Pd(CH3CN)4(BF4)2, >98%) were purchased from Strem Chemicals and stored in a 
nitrogen-filled glovebox. Tetrahydroxydiboron (B2(OH)2, 95%) and copper(I) cyanide 
(CuCN, 99.98%) were purchased from Sigma-Aldrich and stored in a nitrogen-filled 
glovebox. Samarium ingot (99.9% trace rare earth metals basis), tris(2,2,6,6-tetramethyl-
3,5-heptanedionato)manganese(III) (Mn(dpm)3, 97%), phenylsilane (PhSiH3, 97%), 
lithium (wire stored in mineral oil, 99.9% trace metal basis), and tert-butyl hydroperoxide 
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2.7.1 Experimental Procedures 




A flame-dried, 1 L, 3-necked round-bottom flask equipped with a stir bar, reflux 
condenser, addition funnel, and glass stopper was charged with activated magnesium 
turnings (8.02 g, 330.0 mmol, 3 equiv). The atmosphere was exchanged three times with 
argon before addition of THF (40 mL). Added to the rapidly stirred suspension was 1,2-
dibromoethane (3.10 g, 16.5 mmol, 0.15 equiv) dropwise. An exothermic reaction was 
observed, and the suspension became grey. The reaction was cooled to ambient 
temperature, and subsequently, a solution of 2-(2-bromoethyl)-1,3-dioxane (42.9 g, 219.9 
mmol, 2 equiv) in THF (170 mL, 0.64 M) was added dropwise via an addition funnel over 
1 h. Upon completion of addition, the reaction was stirred for an additional 30 min. The 
resulting suspension was filtered via cannula into a flame-dried, 2 L, 2-necked round-
bottom flask equipped with a large stir bar under an atmosphere of argon, and the Grignard 
reagent was diluted with THF (170 mL, 0.64 M). Titration against salicylaldehyde 
phenylhydrazone yielded the concentration of Grignard reagent as 0.38 M. 
The Grignard solution was cooled to –45 °C. Subsequently, a freshly prepared 
solution of CuCN•2LiCl in THF was added via cannula over 20 min. CuCN•2LiCl was 







    CuCN•2LiCl, TMSCl, THF
     –45 ºC, then enone
2. Pd(OAc)2 (10 mol %) 
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2 equiv) in THF (110 mL, 1.0 M w.r.t. CuCN) and vigorously stirred at ambient 
temperature for 1 h. After an additional 20 min, freshly distilled TMSCl (14.3 g, 132.0 
mmol, 1.2 equiv) was added. The reaction became heterogeneous, and stirring was 
difficult. After 10 min, a solution of (R)-enone11,12 15 (12.1 g, 110.0 mmol, 1 equiv) in 
THF (183 mL, 0.6 M) was added via cannula over 30 min. The reaction was stirred for 1 h 
and then quenched with sat. aq. NaHCO3 (10 mL) at –45 °C. After warming to ambient 
temperature, pentane (600 mL) was added, and the suspension was filtered through Celite. 
The volatiles were concentrated under reduced pressure, additional pentane (500 mL) was 
added, and the slurry was filtered through Celite. This process was repeated an additional 
time to afford 38.2 g of a clear oil. 1H NMR (CDCl3) shows desired silyl enol ether along 
with 2-(2-cyanoethyl)-1,3-dioxane. The silyl enol ether was used immediately without 
further purification. 
To a 1 L round-bottom flask equipped with a stir bar was added the silyl enol ether, 
anhydrous DMSO (550 mL, 0.2 M) and Pd(OAc)2 (2.47 g, 11.0 mmol, 10 mol %). The 
mixture was sparged with O2 for 2 h then stirred at ambient temperature for 36 h. At this 
time, 1H NMR analysis showed the ratio of product to remaining silyl enol ether was 11:1. 
Water (700 mL) was added, and the product was extracted into Et2O (4 x 400 mL). The 
combined organic layers were washed with brine (1 x 50 mL), dried over Na2SO4, and 
concentrated under reduced pressure to afford 38.1 g of a viscous, yellow oil.  
Purification was achieved via flash column chromatography on SiO2 [750 g SiO2, 
60 mL fractions, Et2O/hexanes = 40% (1.5 L), 45% (500 mL), 50% (500 mL), 55% (500 
mL), 65% (500 mL), 80% (500 mL)] to afford trisubstituted enone 14 (20.3 g, 90.5 mmol, 
91% yield over 2 steps) as a viscous, clear oil.  
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TLC (25% EtOAc/hexanes): Rf = 0.23 (UV, p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 5.84 (s, 1H, C4), 4.53 (t, J = 5.0 Hz, 1H, C3), 4.09 (ddt, J 
= 10.7, 5.1, 1.3 Hz, 2H, OCH2CH2CH2O), 3.75 (m, 2H, OCH2CH2CH2O), 2.31 (m, 5H, 
C1, C2, C6, C8), 2.05 (m, 2H, OCH2CH2, C7), 1.78 (m, 2H, C1, C2), 1.68 (m, 1H, C7), (d 
sept, J = 13.5, 1.4 Hz, 1H, OCH2CH2), 1.12 (d, J = 6.9 Hz, 3H, C16). 
13C NMR (101 MHz, CDCl3): δ 202.3 (C5=O), 164.5 (C9), 125.1 (C4), 101.2 (C3), 66.9 
(OCH2CH2), 40.8 (C6), 32.3 (C1), 31.9 (C2), 30.8 (C7), 29.3 (C8), 25.7 (OCH2CH2), 15.1 
(C16). 
FTIR (AT-IR): 2857, 2249, 1662, 1375, 1211, 1146, 1079, 1046, 907, 647 cm–1. 
HRMS (FAB+, m/z): calc’d for C13H21O3 [M+H]+ 225.1491, found: 225.1502. 
[𝜶]𝑫𝟐𝟑: +65° (c = 1.055, CHCl3). 
 
Preparation of vinyl stannane 25 
 
A flame-dried, argon-purged, 1 L round-bottom flask equipped with a stir bar was 
charged with trans-1,2-bis(tri-n-butylstannyl)ethylene (61.8 g, 102.0 mmol, 1.9 equiv) and 
THF (270 mL, 0.2 M).  The mixture was cooled to –78 °C, and a 2.42 M solution of n-
BuLi (44.4 mL, 107.4 mmol, 2 equiv) was added dropwise.  The reaction was allowed to 







HMPT (5 equiv), THF
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A separate flame-dried, argon-purged, 1 L bottom flask equipped with a stir bar was 
charged with n-propylethynylcopper (13.3 g, 102.0 mmol, 1.9 equiv), 
hexamethylphosphorous triamide (HMPT, 43.8 g, 268.4 mmol, 5 equiv), and THF (67 mL, 
0.8 M).  The mixture was stirred at rt until all of the polymeric n-propylethynylcopper 
dissolved to give a homogeneous solution (approximately 10 min required).  The solution 
was cooled to –40 °C, and the vinyl lithium-stannyl species prepared above was transferred 
to the n-propylethynylcopper solution via cannula over 30 min.  The resulting mixture was 
cooled to –78 °C and stirred for 45 min before a solution of the chiral enone 14 (12.0 g, 
53.7 mmol, 1 equiv) in THF (54 mL, 1.0 M) was added over 15 min.  The reaction was 
stirred for 30 min then warmed to –40 °C over 15 min.  While cold, the reaction was poured 
into ice-cold saturated aqueous (NH4)2SO4 (100 mL), and the layers were separated.  The 
aqueous layer was back-extracted with Et2O (1 x 50 mL), and the combined organic layers 
were washed with 2% (v/v) H2SO4 (2 x 250 mL).  A black/brown precipitate formed, and 
the mixture was filtered through Celite, dried over Na2SO4, and the volatiles were removed 
in vacuo to afford 95.3 g of a dark red/brown viscous oil. 
The crude reaction was purified via flash column chromatography on silica gel [650 
g SiO2, 60 mL fractions, collected 750 mL forerun, Et2O/hexanes = 15% (1.5 L), 20% (1 
L), 30% (1 L), 40% (500 mL), 50% (1 L)] to afford Bu4Sn, vinyltributylstannane, and 
HMPT (fractions 2–15), minor diastereomer (fractions 17–31), and major diastereomer 25 
(fractions 31–53).  The volatiles were removed in vacuo to afford 8.23 g of minor 
diastereomer and 17.93 g of major diastereomer 25.  1H NMR (CDCl3) shows pure 
diasteromers.  Yield: 90%. Rf (minor diastereomer) = 0.45 (Et2O/hexanes = 30%, 
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visualized with KMnO4). Rf (major diastereomer) = 0.35 (Et2O/hexanes = 30%, visualized 
with KMnO4). 
1H NMR (400 MHz, CDCl3): δ 5.84 (d, J = 19.7 Hz, 1H), 5.56 (d, J = 19.7 Hz, 1H), 4.52 
– 4.38 (m, 1H), 4.08 (ddd, J = 11.5, 4.9, 1.4 Hz, 2H), 3.73 (tdd, J = 12.1, 2.6, 1.2 Hz, 2H), 
2.62 (dd, J = 14.1, 2.1 Hz, 1H), 2.27 – 1.98 (m, 3H), 1.84 (ddt, J = 13.0, 6.3, 3.3 Hz, 1H), 
1.78 – 1.64 (m, 2H), 1.55 – 1.37 (m, 9H), 1.37 – 1.20 (m, 7H), 0.96 (d, J = 6.5 Hz, 3H), 
0.92 – 0.78 (m, 13H). 
13C NMR (101 MHz, CDCl3): δ 212.1, 152.5, 129.3, 102.5, 66.9, 48.6, 47.7, 44.7, 36.8, 
36.0, 30.7, 29.5, 29.1, 27.2, 25.8, 14.4, 13.7, 9.4. 
 
Preparation of alkyne 26 
 
A flame-dried, 1 L bottom flask equipped with a stir bar was charged with major 
diastereomer 25 (17.9 g, 33.1 mmol, 1 equiv) and MeCN (330 mL, 0.1 M). Added to the 
homogenous solution was Pb(OAc)4 (44.1 g, 99.4 mmol, 3 equiv), and the reaction was 
stirred at rt for 72 h, at which time 1H NMR analysis showed complete conversion.  The 
yellowish-white heterogeneous suspension was diluted with pentane (600 mL), filtered 
through Celite, and the volatiles were removed in vacuo.  The oil and white solid obtained 
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were removed in vacuo.  The process was repeated an additional time with 30% 
Et2O/hexanes (100 mL). 
The resulting residue was purified via flash column chromatography on silica gel [450 g 
SiO2, 60 mL fractions, collected 500 mL forerun, Et2O/hexanes = 30% (1 L), 35% (500 
mL), 40% (500 mL), 50% (500 mL), 70% (1 L)] to afford Bu3SnOAc and trace residual 
RSM (fractions 19–31), a faint spot staining in p-anisaldehyde (fractions 35-43), and 
product (fractions 43-68).  The volatiles were removed in vacuo to afford 6.86 g of alkyne 
26 as a viscous, colorless oil.  Yield: 86%.  
 
TLC (50% Et2O/hexanes): Rf = 0.10 (p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 4.58 (t, J = 4.9 Hz, 1H), 4.13 (ddt, J = 10.4, 5.0, 1.4 Hz, 
2H), 3.87 – 3.71 (m, 3H), 2.52 (dd, J = 13.1, 2.6 Hz, 1H), 2.32 (dtd, J = 12.5, 6.2, 1.2 Hz, 
1H), 2.24 (dd, J = 13.1, 1.2 Hz, 1H), 2.17 – 2.00 (m, 2H), 1.96 (dq, J = 12.9, 3.0 Hz, 1H), 
1.89 – 1.78 (m, 3H), 1.72 – 1.62 (m, 3H), 1.37 (dtt, J = 13.5, 2.7, 1.4 Hz, 1H), 1.07 (d, J 
= 6.5 Hz, 3H).	
13C NMR (101 MHz, CDCl3): δ 210.1, 102.0, 85.8, 73.2, 66.9, 52.4, 44.7, 40.8, 36.6, 
36.4, 31.9, 30.3, 25.7, 14.3.	
HRMS (FAB+, m/z): calc’d for C15H21O3 [M+H]–H2 249.1491, found: 249.1482. 





Chapter 2 – Total Synthesis of (+)-Pleuromutilin and (+)-12-epi-Pleuromutilin 70 
Preparation of hydrindanone alkyne 13 
 
A flame-dried, 500 mL bottom flask equipped with a stir bar was charged with 
alkyne 26 (6.86 g, 27.4 mmol, 1 equiv) and THF (137 mL, 0.2 M).  To the homogenous 
solution was added aqueous HCl (13.7 mL of a 6 M solution, 3 equiv).  The system was 
equipped with a reflux condenser, and the reaction was heated to 70 °C.  After 90 min, 
TLC analysis showed complete conversion.  The resulting yellow solution was cooled to 
rt and basified via slow addition of saturated aqueous NaHCO3 (100 mL).  The biphasic 
mixture was transferred to a separatory funnel, and the layers were separated.  The aqueous 
layer was extracted with Et2O (3 x 50 mL), and the combined organic layers were washed 
with brine (1 x 50 mL), dried over Na2SO4, and the volatiles were removed in vacuo 
(rotovap only) to afford a yellow oil. 
The resulting residue was purified via flash column chromatography on silica gel 
(175 g SiO2, Et2O/hexanes = 10%) to afford two faint UV-active spots (fractions 7–12) and 
product 13 (fractions 15-35).  The volatiles were removed in vacuo (rotovap only) to afford 
3.49 g of 13 as a pale yellow oil.  1H NMR (CDCl3) shows pure product as a 4.3:1 mixture 
of diastereomers epimeric at the α-methyl group.  Yield: 73%. Rf = 0.35 (Et2O/hexanes = 
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Preparation of hydrindanone alkyne 12 
 
A flame-dried, 200 mL bottom flask equipped with a stir bar was charged with 
hydrindanone alkyne 13 (2.02 g, 11.6 mmol, 1 equiv).  The atmosphere was exchanged 
with argon three times before adding a solution of CeCl3•2LiCl (0.3 M in THF, 38.6 mL, 
11.6 mmol, 1 equiv).  Upon addition of CeCl3•2LiCl, a bright yellow solution was obtained 
and stirred at rt for 1 h, over which time the reaction became pale yellow.  The mixture was 
then cooled to 0 °C and allowed to equilibrate for 10 min.  Subsequently, a solution of 
methylmagnesium chloride (3.0 M in THF (Aldrich), 7.72 mL, 23.2 mmol, 2 equiv) was 
added dropwise over 10 min, and the reaction was stirred at 0 °C until TLC analysis 
indicated complete consumption of enone 13 (10 min at this scale).  (Note: the separable 
diastereomer has identical polarity to that of starting enone, but while the enone is UV-
active, the separable diastereomer is not; thus TLC analysis may be used to monitor 
reaction progress). 
The resulting dark yellow solution was quenched at 0 °C via slow addition of 1 M 
HCl (25 mL) using a vent needle to relieve excess pressure.  Thereafter, the mixture was 
diluted with H2O (30 mL) and Et2O (50 mL), transferred to a separatory funnel, and the 
layers were separated.  The aqueous layer was extracted with Et2O (3 x 50 mL), the 
combined organic layers were dried over Na2SO4, and the volatiles were removed in vacuo 




    MeMgCl
    THF, 0 ºC
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A flame-dried, 250 mL round-bottom flask equipped with a stir bar was charged 
with PCC (7.83 g, 36.3 mmol, 3 equiv) and CH2Cl2 (36 mL, 0.33 M).  To the heterogeneous 
orange suspension was added a solution of crude allylic alcohol (2.30 g, 12.1 mmol, 1 
equiv) in CH2Cl2 (47 mL, 0.25 M) over 3 min.  The suspension was stirred at rt for 12 h, 
at which time TLC analysis indicated complete conversion. 
Thereafter, the tarry mixture was diluted with Et2O (300 mL) and transferred to a 
separatory funnel.  Added to the tar remaining in the reaction flask was Et2O (150 mL) and 
silica gel (25 g), and the mixture was stirred for 1 h before being filtered over Celite.  The 
resulting solution was combined with the initial reaction mixture.  The combined organic 
layers were washed with 5% NaOH (2 x 100 mL), 5% HCl (1 x 100 mL), saturated aqueous 
NaHCO3 (1 x 100 mL), dried over Na2SO4, and the volatiles were removed in vacuo 
(rotovap only) to afford 1.89 g of a viscous yellow oil. 
Purification was achieved via flash column chromatography on silica gel (80 g 
SiO2, Et2O/hexanes = 10%) to afford a faint UV-active spot with Rf = 0.5 (fractions 7–8) 
and product (fractions 9–20).  The volatiles were removed in vacuo (rotovap only) to afford 
1.51 g of the 12 as a clear, viscous oil.  Yield: 64%.  
 
TLC (10% Et2O/hexanes): Rf = 0.4 (UV, p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 2.63 (ddd, J = 18.0, 13.1, 8.3 Hz, 1H), 2.38 – 2.17 (m, 
3H), 2.17 – 2.07 (m, 5H), 1.89 (ddt, J = 13.4, 6.6, 3.4 Hz, 1H), 1.75 (tdd, J = 13.7, 10.3, 
3.2 Hz, 1H), 1.68 – 1.58 (m, 1H), 1.40 – 1.29 (m, 1H), 1.15 (d, J = 7.1 Hz, 3H).	
13C NMR (101 MHz, CDCl3): δ 206.3, 152.1, 134.1, 88.6, 69.8, 40.5, 37.5, 36.9, 35.8, 
35.5, 29.3, 19.2, 16.8.	
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FTIR (AT-IR): 3285, 2931.24, 2860.32, 2359.59, 1452, 1409, 1370, 1262, 1165, 967, 908 
HRMS (ET+, m/z): calc’ed for C13H16O [M]+ 188.1201, found: 188.1226. 
[𝜶]𝑫𝟐𝟑: –245.4° (c = 0.81, CHCl3). 
 
Preparation of vinyl iodide 8 
 
A flame-dried, 250 mL round-bottom flask equipped with a stir bar was charged 
with the hydrindanone alkyne 8 (645 mg, 3.43 mmol, 1 equiv). The atmosphere was 
exchanged three times with argon and then CH2Cl2 (43 mL, 0.08 M) was added.  The 
homogenous solution was cooled to –20 °C, and a solution of B-I-9-BBN (6.85 mL of a 
1.0 M solution in hexanes, 6.85 mmol, 2 equiv) was added dropwise over 15 min.  The 
yellow solution was stirred for 1 h then warmed to 0 °C and stirred for 1 h. Added to the 
resulting dark red solution was glacial AcOH (2.65 mL, 46.3 mmol, 13.5 equiv) over 2 
min.  The reaction was stirred 30 min at 0 °C then warmed to rt and stirred for 30 min.  
Subsequently, 5% w/w aqueous NaHCO3 (100 mL) was added slowly causing vigorous 
gas evolution, and the biphasic mixture was stirred for 10 min. 
Thereafter, the mixture was transferred to a separatory funnel with CH2Cl2 (50 mL), 
and the layers were separated.  The aqueous layer was extracted with CH2Cl2 (2 x 20 mL), 
and the combined organic layers were washed with 1 M Na2S2O3 (1 x 100 mL), dried over 
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Purification was achieved via flash column chromatography on silica gel (200 g 
SiO2, Et2O/hexanes = 5%) to afford minor diastereomer and bis-iodinated product 
(fractions 19–24) and major diastereomer 8 (fractions 23–36). The volatiles were removed 
in vacuo to afford 631 mg of the product as a clear, viscous oil.  1H NMR analysis revealed 
a 9:1 mixture of diastereomers.  Yield: 58%. 
 
TLC (15% Et2O/hexanes): Rf = 0.4 (UV). 
 
Preparation of hydrindanone enal 10 from vinyl iodide 8 
 
A flame-dried, 250 mL round-bottom flask equipped with a stir bar was charged 
with the hydrindanone vinyl iodide 8 (405 mg, 1.28 mmol, 1 equiv) and anhydrous PhMe 
(32 mL, 0.04 M).  The homogeneous solution was sparged with CO (g) from a double-
walled balloon for 10 min and was subsequently heated to 60 °C.  Stirring and sparging 
was continued at 60 °C for an additional 10 min before adding a solution of Pd(PPh3)4 (104 
mg, 0.0897 mmol, 7 mol %) in anhydrous PhMe (11 mL, 0.11 M) in one portion.  Upon 
addition, the reaction turned brown/black, and sparging was continued for another 5 min.  
Subsequently, the purge needle was placed just above the reaction mixture, and a solution 
of freshly distilled Bu3SnH (485 mg, 1.67 mmol, 1.3 equiv) in anhydrous PhMe (10 mL, 





Pd(PPh3)4 (7 mol %)
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After approximately 5 mL of the Bu3SnH/PhCH3 solution had been added, the reaction 
turned bright yellow and remained as such until addition was complete. 
The reaction was cooled to rt and sparged with argon for 10 min before PhMe was 
removed by distillation under reduced pressure. 
The resulting viscous brown residue was immediately purified via flash column 
chromatography on silica gel (50 g SiO2, Et2O/hexanes = 15%→25%) to afford residual 
[Sn] (fractions 4–7), a bright yellow band (fractions 29–57), and product (fractions 36–57).  
The volatiles were removed in vacuo to afford 293 mg of 10 contaminated with residual 
Pd(PPh3)4.  Given that Pd(PPh3)4 is insoluble in hexanes and the product is soluble in 
hexanes, the yellow solid was triturated with hexanes, filtered, and the volatiles were 
removed to afford 226 mg of the enal 10 as an off-white solid after standing overnight in 
the refrigerator.  Yield: 80%. 
 
TLC (30% Et2O/hexanes): Rf = 0.3 (UV). 
 
Preparation of trityl protected alcohol 31.  
 
A flame-dried, 250 mL round-bottom flask equipped with a stir bar was charged 
with 3-butyn-1-ol 30 (7.01 g, 100.0 mmol, 7.57 mL, 1 equiv), CH2Cl2 (150 mL, 0.67 M), 
and DMAP (2.44 g, 20.0 mmol, 20 mol %). To the homogeneous solution was added Et3N 
(20.2 g, 200.0 mmol, 27.9 mL, 2 equiv) and trityl chloride (27.8 g, 100.0 mmol, 1 equiv). 
The reaction was stirred at ambient temperature for 18 h and H2O (225 mL) was 
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subsequently added. The resultant mixture was extracted with Et2O (3 x 200 mL). The 
combined organic layers were washed with brine (2 x 50 mL), dried over Na2SO4, and 
concentrated under reduced pressure to afford a white solid. 
The solid was dissolved in a minimal volume of CH2Cl2 (30 mL) and purified via 
flash column chromatography on SiO2 (300 g SiO2, Et2O/hexanes = 5%) to afford product 
31 (21.9 g, 70.1 mmol, 70% yield) as a white solid. Spectral data were in complete 
agreement with literature values. 
 
TLC (20% Et2O/hexanes): Rf = 0.73 (UV, KMnO4). 
 
Preparation of ynoate 32 
 
The atmosphere of a flame-dried, 1 L round-bottom flask equipped with a stir bar 
was exchanged three times for nitrogen, then charged with anhydrous THF (180 mL) and 
freshly distilled diisopropylamine (9.58 g, 94.6 mmol, 13.3 mL, 1.35 equiv). The mixture 
was cooled to –78 °C and nBuLi (35.9 mL of a 2.46 M solution, 88.3 mmol, 1.26 equiv) 
was added slowly over 15 min. The solution was stirred at  
–78 °C for 5 min, warmed to 0 °C, stirred 10 min, then cooled back to –78 °C. Thereafter, 
a solution of the trityl-protected substrate 31 (21.9 g, 70.1 mmol, 1 equiv) in anhydrous 
THF (70 mL) was added dropwise over 30 min, and the reaction was stirred for an 
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added over 15 min, and the reaction was stirred for an additional 10 min before being 
warmed to ambient temperature and stirred for 3 h. 
The reaction was quenched via addition of saturated aq. NH4Cl (150 mL) and 
stirred for 10 min. Thereafter, H2O (150 ml) was added, the reaction was extracted into 
Et2O (2 x 150 mL), the combined organic layers were dried over Na2SO4, and concentrated 
under reduced pressure to afford a pale yellow solid. The crude residue was suspended in 
hexanes (80 mL), heated to a boil, additional hexanes (100 mL) was added, and the 
heterogeneous suspension was filtered while hot to remove residual ammonium salts. The 
mixture was re-heated and slowly cooled overnight to afford product 32 (19.6 g, 51.0 
mmol, 73% yield) as white crystals. 
TLC (20% Et2O/hexanes): Rf = 0.52 (UV). 
1H NMR (400 MHz, CDCl3): δ 7.52–7.42 (m, 6H, Ph3CO), 7.34–7.20 (m, 9H, Ph3CO), 
4.25 (q, J = 7.2 Hz, 2H, OCH2CH3), 3.31 (t, J = 6.9 Hz, 2H, C14), 2.63 (t, J = 6.9 Hz, 2H, 
C13), 1.34 (t, J = 7.1 Hz, 3H, OCH2CH3). 
13C NMR (101 MHz, CDCl3): δ 153.7 (C20=O), 143.7 (Ph3CO), 128.6 (Ph3CO), 127.9 
(Ph3CO), 127.1 (Ph3CO), 86.9 (Ph3CO), 86.5 (C12), 74.0 (C19), 61.9 (OCH2CH3), 61.1 
(C14), 20.3 (C13), 14.1 (OCH2CH3). 
FTIR (AT-IR): 2937, 2882, 2243, 1713, 1471, 1377, 1018 cm–1. 
HRMS (FAB+, m/z): calc’d for C26H24O3 [M]+ 384.1726, found 384.1739. 
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Preparation of acrylate 33 
 
In a nitrogen-filled glovebox, a flame-dried 2 L flask equipped with a large stir bar 
was charged with CuI (9.68 g, 50.9 mmol, 1 equiv). Anhydrous THF (390 mL) was 
transferred to the flask via cannula, and the heterogeneous suspension was stirred at 0 °C 
for 20 min. Thereafter, MeLi (64.8 mL of a 1.57 M solution in Et2O, 101.7 mmol, 2 equiv) 
was added dropwise over 25 min during which time the reaction went from a heterogeneous 
brown suspension to a nearly colorless, homogeneous solution. After an additional 5 min 
of stirring, the mixture was cooled to –78 °C and stirred for 20 min prior to dropwise 
addition of alkynoate ester 32 (19.6 g, 50.9 mmol, 1 equiv) in anhydrous THF (130 mL) 
via cannula over 20 min. The reaction was stirred at –78 °C for 2 h then quenched with 
H2O (25 mL) at –78 °C.  
After 10 min, the solution was warmed to ambient temperature, filtered through a 
pad of Celite, and the Celite was rinsed with Et2O (3 x 75 mL). The combined organic 
layers were washed with H2O (2 x 50 mL) and brine (1 x 50 mL), dried over Na2SO4, and 
concentrated under reduced pressure to afford acrylate 33 (19.5 g, 48.7 mmol, 96% yield, 
96:4 Z:E) as a viscous, yellow oil. 
 
TLC (10% Et2O/hexanes): Rf = 0.55 (UV). 
1H NMR (400 MHz, CDCl3): δ 7.48–7.41 (m, 6H, Ph3CO), 7.32–7.19 (m, 9H, Ph3CO), 
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C14), 2.97 (t, J = 6.4 Hz, 2H, C13), 1.90 (d, J = 1.4 Hz, 3H, C18), 1.26 (t, J = 7.1 Hz, 3H, 
OCH2CH3). 
13C NMR (101 MHz, CDCl3): δ 166.2 (C20=O), 157.9 (C12), 144.2 (Ph3CO), 128.7 
(Ph3CO), 127.7 (Ph3CO), 126.8 (Ph3CO), 117.5 (C19), 86.6 (Ph3CO), 62.4 (C14), 59.5 
(OCH2CH3), 33.7 (C13), 26.1 (C18), 14.3 (OCH2CH3). 
FTIR (AT-IR): 2982, 2915, 2873, 1709, 1652, 1489, 1447, 1265, 1194, 1146, 779 cm–1. 
HRMS (FAB+, m/z): calc’d for C17H27O3[(M+H)–H2]+ 399.1960, found 399.1958. 
 
Preparation of allylic alcohol 34 
 
The atmosphere of a flame-dried, 1 L round-bottom flask equipped with a stir bar 
was exchanged three times for argon then charged with acrylate 33 (19.5 g, 48.7 mmol, 1 
equiv) and anhydrous CH2Cl2 (162 mL) and cooled to –78 °C. Subsequently, a freshly-
prepared solution of DIBAL-H (20.8 g, 146.2 mmol, 26.1 mL) in anhydrous hexanes (122 
mL) was added via cannula over 25 min. The resulting light yellow reaction was stirred at 
–78 °C for 2 h. 
The reaction was quenched at –78 °C via slow addition of H2O (30 mL) followed 
by 2 M NaOH (30 mL), stirred 10 min at –78 °C, and warmed to 0 °C. Additional H2O (30 
mL) was added, and the suspension was transferred to a 1 L Erlenmeyer flask containing a 
large stir bar and cooled to 0 °C. Subsequently, anhydrous MgSO4 (100 g) was added 
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min, the slurry was filtered through Celite, the Celite was washed with Et2O (3 x 100 mL), 
and concentrated under reduced pressure to afford a viscous, pale yellow oil. 
Purification was achieved via flash column chromatography on SiO2 [300 g SiO2, 
Et2O/hexanes = 30% → 50%] to afford allylic alcohol 34 (16.2 g, 45.2 mmol, 92% yield) 
as a viscous, colorless oil. 
 
TLC (30% Et2O/hexanes): Rf = 0.30 (KMnO4). 
1H NMR (400 MHz, CDCl3): δ 7.48–7.41 (m, 6H, Ph3CO), 7.32–7.19 (m, 9H, Ph3CO), 
5.59 (t, J = 7.1 Hz, 1H, C19), 4.14 (d, J = 7.1 Hz, 2H, C20), 3.20 (t, J =6.4 Hz, 2H, C14), 
2.37 (t, J = 6.4 Hz, 2H, C13), 1.66 (s, 3H, C18), 1.50 (br m, 1H, OH). 
13C NMR (101 MHz, CDCl3): δ 144.0 (Ph3CO), 137.5 (C12), 128.7 (Ph3CO), 127.8 
(Ph3CO), 127.0 (Ph3CO), 126.1 (C19), 87.0 (Ph3CO), 61.8 (C14), 58.9 (C20), 32.6 (C13), 
23.7 (C18). 
FTIR (AT-IR): 3361 (br), 3057, 2915, 2875, 1596, 1490, 1448, 1265, 1061, 1001 cm–1. 
HRMS (TOF, ES+): calc’d for C25H26O2Na [M+Na]+ 381.1831, found 381.1843. 
 
Preparation of Z-allylic boronic acid 35 
 
This procedure was adapted from the work of Szabó and coworkers.5 In a nitrogen-filled 
glovebox, a flame-dried, 100 mL round-bottom flask equipped with a stir bar was charged 
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mL, 0.4 M). The mixture was stirred until the viscous allylic alcohol dissolved, at which 
time Pd(MeCN)4(BF4)2 (165 mg, 0.373 mmol, 5 mol %) was added, followed by 
tetrahydroxydiboron (801 mg, 8.94 mmol, 1.2 equiv). The reaction was vigorously stirred 
and transformed from a dark orange/red solution to dark green to black within 2 min. After 
stirring for 90 min at ambient temperature, the black mixture was transferred via cannula 
to a 100 mL Schlenk flask, the atmosphere of which had been exchanged with argon three 
times. Degassed PhMe (37.0 mL) was added to the black mixture followed by degassed 
16% aq. NaCl (15 mL). The system was sealed off, shaken, and the layers were separated. 
The organic layer was washed with additional degassed 16% aq. NaCl (3 x 15 mL) to afford 
an organic solution with a black particulate suspension. The suspension was allowed to 
stand for 30 min, during which time the particulates settled. The top solution was 
transferred via cannula to a 100 mL Schlenk tube, the atmosphere of which had been 
exchanged with argon three times, and the tube was pumped into the glovebox where 
naphthalene was added as an internal standard. A 1H NMR sample was prepared in the 
glovebox using dry, degassed CDCl3, and it was determined that [allylicboronic acid] = 
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Preparation of crotylation adducts 36 and 7 
 
This procedure was adapted from the work of Szabó and coworkers.10 In a nitrogen-
filled glovebox, a flame-dried, 100 mL Schlenk flask equipped with a stir bar was charged 
with freshly activated 3 Ǻ molecular sieves (pellets) (1.79 g), allylicboronic acid 35 (25.3 
mL of a 0.18 M solution, 4.47 mmol, 1 equiv), 3,3′-Br2-(R)-BINOL (397 mg, 0.894 mmol, 
20 mol %), freshly distilled tBuOH (1.28 mL, 13.4 mmol, 3 equiv), and a solution of the 
enal hydrindanone 10 (976 mg, 4.47 mmol, 1 equiv) in dry, degassed PhMe (4.5 mL). The 
resulting heterogeneous mixture was sealed, removed from the glovebox, cooled to –30 °C 
for 5 min, then placed in a pre-equilibrated 0 °C bath and stirred. 
After 40 h, the reaction was quenched with MeOH (5 mL), stirred for 5 min, 
filtered, and concentrated under reduced pressure to afford a viscous residue. Purification 
was achieved via flash column chromatography on SiO2 [100 g SiO2, Acetone/hexanes = 
4%→15%] to afford remaining enal (fractions 22–31), the desired diastereomer 36 
(fractions 37–70), and 37 and residual 3,3′-Br2-(R)-BINOL (fractions 71–85). The volatiles 
were concentrated under reduced pressure to afford remaining enal (237 mg, 1.09 mmol, 
24% recovered contaminated with ~5% protodeboronated nucleophile), the desired 
diastereomer 36 (1.03 g, 1.84 mmol, 41% yield), and the more polar diastereomer 
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The 7/BINOL mixture was subjected to flash column chromatography on SiO2 [100 
g SiO2, Et2O/hexanes = 40%] to afford 3,3′-Br2-(R)-BINOL (fractions 1–3) and the more 
polar diastereomer 37 (fractions 23–38). 3,3′-Br2-(R)-BINOL (343 mg, 0.772 mmol, 86% 
recovered) and the more polar diastereomer 37 (972 mg, 1.73 mmol, 39% yield) were 
obtained. Both diastereomers were isolated as puffy white foams. 
 
Experimental Note: It is critical that all operations be carried out in a rigorously oxygen-
free environment. Failure to do so will result in rapid decomposition of the allylicboronic 
acid. 
 
Preparation of vinyl cyclohexanone 41 
 
A flame-dried, 2 L, 2-necked round-bottom flask equipped with a stir bar was 
evacuated and backfilled with argon three times. The flask was charged with CuI (9.27 g, 
48.7 mmol, 1.5 equiv) and THF (325 mL). The suspension was cooled to –78 ºC and stirred 
for 15 min. vinylmagnesium bromide (1.0 M in THF (Aldrich), 97.4 mL, 97.4 mmol, 3 
equiv) was added dropwise via cannula transfer and the solution was stirred for 5 min. The 
reaction was warmed to –25 ºC and stirred for 30 min. Thereafter, the mixture was cooled 
back down to –78 ºC and stirred for 15 min. Trisubstituted enone 14 (7.29 g, 32.5 mmol, 1 
equiv) was dissolved in THF (325 mL) and added dropwise via cannula transfer. The 





–78 ºC → –25 ºC
73%, 6:1 dr O
MeO O
14 41
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mixture was quenched with sat. aq. NH4Cl (400 mL) at –50 ºC and the biphasic solution 
was warmed to ambient temperature. The layers were separated and the aqueous phase was 
extracted with Et2O (3 x 350 mL). The combined organic layers were washed with brine 
(100 mL), dried over MgSO4, and concentrated under reduced pressure to afford a viscous 
oil.  
 Purification was achieved via flash column chromatography on SiO2 [40% 
EtOAc/hexanes → 25% → 50%] to afford vinyl cyclohexenone 41 (4.32 g, 24.4 mmol, 
73% yield) as a clear oil. 
1H NMR (300 MHz, CDCl3): δ 5.47 (ddd, J = 17.7, 11.0, 0.9 Hz, 1H), 5.13 (dd, J = 
11.0, 0.8 Hz, 1H), 4.94 (dd, J = 17.7, 0.8 Hz, 1H), 4.47 (dd, J = 5.0, 3.7 Hz, 1H), 4.11 – 
4.05 (m, 2H), 3.79 – 3.68 (m, 2H), 2.60 – 2.53 (m, 1H), 2.24 (dtd, J = 12.4, 6.1, 1.3 Hz, 
1H), 2.14 (dt, J = 13.9, 1.1 Hz, 1H), 2.14 – 1.97 (m, 2H), 1.87 (ddt, J = 13.0, 6.0, 3.4 Hz, 
1H), 1.72 (ddt, J = 8.7, 3.6, 1.5 Hz, 2H), 1.51 (dt, J = 3.9, 1.3 Hz, 2H), 1.33 (dtt, J = 13.5, 
2.7, 1.4 Hz, 1H), 0.98 (d, J = 6.5 Hz, 3H).	
 
Preparation of aldehyde 42 
 
 A 1 L round-bottom flask equipped with a stir bar was charged with vinyl 
cyclohexanone 41 (7.83 g, 31.0 mmol,  1 equiv), MeOH (62 mL), CH2Cl2 (155 mL), and 
cooled to –78 ºC. The solution was ozonolyzed for 10 min or until complete by TLC 
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sparged with O2 for 20 min, then Ar for 5 min, and quenched with PPh3 (6.24 g, 23.8 mmol. 
1.5 equiv). The suspension was allowed to stir for 3 hours, where it was then concentrated 
under reduced pressure to afford a crude white solid. 
 Purification was achieved via flash column chromatography on SiO2 [40% 
EtOAc/hexanes → 50%] to afford aldehyde 42 (10.6 g, 42.1 mmol, 90% yield). 
1H NMR (400 MHz, CDCl3): δ 9.37 (s, 1H), 4.47 (t, J = 4.8 Hz, 1H), 4.06 (ddt, J = 10.5, 
5.0, 1.4 Hz, 2H), 3.72 (dddt, J = 14.2, 10.4, 2.6, 1.0 Hz, 2H), 2.69 (dd, J = 14.4, 2.5 Hz, 
1H), 2.25 (dddd, J = 12.4, 6.9, 5.9, 1.2 Hz, 1H), 2.15 – 1.89 (m, 4H), 1.84 – 1.38 (m, 6H), 
1.36 – 1.18 (m, 2H), 0.99 (d, J = 6.6 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 209.7, 209.7, 204.0, 204.0, 101.2, 101.2, 66.8, 66.8, 
53.9, 44.9, 44.3, 30.8, 30.6, 30.3, 29.2, 25.6, 14.2. 
HRMS (FAB+, m/z): calc’d for C14H23O4 
[𝜶]𝑫𝟐𝟑: +4.06° (c = 1.16, CHCl3). 
 
Preparation of bicycle 43 
 
 To a 1 dram vial equipped with a stir bar was charged aldehyde 42 (10 mg, 0.039 
mmol, 1 equiv) and MeOH (650 µL) at 23 ºC. Ohira-Bestmann reagent was then added in 
MeOH (650 µL) and the reaction was allowed to stir until complete by TLC analysis. The 
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with Et2O (3 x 1 mL). The combined organic layers were washed with brine (2 mL), dried 
over MgSO4, and concentrated under reduced pressure to afford a clear oil. 
 Purification was achieved via flash column chromatography on SiO2 [70% 
EtOAc/hexanes to afford bicycle 43 (8.3 mg, 0.032 mmol, 83% yield). 
TLC (50% EtOAc/hexanes): Rf = 0.20 (p-anisaldehyde).  
1H NMR (400 MHz, CDCl3): δ 4.60 – 4.52 (m, 1H), 4.11 (ddt, J = 9.6, 4.4, 1.3 Hz, 2H), 
3.83 – 3.71 (m, 2H), 3.48 (d, J = 2.4 Hz, 3H), 2.58 (d, J = 20.6 Hz, 1H), 2.16 – 2.00 (m, 
2H), 1.95 – 1.82 (m, 2H), 1.69 – 1.52 (m, 3H), 1.51 – 1.30 (m, 3H), 1.08 (s, 3H).	
13C NMR (101 MHz, CDCl3): δ 215.6, 102.2, 82.9, 81.3, 67.0, 58.2, 57.2, 50.9, 48.8, 
47.2, 46.9, 45.4, 31.2, 30.8, 29.9, 29.1, 28.5, 27.6, 25.9, 11.3, 11.1.	
 
Preparation of cyclohexanone 44 
 
A flame-dried, 3 L, 2-necked round-bottom flask equipped with a stir bar was 
evacuated and backfilled with argon three times. The flask was charged with CuI (17.6 g, 
92.6 mmol, 1.5 equiv) and THF (617 mL). The suspension was cooled to –78 ºC and stirred 
for 15 min. Isopropenylmagnesium bromide (0.5 M in THF (Aldrich), 371 mL, 185 mmol, 
3 equiv) was added dropwise via cannula transfer and the solution was stirred for 5 min. 
The reaction was warmed to –25 ºC and stirred for 10 min. Thereafter, the mixture was 
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mmol, 1 equiv) was dissolved in THF (617 mL) and added dropwise via cannula transfer. 
The solution was warmed to –50 ºC and stirred for 25 min or until complete by TLC 
analysis. The reaction mixture was quenched with sat. aq. NH4Cl (400 mL) at –50 ºC, and 
the biphasic solution was warmed to ambient temperature. The layers were separated and 
the aqueous phase was extracted with Et2O (3 x 350 mL). The combined organic layers 
were washed with brine (100 mL), dried over MgSO4 and concentrated under reduced 
pressure to afford 18.4 g of a viscous oil.  
 Purification was achieved via flash column chromatography on SiO2 [1400 g SiO2, 
20% EtOAc/hexanes] to afford isopropenyl cyclohexenone 44 (11.64 g, 43.7 mmol, 71% 
yield) as a white solid. 
 
 
Major Diastereomer (44) 
TLC (20% EtOAc/hexanes): Rf = 0.16 (p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 4.93 (br s, 1H, C17), 4.69 (s, 1H, C17), 4.45 (t, J = 4.7 Hz, 
1H, C3), 4.07 (m, 2H, OCH2CH2), 3.72 (m, 2H, OCH2CH2), 2.73 (dd, J = 14.2, 3.0 Hz, 1H, 
C4), 2.20 (app d of septets, J = 6.7, 1.2 Hz, 1H, C6), 2.07 (dd, J = 14.2, 1.0 Hz, 1H, C4), 
2.04 (m, 1H, OCH2CH2), 1.96 (dq, J = 13.8, 3.2 Hz, 1H, C8), 1.83 (m, 1H, C7), 1.65 (m, 
1H, C2), 1.61 (dd, J = 1.2, 0.5 Hz, 3H, C11), 1.59 (m, 1H, C8), 1.46 (m, 1H, C1), 1.41 (m, 
1H, C1), 1.37 (m, 1H, C2), 1.36 (m, 1H, C7), 1.32 (m, 1H, OCH2CH2), 0.97 (d, J = 6.5 Hz, 
3H, C16). 
13C NMR (101 MHz, CDCl3): δ 212.2 (C5=O), 145.7 (C10), 116.0 (C17), 102.3 (C3), 66.9 
(OCH2CH2), 49.8 (C4), 47.7 (C9), 44.8 (C6), 34.8 (C8), 34.5 (C2), 30.4 (C7), 29.5 (C1), 25.7 
(OCH2CH2), 18.9 (C11), 14.5 (C16). 
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FTIR (AT-IR): 2960, 2929, 2853, 1706, 1454, 1239, 1144, 994, 880 cm–1. 
HRMS (FAB+, m/z): calc’d for C16H27O3 [M+H]+ 267.1960, found: 267.1966. 
[𝜶]𝑫
𝟐𝟑: +42° (c = 1.16, CHCl3). 
 
Minor Diastereomer 
TLC (20% EtOAc/hexanes): Rf = 0.27 (p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 4.86 (pent, J = 1.2 Hz, 1H, C17), 4.70 (m, 1H, C17), 4.42 
(m, 1H, C3), 4.06 (ddt, J = 10.5, 5.0, 1.2 Hz, 2H, OCH2CH2), 3.72 (m, 2H, OCH2CH2), 
2.40 (dd, J = 13.3, 2.0 Hz, 1H, C4), 2.35 (m, 1H, C6), 2.32 (m, 1H, C4), 2.07 (tt, J = 13.3, 
5.2 Hz, 1H, OCH2CH2), 1.98 (m, 1H, C7), 1.88 (m, 1H, C1), 1.76 (td, J = 11.5, 4.1 Hz, 1H, 
C1), 1.68 (dd, J = 1.3, 0.8 Hz, 3H, C11), 1.50 (m, 1H, C7), 1.40 (m, 1H, C2), 1.39 (m, 1H, 
C2), 1.37 (m, 1H, C8), 1.35 (m, 1H, C8), 1.30 (m, 1H, OCH2CH2), 1.05 (d, J = 6.7 Hz, 3H, 
C16). 
13C NMR (101 MHz, CDCl3): δ 213.3 (C5=O), 148.8 (C10), 111.9 (C17), 102.3 (C3), 66.9 
(OCH2CH2), 66.8 (OCH2CH2), 50.0 (C4), 46.7 (C9), 44.3 (C6), 31.9 (C1), 30.2 (C7), 29.5 
(C8), 28.2 (C2), 25.7 (OCH2CH2), 19.0 (C11), 14.9 (C16). 
FTIR (AT-IR): 2961, 2930, 2850, 1708, 1635, 1452, 1377, 1143, 994, 880 cm–1. 
HRMS (FAB+, m/z): calc’d for C16H27O3 [M+H]+ 267.1960, found: 267.1949. 
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Preparation of allylic chloride 48 
 
This procedure was adapted from the work of Kumar and coworkers.21 A flame-
dried, 2 L, 2-neck round-bottom flask equipped with a stir bar was charged with activated 
4 Å mol sieves and cyclohexanone 44 (12.06 g, 45.28 mmol, 1 equiv). The atmosphere was 
exchanged three times with argon before adding EtOAc (916 mL, 0.05 M) that had been 
degassed with argon. The resulting colorless solution was cooled to 0 ºC and stirred for an 
additional 10 min. Subsequently, finely ground trichloroisocyanuric acid (TCCA) (10.52 
g, 45.28 mmol, 1 equiv) was added in one portion. The reaction was stirred (900 rpm) for 
10 min or until complete by TLC analysis. The reaction mixture was quenched at 0 ºC with 
sat. aq. Na2S2O3 (150 mL). The biphasic solution was warmed to ambient temperature and 
filtered. The aqueous layer was extracted with EtOAc (4 x 100 mL). The combined organic 
layers were washed with H2O (100 mL), dried over MgSO4, filtered, and concentrated 
under reduced pressure to afford a yellow oil.  
Purification was achieved via flash column chromatography on SiO2 [1400 g SiO2, 
15% EtOAc/hexanes → 30%] to afford allylic chloride 48 (10.52 g, 39.5 mmol, 77% yield) 
as a white solid. 
 
TLC (50% EtOAc/hexanes): Rf = 0.5 (p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 5.54 (s, 1H, C17), 5.15 (s, 1H, C17), 4.46 (t, J = 4.8 Hz, 
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12.2, 2.4 Hz, 2H, OCH2CH2CH2O), 2.76 (dd, J = 14.2, 3.0 Hz, 1H, C4), 2.34 – 2.20 (m, 
1H, C6), 2.14 (dd, J = 14.2, 1.1 Hz, 1H, C2), 2.04 (tdd, J = 17.5, 8.7, 4.2 Hz, 2H, C1), 1.89 
(ddt, J = 13.3, 6.6, 3.5 Hz, 1H, C7), 1.80 – 1.65 (m, 2H, C8), 1.55 – 1.28 (m, 4H, C1, C7, 
C2, OCH2CH2CH2O), 0.99 (d, 3H, C16). 
13C NMR (101 MHz, CDCl3): δ 211.7 (C5=O), 145.0 (C10), 121.0 (C17), 101.9 (C3), 66.9 (OCH-
2CH2CH2O), 50.2 (C4), 48.1 (C9), 44.9 (C6), 44.0 (C11), 35.0 (C8), 35.0 (C1), 30.6 (C7), 29.5 (C2), 
25.7 (OCH2CH2CH2O), 14.4 (C16). 
FTIR (AT-IR): 2929, 2359, 1707, 1377, 1214, 1143, 1079, 880, 730, 668 cm–1. 
HRMS (FAB+, m/z): calc’d for C16H26O3Cl [M+H]+ 301.1571, found: 301.1564. 
[𝜶]𝑫𝟐𝟑: +49° (c = 0.495, CHCl3). 
 
Preparation of hydrindanone 49 
 
A 250 mL round-bottom flask equipped with a stir bar and reflux condenser was 
charged with allylic chloride 48 (10.8 g, 35.9 mmol, 1 equiv) and THF (125 mL). The 
homogeneous solution was vigorously stirred (960 rpm), and 6 N HCl (17.96 mL, 108 
mmol, 3 equiv) was added dropwise. The reaction was heated to 70 ºC and stirred for 4 h. 
The reaction was quenched with sat. aq. NaHCO3 (45 mL). The layers were separated and 
the aqueous layer was extracted with Et2O (3 x 75 mL). The combined organic layers were 
washed with brine (25 mL) and dried over MgSO4. The suspension was filtered, and 
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 Purification was achieved via flash column chromatography on SiO2 [1400 g SiO2, 
5% Et2O/hexanes → 10%] to afford enone 49 (4.15 g, 18.5 mmol, 52% yield) as a colorless 
solid. 
 
Major Diastereomer (49) 
TLC (50% Et2O/hexanes): Rf = 0.75 (UV, p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 6.55 (t, J = 2.7 Hz, 1H, C3), 5.39 (s, 1H, C17), 4.96 (s, 1H, C17), 
4.16 – 4.05 (m, 2H, C11), 2.39 – 2.32 (m, 3H, C1, C2), 2.29 – 2.18 (m, 2H, C6, C8), 1.95 – 1.84 (m, 
2H, C7, C8), 1.73 – 1.45 (m, 2H, C1, C7), 1.09 (d, J = 6.7 Hz, 2H, C6). 
13C NMR (101 MHz, CDCl3): δ 202.1 (C5=O), 146.8 (C4), 146.4 (C10), 137.6 (C3), 119.0 (C17), 
57.9 (C9), 45.2 (C6), 44.7 (C11), 39.4 (C8), 35.3 (C1), 30.5 (C7), 30.1 (C2), 14.9 (C16). 
FTIR (AT-IR): 2929, 2860, 1682, 1622, 1454, 1312, 1232, 1012, 927, 757, cm–1. 
HRMS (FAB+, m/z): calc’d for C13H18ClO [M+H]+ 225.1046, found: 225.1061. 
[𝜶]𝑫𝟐𝟑: +58.4° (c = 0.715, CHCl3).  
 
Minor Diastereomer 
TLC (50% Et2O/hexanes): Rf = 0.75 (UV, p-anisaldehyde) 
1H NMR (400 MHz, CDCl3): δ 6.70 (t, J = 2.7 Hz, 1H, C3), 5.3 (s, 1H, C17), 5.00 (s, 1H, C17), 4.21 
– 4.01 (m, 2H, C11), 2.55 – 2.44 (m, 1H, C6), 2.42 – 2.32 (m, 2H, C2), 2.28 (ddt, J = 12.6, 5.4, 2.7 
Hz, 1H, C1), 2.16 (dt, J = 13.8, 4.0 Hz, 1H, C8), 2.04 – 1.83 (m, 2H, C1, C7), 1.74 (td, J = 13.4, 3.9 
Hz, 1H, C8), 1.54 (dq, J = 13.9, 3.9 Hz, 1H, C7), 1.12 (d, J = 7.4 Hz, 3H, C16).  
13C NMR (101 MHz, CDCl3): δ 203.4 (C5=O), 146.7 (C4), 145.3 (C10), 140.1 (C3), 118.2 (C17), 
56.7 (C9), 44.8 (C11), 41.9 (C6), 39.8 (C12), 30.7 (C8), 30.0 (C2), 28.0 (C7), 17.8 (C16). 
FTIR (AT-IR): 2925, 2855, 1687, 1620, 1456, 1376, 1262, 1175, 1098, 924 cm–1. 
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HRMS (EI+, m/z): calc’d for C13H17ClO [M]+224.0968, found: 224.0940. 
[𝜶]𝑫𝟐𝟑: 46.8° (c = 0.115, CHCl3). 
 
Preparation of allylic alcohol 50 
 
A flame-dried, 50 mL round-bottom flask equipped with a stir bar was charged with 
enone 49 (1.101 g, 4.9 mmol, 1 equiv). The atmosphere was exchanged with argon three 
times before adding a solution of CeCl3•2LiCl (0.3 M in THF, 16.3 mL, 1 equiv). Upon 
addition of CeCl3•2LiCl, a bright yellow solution was obtained and stirred for 1 h at 
ambient temperature. The reaction mixture was then cooled to –78 ºC and stirred for 15 
min. The solution then became pale yellow slurry and stirring became difficult. A solution 
of methylmagnesium chloride (3.0 M in THF (Aldrich), 3.3 mL, 9.8 mmol, 2 equiv) was 
added dropwise over 30 min. The slurry was perturbed by hand until magnetic stirring 
resumed. The reaction was stirred at –78 ºC until TLC analysis indicated complete 
consumption of starting material (about 15 min).  
The gray solution was quenched at –78 ºC via slow addition of 1 M HCl (15 mL) 
using a vent needle to relieve excess pressure. Thereafter, the solution was warmed to 
ambient temperature while the slurry slowly quenched. The mixture was then transferred 
to a separatory funnel and diluted with H2O (20 mL) and Et2O (50 mL). The layers 
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organic layers were washed with brine (40 mL) and dried over MgSO4. The suspension 
was filtered and concentrated under reduced pressure to afford a yellow oil.  
Purification was achieved via flash column chromatography on SiO2 [100 g SiO2, 
45 mL fractions, 200 mL forerun, Et2O/hexanes = 15% (1.2 L), 30% (250 mL), 40% (1 L)] 
to afford the less polar diastereomer (fractions 3–10) followed by the more polar 
diastereomer (fractions 17–33). The volatiles were concentrated under reduced pressure to 
afford an inconsequential mixture of diastereomers 50 (1.15 g, 4.78 mmol, 97% combined 
yield). An analytically pure sample of the less polar diastereomer was obtained and a 
representative spectrum of the mixture as used in the next step is also provided.  
 
TLC (20% Et2O/hexanes): Rf = 0.46 and 0.09 (p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 5.79 (t, J = 2.4 Hz, 1H, C3), 5.44 – 5.41 (m, 1H, C17), 5.27 (s, 1H, 
C17), 4.24 (dd, J = 13.1, 0.6 Hz, 1H, C11), 4.08 (dd, J = 13.1, 1.0 Hz, 1H, C11), 2.46 – 2.33 (m, 3H, 
C2, C8), 2.05 (ddd, J = 13.4, 7.9, 3.4 Hz, 1H, C1), 1.76 (dt, J = 13.3, 9.0 Hz, 1H, C1), 1.57 (s, 1H, 
OH), 1.46 – 1.38 (m, 3H, C6, C7, C8), 1.37 (s, 3H, C15), 0.92 (d, J = 6.4 Hz, 3H, C16). 
13C NMR (101 MHz, CDCl3): δ 150.1 (C4), 149.7 (C10), 126.5 (C3), 113.8 (C17), 72.1 (C5), 
54.5 (C9), 45.7 (C11), 43.1 (C6), 41.4 (C1), 38.2 (C8), 30.3 (C2), 28.3 (C7), 24.4 (C15), 14.8 
(C16). 
FTIR (AT-IR): 3315, 2872, 2360, 1596, 1489, 1275, 1031, 1001, 899, 697 cm–1. 
HRMS (FAB+, m/z): calc’d for C14H20ClO [M+H]+–H2 239.1203, found: 239.1176. 
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Preparation of hydrindenone 51 
 
This procedure was adapted from the work of Dauben and coworkers.16 To a 100 
mL round-bottom flask equipped with a stir bar was added allylic alcohol 50 (1.15 g, 4.78 
mmol, 1 equiv) and CH2Cl2 (32 mL). Pyridinium chlorochromate (3.09 g, 14.24 mmol. 3 
equiv) was added in one portion and the reaction was stirred at ambient temperature for 12 
h or until complete by aliquot NMR.  
Upon complete consumption of starting material, the reaction mixture was 
transferred to a 500 mL separatory funnel. In the reaction flask remained a black resin, 
which was diluted with 20 mL Et2O and 60 mL of 5% NaOH. The biphasic mixture was 
stirred until all the black resin had gone into solution, where it was then transferred into 
the separatory funnel. The organic layer was separated, and the aqueous layer was extracted 
with Et2O (3 x 20 mL). The combined organic layers were then washed with 1 M HCl (2 x 
15 mL) which gave a pale yellow organic layer. The phases were again separated, and 
washed with sat. aq. NaHCO3. The combined organic layers were dried over MgSO4, 
filtered, and concentrated under reduced pressure.  
Purification was achieved via flash column chromatography with SiO2 [50 g SiO2, 
10% Et2O/hexanes] to afford enone 51 (902 mg, 3.78 mmol, 80% yield) as viscous, clear 
oil. 
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1H NMR (400 MHz, CDCl3): δ 5.49 (s, 1H, C17), 4.93 (d, J = 0.8 Hz, 1H, C17), 4.10 (d, J = 0.9 Hz, 
2H, C11), 2.34 – 2.04 (m, 5H, C1, C2, C6, C8, C15), 1.75 – 1.66 (m, 1H, C7), 1.63 – 1.54 (m, 1H, C1), 
1.39 – 1.15 (m, 2H, C7, C8), 1.06 (d, J = 7.1 Hz, 3H, C16). 
13C NMR (101 MHz, CDCl3): δ 207.4 (C3=O), 152.3 (C4), 147.4 (C5), 135.6 (C10), 121.8 (C17), 
50.6 (C9), 43.9 (C11), 37.7 (C6), 35.6 (C2), 33.2 (C8), 32.5 (C1), 28.2 (C7), 19.1 (C16), 16.9 (C15). 
FTIR (AT-IR): 2932, 1707, 1630, 1444, 1267, 1211, 1077, 926, 801, 754, 622 cm–1. 
HRMS (TOF, ES+): calc’d for C14H19ClONa[M+Na]+ 261.1022, found 261.1006. 
[𝜶]𝑫𝟐𝟑: –252.8° (c = 0.66, CHCl3). 
 
Preparation of enal 10 
 
This procedure was adapted from the work of Kumar and coworkers.2 A 20 mL 
scintillation vial equipped with a stir bar was charged with hydrindenone 51 (250 mg, 1.047 
mmol, 1 equiv), K2HPO4•3H2O (595 mg, 2.62 mmol, 2.5 equiv), NaI (65 mg, 0.419 mmol, 
0.4 equiv) and DMSO (10 mL). The vial was sealed with a teflon cap and the heterogeneous 
mixture was heated to 95 ºC with vigorous stirring (1000 rpm). After 7.5 h, aliquot NMR 
analysis indicated complete consumption of starting material. The heterogeneous mixture 
was allowed to cool to ambient temperature and sat. aq. NaHCO3 (5 mL) was added. The 
layers were separated and the aqueous layer was extracted with Et2O (4 x 15 mL). The 
combined organic layers were washed with H2O (10 mL), and dried over MgSO4. The 
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 Purification was achieved via flash column chromatography on SiO2 [75 g SiO2, 
Et2O/hexanes = 20%] to afford enal 10 (157 mg, 0.719 mmol, 69% yield) as a white solid. 
 
TLC (30% Et2O/hexanes): Rf = 0.30 (UV, p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 9.57 (s, 3H, C11), 6.17 (s, 1H, C17), 6.06 (s, 1H, C17), 2.58 
(ddd, J = 12.9, 7.9, 1.2 Hz, 1H, C2), 2.48 (dt, J = 13.1, 3.4 Hz, 1H, C8), 2.17 (m, 1H, C6), 
2.16 (s, 3H, C15), 2.12 (ddd, J = 18.5, 8.6, 1.1 Hz, 1H, C1) 2.06 (ddd, J = 18.5, 12.6, 7.9 
Hz, 1H, C1), 1.70 (m, 1H, C7), 1.64 (dd, J = 12.6, 8.7, Hz, 1H, C2), 1.34 (td, J = 14.0, 2.7 
Hz, 1H, C8), 1.04 (s, 3H, C16), 0.97 (m, 1H, C7). 
13C NMR (101 MHz, CDCl3): δ 207.9 (C3=O), 193.8 (C11=O), 153.5 (C5), 152.8 (C10), 
140.5 (C17), 135.1 (C4), 48.1 (C9), 37.5 (C6), 35.9 (C1), 32.3 (C8), 31.8 (C2), 28.5 (C7), 19.3 
(C16) 17.0 (C15). 
FTIR (AT-IR): 2950, 2931, 1705, 1629, 1080, 907, 878, 764, 702, 647 cm–1. 
HRMS (FAB+, m/z): calc’d for C14H19O2 [M+H]+ 219.1385, found 219.1387. 
[𝜶]𝑫𝟐𝟑: –215° (c = 1.01, CHCl3). 
 
Preparation of MOM protected crotylation adduct 54 
 
A flame-dried, 25 mL round-bottom flask equipped with a stir bar was charged with 
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(2.42 mL, 13.9 mmol, 26 equiv). To the homogeneous solution was added chloromethyl 
methyl ether (1.02 mL, 7.80 mmol, 25 equiv) dropwise over 10 min, taking care to vent 
HCl fumes formed via the use of a needle. The reaction was stirred at ambient temperature 
for 36 h. The resulting viscous, orange mixture was quenched via addition of sat. aq. 
NaHCO3 (20 mL) and stirred at ambient temperature for 30 min. The aqueous layer was 
extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were washed with H2O 
(1 x 10 mL), brine (1 x 10 mL), dried over Na2SO4, and concentrated via distillation to 
afford a viscous, dark orange residue. 
Purification was achieved via flash column chromatography on SiO2 [35 g SiO2, 
Et2O/hexanes = 16% → 35%] to afford MOM ether 54 (281 mg, 0.465 mmol, 79% yield) 
as a puffy white solid. Starting material 36 was also isolated (38.0 mg, 0.0678 mmol, 13% 
recovered). 
 
TLC (40% Et2O/hexanes): Rf = 0.71 (UV, p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 7.46–7.38 (m, 6H, Ph3CO), 7.32–7.19 (m, 9H, Ph3CO), 
5.77 (dd, J = 16.9, 9.9 Hz, 1H, C19), 5.42 (d, J = 1.1 Hz, 1H, C17), 4.93 (br m, 1H, C17), 
4.84 (dd, J = 9.9, 2.4 Hz, 1H, C20), 4.80 (dd, J = 16.9, 2.4 Hz, 1H, C20), 4.52 (d, J = 6.7 Hz, 
1H, OCH2OMe), 4.46 (d, J = 6.7 Hz, 1H, OCH2OMe), 3.87 (br s, 1H, C11), 3.37 (s, 3H, 
OCH2OCH3), 3.10 (m, m, 2H, C14), 2.17 (app dt, J = 12.0, 7.9 Hz, 1H, C2), 2.15 (m 1H, 
C1), 2.11 (m, 1H, C6), 2.10 (s, 3H, C15), 2.08 (m, 1H, C8), 1.98 (m, 1H, C13), 1.93 (m, 1H, 
C2), 1.86 (m, 1H, C13), 1.62 (m, 1H, C7), 1.44 (m, 1H, C1), 1.25 (m, 1H, C7), 1.23 (m, 1H, 
C8), 1.05 (d, J = 7.0 Hz, 3H, C16), 0.99 (s, 3H, C18). 
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13C NMR (101 MHz, CDCl3): δ 208.4 (C3=O), 151.1 (C5), 149.7 (C10), 144.4 (Ph3CO), 
142.6 (C19), 136.4 (C4), 128.7 (Ph3CO), 127.7 (Ph3CO), 126.8 (Ph3CO), 122.3 (C17), 113.9 
(C20), 95.1 (OCH2OCH3), 86.7 (Ph3CO), 80.2 (C11), 60.7 (C14), 56.4 (OCH2OCH3), 50.8 
(C9), 45.2 (C12), 38.3 (C13), 37.5 (C6), 35.9 (C2), 33.2 (C8), 32.7 (C1), 28.2 (C7), 19.1 (C16), 
17.9 (C18), 17.0 (C15). 
FTIR (AT-IR): 2930, 1703, 1627, 1448, 1213, 1034, 919, 735 cm–1. 
HRMS (TOF, ES+): calc’d for C41H48O4Na [M+Na]+ 627.3450, found 627.3419. 
[𝜶]𝑫𝟐𝟑: –39° (c = 1.06, CHCl3). 
Melting point: 62.0–63.3 °C 
 
Preparation of alcohol 55 
 
A flame-dried, 250 mL round-bottom flask equipped with a stir bar was charged 
with MOM ether 54 (431 mg, 0.713 mmol, 1 equiv). Thereafter, a freshly prepared solution 
of formic acid (98%, 4.8 mL) and Et2O (4.8 mL) was rapidly added, and within 5 min, the 
reaction was judged to be complete by TLC analysis. We found it critical to stop this 
reaction immediately after full conversion was achieved. Prolonged times afforded copious 
quantities of formate ester product. The reaction was diluted with Et2O (10 mL) and 
quenched via slow addition of NaHCO3 (100 mL). The aqueous layer was extracted with 
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washed with brine (1 x 5 mL), dried over Na2SO4, and concentrated under reduced pressure 
to afford a viscous yellow residue. 
Purification was achieved via flash column chromatography on SiO2 [15 g SiO2, 
Et2O/hexanes = 70%] to afford alcohol 55 (225 mg, 0.621 mmol, 88% yield) as a viscous, 
colorless oil. 
 
TLC (70% Et2O/hexanes): Rf = 0.20 (UV, p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 5.99 (dd, J = 16.9, 9.9 Hz, 1H, C19), 5.49 (d, J = 1.1 Hz, 
1H, C17), 5.05 (dd, J= 9.9, 2.4 Hz, 1H, C20), 5.01 (br m, 1H, C17), 4.99 (dd, J = 16.9, 2.4 
Hz, 1H, C20), 4.58 (d, J = 6.7 Hz, 1H, OCH2OMe), 4.50 (d, J = 6.7 Hz, 1H, OCH2OMe), 
4.01 (br s, 1H, C11), 3.66 (m, 2H, C14), 3.41 (s, 3H, OCH2OCH3), 2.24 (m, 1H, C2), 2.22 
(m 1H, C1), 2.13 (m, 1H, C6), 2.11 (m, 1H, C8), 2.10 (s, 3H, C15), 1.99 (m, 1H, C2), 1.95 
(m, 1H, C13), 1.88 (m, 1H, C13), 1.63 (m, 1H, C7), 1.50 (m, 1H, C1), 1.27 (m, 1H, C8), 1.25 
(m, 1H, C7), 1.12 (s, 3H, C18), 1.05 (d, J = 7.0 Hz, 3H, C16). 
13C NMR (101 MHz, CDCl3): δ 208.3 (C3=O), 151.2 (C5), 149.7 (C10), 143.1 (C19), 136.4 
(C4), 122.5 (C17), 114.1 (C20), 95.0 (OCH2OCH3), 80.0 (C11), 59.8 (C14), 56.4 
(OCH2OCH3), 50.7 (C9), 45.3 (C12), 41.5 (C13), 37.5 (C6), 35.9 (C2), 33.2 (C8), 32.8 (C1), 
28.2 (C7), 19.1 (C16), 17.7 (C18), 17.0 (C15). 
FTIR (AT-IR): 3397, 2930, 1701, 1625, 1456, 1371, 1212, 1145, 1035, 917, 734 cm–1. 
HRMS (TOF, ES+): calc’d for C22H34O4Na [M+Na]+ 385.2355, found 385.2371. 
[𝜶]𝑫𝟐𝟑: –53° (c = 0.475, CHCl3). 
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Preparation of aldehyde 56 
 
A flame-dried, 2 dram vial equipped with a stir bar was charged with alcohol 55 
(165 mg, 0.455 mmol, 1 equiv) and MeCN (2.0 mL). Thereafter, added 860 μL of the 
[Cu]/bpy stock solution, 860 μL of the NMI stock solution, and 860 μL of the ABNO stock 
solution, in that order. The orange reaction was stirred at 960 rpm open to the atmosphere 
for 90 min. Subsequently, the resulting light blue solution was diluted with Et2O (10 mL), 
passed through a short pad of SiO2 using Et2O as the eluent and concentrated under reduced 
pressure to afford a pale yellow oil. 
Purification was achieved via flash column chromatography on SiO2 [8 g SiO2, 
Et2O/hexanes = 30%→60%] to afford aldehyde 56 (151 mg, 0.419 mmol, 92% yield) as a 
viscous, colorless oil that solidified to a white solid upon standing in the freezer. 
 
Preparation of stock solutions: [Cu(MeCN)4]OTf (30.0 mg) and 4,4′-dimethoxy-2,2′-
bipyridyl (4-OMebpy) (17.0 mg) were suspended in MeCN (3.0 mL) and stirred for 5 min 
resulting in a homogeneous, green solution. ABNO (2.5 mg) was dissolved in MeCN (3.0 
mL). N-methylimidazole (13.4 mg) was dissolved in MeCN (3.0 mL). 
 














[Cu(MeCN)4]OTf (5 mol %)
4-OMebpy (5 mol %)
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1H NMR (400 MHz, CDCl3): δ 9.74 (t, J = 2.8 Hz, 1H, C14), 6.07 (dd, J = 16.9, 9.9 Hz, 
1H, C19), 5.48 (d, J = 0.7 Hz, 1H, C17), 5.13 (dd, J = 9.9, 2.4 Hz, 1H, C20), 5.09 (dd, J = 
16.9, 2.4 Hz, 1H, C20), 5.05 (br m, 1H, C17), 4.54 (d, J = 6.7 Hz, 1H, OCH2OMe), 4.42 (d, 
J = 6.7 Hz, 1H, OCH2OMe), 4.12 (br s, 1H, C11), 3.36 (s, 3H, OCH2OCH3), 2.56 (m, 2H, 
C13), 2.26 (m, 1H, C1), 2.19 (m, 1H, C8), 2.17 (m, 1H, C2), 2.14 (m 1H, C6), 2.11 (s, 3H, 
C15), 2.00 (dd, J = 17.0, 7.6 Hz, 1H, C2), 1.65 (m, 1H, C7), 1.52 (m, 1H, C1), 1.27 (s, 3H, 
C18), 1.25 (m, 1H, C8), 1.23 (m, 1H, C7), 1.07 (d, J = 7.0 Hz, 3H, C16). 
13C NMR (101 MHz, CDCl3): δ 208.1 (C3=O), 202.2 (C14=O), 151.4 (C5), 149.0 (C10), 
142.4 (C19), 136.2 (C4), 122.7 (C17), 114.5 (C20), 94.2 (OCH2OCH3), 78.2 (C11), 56.6 
(OCH2OCH3), 52.4 (C13), 50.5 (C9), 45.5 (C12), 37.4 (C6), 35.9 (C2), 33.1 (C8), 32.7 (C1), 
28.2 (C7), 19.1 (C16), 18.9 (C18), 17.0 (C15). 
FTIR (AT-IR): 2931, 1704, 1627, 1456, 1212, 1146, 1032, 919, 708 cm–1. 
HRMS (TOF, ES+): calc’d for C22H32O4[M+Na]+ 383.2198, found 383.2189. 
[𝜶]𝑫𝟐𝟑: –56° (c = 0.475, CHCl3). 
 
Preparation of tricycle 59 
 
A 100 mL Schlenk flask equipped with a stir bar was charged with aldehyde 56 
(108 mg, 0.300 mmol, 1 equiv), deionized H2O (32 μL, 1.80 mmol, 6 equiv), and THF 
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and stirred at this temperature for 15 min. Thereafter, SmI2/THF (9.0 mL, 0.900 mmol, 3 
equiv) was added dropwise over 8 min. The deep blue color of SmI2 was immediately 
quenched upon addition of each drop. The first drop afforded a yellow solution, fading to 
pale yellow and almost clear by the time 1.6 equiv SmI2 had been added. When 2.2 equiv 
SmI2 had been added, the blue color became increasingly persistent and upon addition of 
2.6 equiv SmI2, the reaction was dark blue/green. After stirring an additional 10 min at 0 
°C, TMSCl/THF (1.5 mL, 1.50 mmol, 5 equiv TMSCl) was added dropwise over 2 min, 
and the reaction was stirred an additional 10 min. Throughout this time, the deep blue color 
was quenched to yellow. Thereafter, the reaction was removed from the ice bath and stirred 
open to the atmosphere for 5 min. 
The resulting pale yellow solution was diluted with Et2O (75 mL), and washed with 
H2O (2 x 15 mL). The aqueous layer was back-extracted with Et2O (2 x 15 mL), and the 
combined organic layers were dried over Na2SO4, filtered, and concentrated under reduced 
pressure to afford a dark orange oil.  
Purification was achieved via flash column chromatography on SiO2 [12 g SiO2, 
Et2O/hexanes = 30%] to afford tricycle 59 (100 mg, 0.276 mmol, 92% yield) as a 
crystalline white solid. 
 
Preparation of SmI2: A 100 mL Schlenk flask containing a stir bar was charged with 
freshly filed Sm metal (650 mg). The system was flame-dried under high vacuum then 
cooled to ambient temperature before adding freshly purified 1,2-diiodoethane (700 mg). 
1,2-diiodoethane (1.6 g) was dissolved in Et2O (50 mL) and washed with sat. aq. Na2S2O3 
(3 x 10 mL) and deionized water (2 x 10 mL), dried over Na2SO4, filtered, and dried to 
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1.41 g of a white solid. The atmosphere was exchanged three times for argon. 
Subsequently, the flask was charged with anhydrous THF (25 mL) that had been submitted 
to five freeze-pump-thaw cycles. Note: The THF used for the synthesis of SmI2 must 
contain <50 ppm H2O; THF containing greater quantities of water resulted in excessive 
induction times for the synthesis of SmI2. Further, residual oxygen results in formation of 
oxidative fragmentation products in the radical cyclization. The suspension was stirred for 
2 min and the flask was cautiously and briefly (5 s) placed under partial high vacuum, then 
purged with argon. This process was repeated two additional times to remove ethylene gas 
formed from insertion of Sm metal into 1,2-diiodoethane. The resulting heterogeneous 
suspension was rapidly (930 rpm) stirred; after 5 min, the reaction turned dark green, and 
within 10 min, a dark blue color was observed. After stirring under argon for 3 h at ambient 
temperature, the system was cautiously and briefly placed under high vacuum, then purged 
with argon. This process was repeated two additional times, then stirring was halted. The 
mixture was allowed to settle for 15 min prior to use. 
 
Stock solution of TMSCl: TMSCl was freshly distilled from CaH2 (5% w/w) under argon, 
collecting a 15% forerun then taking the middle fraction. A solution of TMSCl (350 μL) 
in THF (5.0 mL) was submitted to five freeze-pump-thaw cycles. 
 
TLC (50% Et2O/hexanes): Rf = 0.55 (p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 6.35 (dd, J = 17.8, 11.3 Hz, 1H, C19), 5.33 (dd, J = 17.8, 
1.4 Hz, 1H, C20), 5.34 (s, 1H, C17), 5.28 (s, 1H, C17), 5.19 (dd, J = 11.2, 1.4 Hz, 1H, C20), 
4.54 (d, J = 7.1 Hz, 1H, OCH2OMe), 4.40 (d, J = 6.7 Hz, 1H, OCH2OMe), 4.13 (d, J = 5.9 
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Hz, 1H, C14), 3.95 (s, 1H, C11), 3.38 (s, 3H, OCH2OCH3), 2.33 (m, 1H, C2), 2.29 (m, 1H, 
C2), 2.24 (m, 1H, C4), 2.06 (m, 1H, C1), 2.03 (m, 1H, C8), 1.92 (dd, J = 16.1, 6.5 Hz, 1H, 
C13), 1.70 (m, 1H, C6), 1.60 (dt, J = 13.3, 3.4 Hz, 1H, C7), 1.50 (dd, J = 16.1, 0.9 Hz, 1H, 
C13), 1.39 (ddt, J = 13.3, 6.5, 3.4 Hz, 1H, C7), 1.33 (m, 1H, C1), 1.30 (s, 3H, C15), 1.28 (m, 
1H, C8), 1.24 (s, 3H, C18), 0.96 (d, J = 7.0 Hz, 3H, C16). 
13C NMR (101 MHz, CDCl3): δ 216.8 (C3=O), 148.3 (C10), 139.9 (C19), 114.2 (C20), 112.2 
(C17), 92.1 (OCH2OCH3), 77.2 (C11), 67.2 (C14), 59.6 (C4), 56.0 (OCH2OCH3), 46.5 (C9), 
45.2 (C13), 44.7 (C12), 42.1 (C5), 37.3 (C6), 34.9 (C2), 31.0 (C8), 29.7 (C1), 28.8 (C18), 26.8 
(C7), 18.2 (C16), 13.4 (C15). 
FTIR (AT-IR): 3508 (br), 2926, 1735, 1628, 1458, 1264, 1144, 1093, 1024, 907, 738 cm–
1. 
HRMS (TOF, ES+): calc’d for C22H35O4 [M+H]+ 363.2535, found 363.2536. 
[𝜶]𝑫𝟐𝟑: +155° (c = 0.330, CHCl3). 
Melting point: 142.0–143.4 °C 
 
Preparation of diketone 65 
 
This procedure was adapted from work by Shenvi and coworkers.33 A flame-dried 
1 dram vial was charged with tricycle 59 (30.0 mg, 0.0828 mmol, 1 equiv) and adventitious 
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oven-dried stir bar was added, and the atmosphere was exchanged three times for argon. 
Thereafter, iPrOH (830 μL), PhSiH3 (13.4 mg, 0.124 mmol, 15.2 μL, 1.5 equiv), and tert-
butyl hydroperoxide (33.1 μL of a 5.0 M solution in nonane, 0.166 mmol, 2 equiv) were 
added. The heterogeneous mixture was sparged with argon for 10 min. Subsequently, 
tris(2,2,6,6-tetramethyl-3,5-heptanedionato)manganese(III) (5.0 mg, 0.00828 mmol, 10 
mol %) was added as a solid, sparging was continued for an additional 20 sec, and the 
reaction was stirred at ambient temperature. After 10 min, the reaction was diluted with 
Et2O/hexanes = 50%, passed through a plug of SiO2 (eluting with Et2O/hexanes = 50%), 
and concentrated under reduced pressure to afford a dark orange oil.  
Purification was achieved via flash column chromatography on SiO2 [15 g SiO2, 
Et2O/hexanes = 20% → 35%] to afford ketone 65 (16.9 mg, 0.047 mmol, 56% yield) as a 
clear residue. Isolated starting material (12.1 mg, 0.033 mmol, 40%). 
 
Experimental Notes: This reaction exhibits a pronounced sensitivity to both residual 
oxygen and water. In addition, we found it critical to perform this reaction at 23 °C, as 
higher temperatures promoted over-reduction and lower temperatures slowed catalysis. 
iPrOH was stored over activated 4 Ǻ molecular sieves (pellets) overnight then was distilled 
from CaH2 (10% w/v) in a flame-dried, argon-filled apparatus immediately prior to use. 
 
TLC (40% Et2O/hexanes): Rf = 0.24 (p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 6.18 (dd, J = 17.8, 11.3 Hz, 1H, C19), 5.36 (dd, J = 17.8, 
1.5 Hz, 1H, C20), 5.27 (dd, J = 11.2, 1.5 Hz, 1H, C20), 4.67 (ABq, J = 6.8 Hz, 2H, 
OCH2OMe), 3.54 (d, J = 5.2 Hz, 1H, C11), 3.42 (s, 3H, OCH2OCH3), 2.70 (d, J = 12.4 Hz, 
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1H, C13), 2.57 (d, J = 2.3 Hz, 1H, C4), 2.27 (m, 2H, C2), 2.07 (d, J = 12.4 Hz, 1H, C13), 
1.99 (dq, J = 7.2, 5.2 Hz, 1H, C10), 1.83 (dd, J = 12.9, 9.6 Hz, 1H, C1), 1.74 (dq, J = 14.3, 
2.9 Hz, C8), 1.63 (dt, J = 12.9, 3.3 Hz, 1H, C7), 1.56 (m, 1H, C6), 1.53 (m, 1H, C1), 1.46 (s, 
3H, C15), 1.29 (m, 1H, C7), 1.21 (s, 3H, C18), 1.18 (d, J = 6.8 Hz, 3H, C16), 1.17 (m, 1H, 
C8), 0.89 (d, J = 7.2 Hz, 3H, C17). 
13C NMR (101 MHz, CDCl3): δ 216.9 (C3=O), 212.5 (C14=O), 138.5 (C19), 116.1 (C20), 
98.1 (OCH2OCH3), 81.9 (C11), 57.9 (C4), 56.8 (OCH2OCH3), 50.6 (C5), 48.1 (C12), 47.5 
(C13), 45.6 (C9), 36.5 (C6), 35.5 (C10), 34.6 (C2), 31.0 (C8), 27.9 (C18), 26.1 (C7), 24.7 (C1), 
21.0 (C15), 16.2 (C16), 11.1 (C17). 
FTIR (AT-IR): 2957, 1734, 1698, 1455, 1089, 1035, 916 cm–1. 
HRMS (TOF, ES+): calc’d C22H34O4 [(M+H)–H2]+ 361.2379, found 361.2396. 
[𝜶]𝑫𝟐𝟑: +34.0° (c = 0.951, CHCl3). 
 
Preparation of deuterium-labeled aldehyde 67 
 
A 25 mL round-bottom flask equipped with a stir bar was charged with aldehyde 
56 (32.2 mg, 0.0894 mmol, 1 equiv) and tBuOH (4.5 mL) followed by deionized water (3.2 
mL) and 2-methyl-2-butene (163 mg, 2.32 mmol, 246 μL, 26 equiv). Thereafter, a solution 










    2-methyl-2-butene













    0 ºC → 23 ºC
OHD










Chapter 2 – Total Synthesis of (+)-Pleuromutilin and (+)-12-epi-Pleuromutilin 107 
solution of NaClO2 (8.9 mg, 0.0983 mmol, 1.1 equiv) in H2O (650 μL). The mixture was 
rapidly stirred at ambient temperature for 6 h, at which time the reaction was extracted into 
Et2O (4 x 2 mL). The combined organic layers were dried over Na2SO4, filtered, and 
concentrated under reduced pressure to afford 25.8 mg of a clear oil that was used in the 
next step without further purification. 
A flame-dried 2 dram vial equipped with a stir bar was charged with LiAlD4 (11.5 
mg, 0.274 mmol, 4 equiv) and the atmosphere was exchanged three times for argon. 
Subsequently, anhydrous Et2O (1.7 mL) was added followed by dropwise addition of 
carboxylic acid in Et2O (1.7 mL) over 5 min. The resulting light grey suspension was 
rapidly stirred at ambient temperature for 45 min, at which time H2O (1 mL) was cautiously 
added, using a vent needle to aid in expulsion of gas. The slurry was extracted into Et2O (4 
x 2 mL), the combined organic layers were dried over Na2SO4, and concentrated under 
reduced pressure to afford 14.1 mg of a viscous oil that was used in the next step without 
further purification. 
Stahl Oxidation: 
A flame-dried, 2 dram vial equipped with a stir bar was charged with alcohol 66 
and MeCN (100 μL). Thereafter, added 140 μL of the [Cu]/bpy stock solution, 140 μL of 
the NMI stock solution, and 140 μL of the ABNO stock solution, in that order. The orange 
reaction was stirred at 960 rpm open to the atmosphere. Within 15 min, TLC analysis 
(Et2O/hexanes = 70%, UV and anisaldehyde) indicated complete conversion to aldehyde 
67 (Rf = 0.57, stains deep blue), and after 2 h, complete conversion to the desired enone-
aldehyde product (Rf = 0.66, stains brown) was observed. Subsequently, the resulting light 
Chapter 2 – Total Synthesis of (+)-Pleuromutilin and (+)-12-epi-Pleuromutilin 108 
blue solution was diluted with Et2O (2 mL), passed through a short pad of SiO2 using Et2O 
as the eluent, and concentrated under reduced pressure to afford a pale yellow oil. 
Purification was achieved via flash column chromatography on SiO2 [1.5 g SiO2, 
Et2O/hexanes = 30%→45%] to afford deuterated aldehyde 67 (9.8 mg, 0.027 mmol, 40% 
yield over 3 steps) as a viscous, colorless oil. It should be noted that this compound was 
isolated as a 9:1 mixture of C6-epimers, separable after the reductive radical cyclization. 
1H NMR indicates 94% deuterium incorporation at C14. 
 
Preparation of stock solutions: See page 101. 
 
TLC (80% Et2O/hexanes): Rf = 0.65 (UV). 
1H NMR (400 MHz, CDCl3): δ 6.07 (dd, J = 16.9, 9.9 Hz, 1H, C19), 5.48 (d, J = 0.7 Hz, 
1H, C17), 5.13 (dd, J = 9.9, 2.4 Hz, 1H, C20), 5.09 (dd, J = 16.9, 2.4 Hz, 1H, C20), 5.05 (br 
m, 1H, C17), 4.54 (d, J = 6.7 Hz, 1H, OCH2OMe), 4.42 (d, J = 6.7 Hz, 1H, OCH2OMe), 
4.12 (br s, 1H, C11), 3.36 (s, 3H, OCH2OCH3), 2.56 (m, 2H, C13), 2.26 (m, 1H, C1), 2.19 
(m, 1H, C8), 2.17 (m, 1H, C2), 2.14 (m 1H, C6), 2.11 (s, 3H, C15), 2.00 (dd, J = 17.0, 7.6 
Hz, 1H, C2), 1.65 (m, 1H, C7), 1.52 (m, 1H, C1), 1.27 (s, 3H, C18), 1.25 (m, 1H, C8), 1.23 
(m, 1H, C7), 1.07 (d, J = 7.0 Hz, 3H, C16). 
13C NMR (101 MHz, CDCl3): δ 208.1 (C3=O), 202.2 (C14=O) (1:1:1 triplet) (coupling of 
I = ½ 13C nucleus to quadrupolar 2H nucleus also causes T2 broadening), 151.4 (C5), 149.0 
(C10), 142.4 (C19), 136.2 (C4), 122.7 (C17), 114.5 (C20), 94.2 (OCH2OCH3), 78.2 (C11), 56.6 
(OCH2OCH3), 52.4 (C13) (reduced intensity due to 2H coupling), 50.5 (C9), 45.5 (C12), 37.4 
(C6), 35.9 (C2), 33.1 (C8), 32.7 (C1), 28.2 (C7), 19.1 (C16), 18.9 (C18), 17.0 (C15). 
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FTIR (AT-IR): 2931, 2359, 2323, 1704, 1628, 1456, 1212, 1148, 1036, 919 cm–1. 
HRMS (TOF, ES+): calc’d for C22H31DO4Na [M+Na]+ 384.2261, found 384.2270. 
[𝜶]𝑫𝟐𝟑: –43.2° (c = 0.455, CHCl3). 
 
Preparation of deuterium-labeled tricycle 68 
 
A 25 mL Schlenk flask equipped with a stir bar was charged with deuterated 
aldehyde 67 (7.3 mg, 0.0202 mmol, 1 equiv), THF (1.0 mL), and a solution of deionized 
H2O (2.2 μL, 0.121 mmol, 6 equiv) in THF (184 μL) and submitted to five freeze-pump-
thaw cycles. The solution was cooled to 0 °C and stirred at this temperature for 15 min. 
Thereafter, SmI2/THF (606 μL, 0.0606 mmol, 3 equiv) was added dropwise over 8 min. 
After stirring an additional 10 min at 0 °C, TMSCl/THF (195 μL, 0.101 mmol, 5 equiv 
TMSCl) was added dropwise over 2 min, and the reaction was stirred an additional 10 min. 
Throughout this time, the deep blue color was quenched to yellow. Thereafter, the reaction 
was removed from the ice bath and stirred open to the atmosphere for 5 min. The resulting 
pale yellow solution was diluted with Et2O (5 mL), and washed with H2O (2 x 2 mL). The 
aqueous layer was back-extracted with Et2O (2 x 2 mL), and the combined organic layers 
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Purification was achieved via flash column chromatography on SiO2 [1.5 g SiO2, 
Et2O/hexanes = 30% → 40%] to afford deuterated tricycle 68 (6.3 mg, 0.017 mmol, 84% 
yield) as a clear residue. 
 
Preparation of SmI2: See page 103. 
Stock solution of TMSCl: See page 104. 
 
TLC (50% Et2O/hexanes): Rf = 0.55 (p-anisaldehyde, KMnO4). 
1H NMR (400 MHz, CDCl3): δ 6.35 (dd, J = 17.8, 11.3 Hz, 1H, C19), 5.33 (dd, J = 17.8, 
1.4 Hz, 1H, C20), 5.34 (s, 1H, C17), 5.28 (s, 1H, C17), 5.19 (dd, J = 11.2, 1.4 Hz, 1H, C20), 
4.54 (d, J = 7.1 Hz, 1H, OCH2OMe), 4.40 (d, J = 6.7 Hz, 1H, OCH2OMe), 3.95 (s, 1H, 
C11), 3.38 (s, 3H, OCH2OCH3), 2.33 (m, 1H, C2), 2.29 (m, 1H, C2), 2.24 (m, 1H, C4), 2.06 
(m, 1H, C1), 2.03 (m, 1H, C8), 1.92 (dd, J = 16.1, 6.5 Hz, 1H, C13), 1.70 (m, 1H, C6), 1.60 
(dt, J = 13.3, 3.4 Hz, 1H, C7), 1.50 (dd, J = 16.1, 0.9 Hz, 1H, C13), 1.39 (ddt, J = 13.3, 6.5, 
3.4 Hz, 1H, C7), 1.33 (m, 1H, C1), 1.30 (s, 3H, C15), 1.28 (m, 1H, C8), 1.24 (s, 3H, C18), 
0.96 (d, J = 7.0 Hz, 3H, C16). 
13C NMR (101 MHz, CDCl3): δ 216.8 (C3=O), 148.3 (C10), 139.9 (C19), 114.2 (C20), 112.2 
(C17), 92.1 (OCH2OCH3), 77.2 (C11), 67.2 (C14) (1:1:1 triplet) (coupling of I= ½ 13C nucleus 
to quadrupolar 2H nucleus also causes T2 broadening), 59.6 (C4), 56.0 (OCH2OCH3), 46.5 
(C9), 45.2 (C13) (reduced intensity due to 2H coupling), 44.7 (C12), 42.1 (C5), 37.3 (C6), 
34.9 (C2), 31.0 (C8), 29.7 (C1), 28.8 (C18), 26.8 (C7), 18.2 (C16), 13.4 (C15). 
FTIR (AT-IR): 3508, 2926, 1735, 1628, 1458, 1264, 1144, 1093, 1024, 907, 738 cm–1. 
HRMS (TOF, ES+): calc’d for C22H34DO4 [M+H]+ 364.2598, found 364.2595. 
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[𝜶]𝑫𝟐𝟑: +123.5° (c = 0.235, CHCl3). 
 
Redox relay by transannular 1,5-HAT is confirmed by deuterium-labeling 
 
This procedure was adapted from work by Shenvi and coworkers.33 A flame-dried 
0.5 dram vial was charged with deuterated tricycle 68 (3.0 mg, 0.00825 mmol, 1 equiv) 
and adventitious water was removed via azeotropic drying with PhMe (3 x 200 μL) under 
high vacuum. An oven-dried stir bar was added, and the atmosphere was exchanged three 
times for argon. Thereafter, a stock solution of PhSiH3 (0.89 mg, 0.00825 mmol, 1.0 μL, 
1.5 equiv) and tert-butyl hydroperoxide (2.5 μL of a 5.0 M solution in nonane, 0.0124 
mmol, 2 equiv) in iPrOH (96 μL) were added. Additional iPrOH (100 μL) was added, and 
the mixture was sparged with argon for 10 min. Subsequently, tris(2,2,6,6-tetramethyl-3,5-
heptanedionato)manganese(III) (0.50 mg, 0.000825 mmol, 10 mol %) was added as a solid, 
sparging was continued for an additional 20 sec, and the reaction was stirred at ambient 
temperature. After 10 min, the reaction was diluted with Et2O/hexanes = 50%, passed 
through a plug of SiO2 (eluting with Et2O/hexanes = 50%), and concentrated under reduced 
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Purification was achieved via flash column chromatography on SiO2 [750 mg SiO2, 
Et2O/hexanes = 20%→30%] to afford ketone 69 (1.4 mg, 0.00385 mmol, 47%) as a clear 
residue. Isolated starting material (1.4 mg, 0.00385 mmol, 47%). 
 
Experimental Notes: This reaction exhibits a pronounced sensitivity to both residual 
oxygen and water. In addition, we found it critical to perform this reaction at 23 °C, as 
higher temperatures promoted over-reduction and lower temperatures slowed catalysis. 
iPrOH was stored over activated 4 Ǻ molecular sieves (pellets) overnight then was distilled 
from CaH2 (10% w/v) in a flame-dried, argon-filled apparatus immediately prior to use.  
 
Preparation of Stock Solutions: A stock solution of PhSiH3 (20 μL) and tert-butyl 
hydroperoxide (50 μL of a 5.0 M solution in nonane) in iPrOH (1.6 mL) was prepared 
under an atmosphere of argon, and 100 μL of this stock solution was added to substrate, as 
described below. 
 
TLC (40% Et2O/hexanes): Rf = 0.24 (p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 6.18 (dd, J = 17.8, 11.3 Hz, 1H, C19), 5.36 (dd, J = 17.8, 
1.5 Hz, 1H, C20), 5.27 (dd, J = 11.2, 1.5 Hz, 1H, C20), 4.67 (ABq, J = 6.8 Hz, 2H, 
OCH2OMe), 3.54 (d, J = 5.2 Hz, 1H, C11), 3.42 (s, 3H, OCH2OCH3), 2.70 (d, J = 12.4 Hz, 
1H, C13), 2.57 (d, J = 2.3 Hz, 1H, C4), 2.27 (m, 2H, C2), 2.07 (d, J = 12.4 Hz, 1H, C13), 
[1.99 (C10) (dq signal absent)], 1.83 (dd, J = 12.9, 9.6 Hz, 1H, C1), 1.74 (dq, J = 14.3, 2.9 
Hz, C8), 1.63 (dt, J = 12.9, 3.3 Hz, 1H, C7), 1.56 (m, 1H, C6), 1.53 (m, 1H, C1), 1.46 (s, 
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3H, C15), 1.29 (m, 1H, C7), 1.21 (s, 3H, C18), 1.18 (d, J = 6.8 Hz, 3H, C16), 1.17 (m, 1H, 
C8), 0.89 (d, J = 7.2 Hz, 3H, C17). 
13C NMR (101 MHz, CDCl3): δ 216.9 (C3=O), 212.5 (C14=O), 138.5 (C19), 116.1 (C20), 
98.1 (OCH2OCH3), 81.9 (C11) (reduced intensity due to 2H coupling), 57.9 (C4), 56.8 
(OCH2OCH3), 50.6 (C5), 48.1 (C12), 47.5 (C13), 45.6 (C9), 36.5 (C6), 35.5 (C10) (signal 
absent), 34.6 (C2), 31.0 (C8), 27.9 (C18), 26.1 (C7), 24.7 (C1), 21.0 (C15), 16.2 (C16), 11.1 
(C17). 
FTIR (AT-IR): 2930, 1733, 1698, 1455, 1089, 1035 cm–1. 
HRMS (TOF, ES+): calc’d for C22H34DO4 [M+H]+ 364.2598, found 364.2600. 
[𝜶]𝑫𝟐𝟑: +24.3° (c = 0.065, CHCl3). 
 
Preparation of silyl enol ether 70 
 
A flame-dried 25 mL round-bottom flask equipped with a stir bar was charged with 
tricycle 59 (129 mg, 0.356 mmol, 1 equiv) and anhydrous THF (7.1 mL) under an 
atmosphere of argon. The mixture was cooled to –78 °C and stirred for 5 min prior to 
dropwise addition of LiHMDS in THF (1.07 mL of a 1.0 M solution, 1.07 mmol, 3 equiv) 
over 5 min. The resulting yellow solution was stirred at –78 °C for 5 min and was then 
placed in an ice bath and stirred for 5 min. Subsequently, TIPSOTf (191 μL, 0.712 mmol, 
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addition of sat. aq. NaHCO3 (3 mL) and vigorously stirred at 0 °C for 10 min. Thereafter, 
the mixture was extracted into Et2O (3 x 20 mL) and the combined organic layers were 
washed with sat. aq. NaHCO3 (3 x 10 mL) (note: failure to quench residual TIPSOTf in 
this manner resulted in extensive decomposition of product upon concentration). The 
combined organic layers were dried over Na2SO4, filtered, and concentrated under reduced 
pressure to afford a pale yellow oil. 
Purification was achieved via flash column chromatography on SiO2 [15 g SiO2, 
Et2O/hexanes = 8%] to afford silyl enol ether 70 (141 mg, 0.272 mmol, 76% yield) as a 
puffy, viscous, colorless oil that formed a white solid upon standing in the freezer 
overnight. 
 
TLC (15% Et2O/hexanes): Rf = 0.48 (p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 6.39 (dd, J = 17.8, 11.3 Hz, 1H, C19), 5.28 (dd, J = 17.8, 
1.4 Hz, 1H, C20), 5.17 (dd, J = 11.2, 1.4 Hz, 1H, C20), 5.13 (s, 1H, C17), 5.05 (s, 1H, C17), 
4.68 (d, J = 7.1 Hz, 1H, OCH2OMe), 4.40 (d, J = 6.7 Hz, 1H, OCH2OMe), 4.06 (m, 1H, 
C14), 3.64 (s, 1H, C11), 3.34 (s, 3H, OCH2OCH3), 2.53 (ddd, J = 15.6, 10.2, 7.5 Hz, 1H, 
C2), 2.37 (dd, J = 15.6, 11.0, 3.8 Hz, 1H, C2), 2.32 (dd, J = 10.9, 3.6 Hz, 1H, C8), 2.11 (dd, 
J = 15.0, 6.0 Hz, 1H, C13), 1.78 (ddd, J = 13.9, 10.2, 3.8 Hz, 1H, C1), 1.64 (m, 1H, C7), 
1.51 (m, 1H, C6), 1.46 (ddd, J = 13.9, 6.3, 3.8 Hz, 1H, C1), 1.41 (m, 1H, C13), 1.40 (m, 1H, 
C7), 1.39 (m, 1H, C8), (s, 3H, C15), 1.17 (s, 3H, C18), 1.15 (m, 3H, OSi(CH(CH3)2)3), 1.12 
(m, 18H, OSi(CH(CH3)2)3), 0.97 (d, J = 7.0 Hz, 3H, C16). 
13C NMR (101 MHz, CDCl3): δ 151.8 (C10), 147.8 (C3), 140.7 (C19), 119.2 (C4), 113.9 
(C20), 108.9 (C17), 92.2 (OCH2OCH3), 79.0 (C11), 67.6 (C14), 55.6 (OCH2OCH3), 51.5 (C9), 
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46.9 (C13), 46.6 (C5), 44.8 (C12), 44.1 (C6), 38.8 (C8), 34.9 (C1), 34.4 (C2), 28.9 (C18), 28.7 
(C7), 18.19 (OSi(CH(CH3)2)3), 18.15 (OSi(CH(CH3)2)3), 18.1 (C16), 16.4 (C15), 13.6 
(OSi(CH(CH3)2)3). 
FTIR (AT-IR): 3495 (br), 2941, 2866, 2359, 2323, 1627, 1462, 1327, 1040, 1002, 882 
cm–1. 
HRMS (TOF, ES+): calc’d for C31H54O4SiNa [M+Na]+ 541.3689, found 541.3711. 
[𝜶]𝑫𝟐𝟑: +42.2° (c = 0.490, CHCl3). 
Melting point: 99.8–101.1°C 
 
Preparation of ketone 71 
 
This procedure was adapted from the work of Shenvi and coworkers.33 A flame-
dried 25 mL Schlenk tube was charged with silyl enol ether 70 (116 mg, 0.224 mmol, 1 
equiv) and adventitious water was removed via azeotropic drying with PhH (3 x 1 mL) 
under high vacuum. An oven-dried stir bar was added, and the atmosphere was exchanged 
three times for argon. Thereafter, iPrOH (3.4 mL), PhSiH3 (36.3 mg, 0.336 mmol, 41.4 μL, 
1.5 equiv), and tert-butyl hydroperoxide (89.5 μL of a 5.0 M solution in nonane, 0.448 
mmol, 2 equiv) were added. The mixture was subjected to three freeze-pump-thaw cycles. 
Another Schlenk tube was charged with tris(2,2,6,6-tetramethyl-3,5-
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for argon before adding iPrOH (1.4 mL). This solution was subjected to three freeze-pump-
thaw cycles then purged with argon. A portion of this stock solution (1.1 mL, equating to 
13.5 mg Mn(dpm)3, 0.0224 mmol, 10 mol %) was added to the substrate solution, and the 
reaction was stirred at ambient temperature. The reaction began as a dark orange solution 
but became light yellow within 10 min. After 30 min, an additional portion (300 μL) of the 
Mn(dpm)3 stock solution was added. 
After 1 h, the reaction was passed through a plug of SiO2 (eluting with 
Et2O/hexanes = 10%), and concentrated under reduced pressure to afford a dark orange oil 
that was immediately purified via flash column chromatography on SiO2 [15 g SiO2, 
Et2O/hexanes = 7%→11%] to afford ketone 71 (63.9 mg, 0.123 mmol, 55% yield) as a 
viscous, colorless oil.  
In addition, the following were isolated: C19–C20 reduced product (9.9 mg, 0.0190 
mmol, 8% yield) (15% Et2O/hexanes, Rf = 0.70 [p-anisaldehyde, stains green]), fully 
reduced product (4.4 mg, 0.00842 mmol, 4% yield, 1:1 dr) (15% Et2O/hexanes, Rf = 0.53 
[p-anisaldehyde, stains dark blue]), and remaining starting material (26.6 mg, 0.0513 
mmol, 23% recovered). 
Experimental Notes: This reaction exhibits a pronounced sensitivity to both residual 
oxygen and water. In addition, we found it critical to perform this reaction at 23 °C, as 
higher temperatures promoted over-reduction and lower temperatures slowed catalysis. 
iPrOH was stored over activated 4 Ǻ molecular sieves (pellets) overnight then was distilled 
from CaH2 (10% w/v) in a flame-dried, argon-filled apparatus immediately prior to use. 
 
TLC (15% Et2O/hexanes): Rf = 0.60 (p-anisaldehyde). 
Chapter 2 – Total Synthesis of (+)-Pleuromutilin and (+)-12-epi-Pleuromutilin 117 
1H NMR (500 MHz, CDCl3): δ 6.15 (dd, J = 17.6, 11.1 Hz, 1H, C19), 5.28 (dd, J = 17.6, 
1.6 Hz, 1H, C20), 5.23 (dd, J = 11.1, 1.6 Hz, 1H, C20), 4.69 (d, J = 7.0 Hz, 1H, OCH2OMe), 
4.62 (d, J = 7.0 Hz, 1H, OCH2OMe), 3.40 (s, 3H, OCH2OCH3), 3.29 (d, J = 4.6 Hz, 1H, 
C11), 2.80 (d, J = 11.4 Hz, 1H, C13), 2.47 (m, 2H, C2), 2.04 (ddd, J = 13.8, 10.2, 5.1 Hz, 
1H, C1), 1.98 (dt, J = 13.1, 3.0 Hz, 1H, C8), 1.95 (d, J = 11.4 Hz, 1H, C13), 1.91 (dq, J = 
7.1, 4.6 Hz, 1H, C10), 1.65 (qd, J = 13.8, 3.4 Hz, 1H, C7), 1.57 (s, 3H, C15), 1.43 (m, 1H, 
C6), 1.34 (m, 1H, C7), 1.31 (m, 1H, C1), 1.26 (m, 1H, C8), 1.24 (d, J = 7.0 Hz, 3H, C16), 
1.18 (m, 3H, OSi(CH(CH3)2)3), 1.13 (m, 18H, OSi(CH(CH3)2)3), 1.10 (s, 3H, C18), 0.83 
(d, J = 7.1 Hz, 3H, C17). 
13C NMR (125 MHz, CDCl3): δ 215.1 (C14=O), 148.2 (C3), 139.0 (C19), 117.8 (C4), 115.5 
(C20), 99.3 (OCH2OCH3), 85.2 (C11), 56.4 (OCH2OCH3), 54.8 (C5), 51.5 (C9), 49.3 (C13), 
48.3 (C12), 43.8 (C6), 39.4 (C8), 37.1 (C10), 34.0 (C2), 27.8 (C7), 27.5 (C1), 27.3 (C18), 22.2 
(C15), 18.15 (OSi(CH(CH3)2)3), 18.11 (OSi(CH(CH3)2)3), 16.5 (C16), 13.6 
(OSi(CH(CH3)2)3), 11.5 (C17). 
FTIR (AT-IR): 2944, 2867, 1698, 1650, 1463, 1331, 1206, 1038, 1004 cm–1. 
HRMS (TOF, ES+): calc’d for C31H54O4SiNa [M+Na]+ 541.3689, found 541.3701. 
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Preparation of alcohol 72 
 
A 250 mL 3-necked flask equipped with a stir bar was equipped with a cold finger 
connected to a two-way valve, and the entire apparatus was flame-dried under high 
vacuum. After cooling to ambient temperature, the atmosphere was exchanged three times 
for argon, and anhydrous EtOH (13.3 mL) and Et2O (7.3 mL) were added. The mixture 
was cooled to –78 °C, and ammonia (53 mL) was condensed into the vessel. Subsequently, 
a solution of ketone 71 (41.4 mg, 0.0798 mmol, 1 equiv) in Et2O (8.3 mL) was added. After 
allowing the system to equilibrate for 5 min, Li0 wire (124 mg, 17.9 mmol, 224 equiv) that 
had been freshly washed with hexanes and cut into ~5 mg pieces was added. Within 3 min, 
a deep blue color developed, and after 30 min, the reaction was colorless. 
The apparatus was removed from the cooling bath, and ammonia was boiled off 
over 2 h. The resulting slurry was extracted into Et2O (100 mL), washed with sat. aq. 
NaHCO3 (1 x 15 mL), dried over Na2SO4, filtered, and concentrated under reduced 
pressure to afford an oil. Purification was achieved via flash column chromatography on 
SiO2 [3 g SiO2, Et2O/hexanes = 7%] to afford alcohol 72 (25.2 mg, 0.0487 mmol, 61% 
yield) as a viscous, colorless oil. 
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1H NMR (400 MHz, CDCl3): δ 6.07 (ddd, J = 17.9, 11.2 Hz, 0.7 Hz, 1H, C19), 5.28 (dd, 
J = 17.9, 1.6 Hz, 1H, C20), 5.23 (dd, J = 11.2, 1.6 Hz, 1H, C20), 4.64 (d, J = 6.7 Hz, 1H, 
OCH2OMe), 4.62 (d, J = 6.7 Hz, 1H, OCH2OMe), 4.16 (dd, J = 7.1, 2.6 Hz, 1H, C14), 3.40 
(s, 3H, OCH2OCH3), 3.01 (d, J = 5.6 Hz, 1H, C11), 2.46–2.34 (m, 2H, C2), 2.04 (ddd, J = 
14.9, 7.8, 0.8 Hz, 1H, C13), 1.99 (m, 1H, C10), 1.96 (dt, J = 9.4, 3.4 Hz, 1H, C1), 1.60 (d, J 
= 14.9 Hz, 1H, C13), 1.46 (m, 1H, C7), 1.41 (m, 1H, C6), 1.40 (s, 3H, C15), 1.35 (m, 1H, 
C7), 1.23 (m, 1H, C8), 1.21 (m, 1H, C8), 1.17 (m, 1H, C1), 1.15 (m, 3H, OSi(CH(CH3)2)3), 
1.13 (m, 18H, OSi(CH(CH3)2)3), 1.01 (s, 3H, C18), 0.99 (d, J = 6.3 Hz, 3H, C16), 0.85 (d, J 
= 7.1 Hz, 3H, C17). 
13C NMR (101 MHz, CDCl3): δ 147.0 (C3=O), 141.3 (C19), 120.5 (C4), 114.4 (C20), 99.2 
(OCH2OCH3), 84.6 (C11), 68.6 (C14), 56.5 (OCH2OCH3), 50.7 (C9), 46.5 (C12), 46.1 (C13), 
46.0 (C5), 43.3 (C6), 39.3 (C1), 38.2 (C10), 34.3 (C2), 30.0 (C18), 28.5 (C8), 28.3 (C7), 18.3 
(C15), 18.24 (OSi(CH(CH3)2)3), 18.18 (OSi(CH(CH3)2)3), 17.8 (C16), 13.8 
(OSi(CH(CH3)2)3), 11.8 (C17). 
FTIR (AT-IR): 3493 (br), 2944, 2866, 2359, 2341, 1637, 1461, 1218, 1038, 1002 cm–1. 
HRMS (TOF, ES+): calc’d for C31H55O4Si [(M+H)–H2]+ 519.3870, found 519.3873. 
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Preparation of (+)-pleuromutilin (1) 
 
This procedure was adapted from the work of Procter and coworkers.4 A flame-
dried 2 dram vial equipped with a stir bar was charged with alcohol 72 (20.2 mg, 0.0388 
mmol, 1 equiv), EDCI•HCl (44.6 mg, 0.233 mmol, 6 equiv), and DMAP (28.4 mg, 0.233 
mmol, 6 equiv), and the atmosphere was exchanged three times for argon. Subsequently, 
the vessel was charged with anhydrous CH2Cl2 (1.9 mL) and 2-(2,2,2-
trifluoroacetoxy)acetic acid (40.0 mg, 0.230 mmol, 6 equiv), and the reaction was stirred 
at ambient temperature. After 10 min, a light yellow color developed, and after 30 min, the 
reaction was complete by TLC analysis (30% Et2O/hexanes, Rf = 0.77 [p-anisaldehyde, 
stains dark blue/purple], Rf (starting material) = 0.70). Thereafter, a solution of anhydrous 
MeOH (31 μL, 0.776 mmol, 20 equiv) in freshly distilled Et3N (107 μL, 0.768 mmol, 20 
equiv) was added, and the reaction immediately turned bright yellow. After 5 min, the 
reaction was judged was complete by TLC analysis (30% Et2O/hexanes, Rf = 0.35 [p-
anisaldehyde, stains dark blue/purple]). A solution of HCl in THF (1.16 mL of a 2.0 M 
solution, 1.92 mmol) was added, and the reaction was heated to 50 °C. After 30 min, an 
additional portion of HCl in THF (500 uL) was added. At this time, hydrolysis of the 
methoxymethyl group was judged complete by TLC analysis (70% Et2O/hexanes, Rf = 0.42 
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The reaction was cooled to 0 °C and was cautiously quenched with sat. aq. NaHCO3 
(3 mL). After warming to ambient temperature, the crude mixture was extracted into Et2O 
(3 x 5 mL), dried over Na2SO4, filtered, and concentrated under reduced pressure to afford 
an orange oil. Purification was achieved via flash column chromatography on SiO2 [1.5 g 
SiO2, Et2O/hexanes = 50%→70%] to afford (+)-pleuromutilin (1) (11.8 mg, 0.0312 mmol, 
80% yield) as a white solid. 
 
TLC (70% Et2O/hexanes): Rf = 0.22 (p-anisaldehyde). 
1H NMR (500 MHz, CDCl3): δ 6.50 (dd, J = 17.4, 11.0 Hz, 1H, C19), 5.85 (d, J = 8.6 Hz, 
1H, C14), 5.37 (dd, J = 11.0, 1.3 Hz, 1H, C20), 5.22 (dd, J = 17.4, 1.4 Hz, 1H, C20), 4.05 
(qd, J = 17.1, 5.4 Hz, 2H, C22), 3.34 (dd, J = 10.8, 6.6 Hz, 1H, C11), 2.35 (t, J = 5.5 Hz, 1H, 
C22–OH), 2.33 (m, 1H, C10), 2.25 (m, 1H, C2), 2.22 (m, 1H, C2), 2.11 (br s, 1H, C4), 2.10 
(dd, J = 16.0, 8.7 Hz, 1H, C13), 1.79 (dq, J = 14.5, 3.1 Hz, 1H, C8), 1.68 (m, 1H, C6), 1.66 
(m, 1H, C1), 1.55 (dd, J = 13.8, 2.7 Hz, 1H, C7), 1.51 (m, 1H, C1), 1.46 (br m, 1H, C12–
OH), 1.44 (s, 3H, C15), 1.40 (ddd, J = 13.8, 6.0, 2.7 Hz, 1H, C7), 1.33 (d, J = 16.0 Hz, 1H, 
C13), 1.19 (s, 3H, C18), 1.15 (td, J = 14.3, 4.4 Hz, 1H, C8), 0.91 (d, J = 7.1 Hz, 3H, C17), 
0.72 (d, J = 7.1 Hz, 3H, C16). 
13C NMR (126 MHz, CDCl3): δ 216.8 (C3=O), 172.1 (C21=O), 138.8 (C19), 117.4 (C20), 
74.5 (C11), 69.8 (C14), 61.3 (C22), 58.0 (C4), 45.4 (C9), 44.7 (C13), 44.0 (C12), 41.8 (C5), 
36.6 (C6), 36.0 (C10), 34.4 (C2), 30.4 (C8), 26.8 (C7), 26.3 (C18), 24.8 (C1), 16.6 (C16), 14.7 
(C15), 11.5 (C17). 
FTIR (AT-IR): 3437 (br), 2931, 1728, 1454, 1374, 1267, 1215, 1153, 1094, 1015, 915, 
858, 734 cm–1. 
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HRMS (TOF, ES+): calc’d for C22H34O5Na [M+Na]+ 401.2304, found 401.2296. 
[𝜶]𝑫𝟐𝟑: +33.4° (c = 0.252, CHCl3). 
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Comparison of 1H NMR data for (+)-pleuromutilin (1) 
 




































1H NMR, 500 MHz, CDCl3 
1H [δ, multi, J (Hz)] 
This Work, 
Synthetic (+)-Pleuromutilin 
1H NMR, 500 MHz, CDCl3 
1H [δ, multi, J (Hz)] 
1α 1.41–1.53 (m) 1.41–1.52 (m) 
1β 1.61–1.73 (m) 1.61–1.73 (m) 
2α 2.16–2.30 (m) 2.16–2.30 (m) 
2β 2.16–2.30 (m) 2.16–2.30 (m) 
3   
4 2.11 (s) 2.11 (s) 
5   
6 1.61–1.73 (m) 1.61–1.73 (m) 
7α 1.55 (dd, J = 13.8, 2.7 Hz) 1.55 (dd, J = 13.8, 2.7 Hz) 
7β 1.40 (ddd, J = 13.8, 6.0, 2.7 Hz) 1.40 (ddd, J = 13.8, 6.0, 2.7 Hz) 
8α 1.79 (dq, J = 14.5, 3.1 Hz) 1.79 (dq, J = 14.5, 3.1 Hz) 
8β 1.15 (td, J = 14.3, 4.4 Hz) 1.15 (td, J = 14.3, 4.4 Hz) 
9   
10 2.29–2.40 (m) 2.29–2.40 (m) 
11 3.34 (dd, J = 10.8, 6.6 Hz) 3.34 (dd, J = 10.8, 6.6 Hz) 
12   
13α 2.10 (dd, J = 16.0, 8.7 Hz) 2.10 (dd, J = 16.0, 8.7 Hz) 
13β 1.33 (d, J = 16.0 Hz) 1.33 (d, J = 16.0 Hz) 
14 5.85 (d, J = 8.6 Hz) 5.85 (d, J = 8.6 Hz) 
15 1.44 (s) 1.44 (s) 
16 0.71 (d, J = 7.1 Hz) 0.71 (d, J = 7.1 Hz) 
17 0.90 (d, J = 7.1 Hz) 0.90 (d, J = 7.1 Hz) 
18 1.18 (s) 1.18 (s) 
19 6.50 (dd, J = 17.4, 11.0 Hz) 6.50 (dd, J = 17.4, 11.0 Hz) 
20α 5.37 (dd, J = 11.0, 1.4 Hz) 5.37 (dd, J = 11.0, 1.3 Hz) 
20β 5.22 (dd, J = 17.4, 1.4 Hz) 5.22 (dd, J = 17.4, 1.4 Hz) 
21   
22 4.05 (qd, J = 17.1, 5.4 Hz) 4.05 (qd, J = 17.1, 5.4 Hz) 
23 2.30–2.40 (br)* 2.30–2.40 (br)* 
24 1.44–1.52 (br)* 1.44–1.52 (br)* 
Chapter 2 – Total Synthesis of (+)-Pleuromutilin and (+)-12-epi-Pleuromutilin 124 
§Spectrum acquired using a sample of natural (+)-pleuromutilin purchased from Sigma-
Aldrich (SML0285-5MG, Lot# 032M4709V) 
 








































Schulz and Berner Report37, 
Natural (+)-Pleuromutilin 
13C NMR, 90 MHz, CDCl3 




13C NMR, 126 MHz, 
CDCl3 
13C (δ) ppm 
Chemical Shift 
Difference 
1 24.9 24.8 0.1 
2 34.5 34.4 0.1 
3 216.8 216.8 0 
4 58.2 58.0 0.2 
5 41.9 41.8 0.1 
6 36.7 36.6 0.1 
7 26.9 26.8 0.1 
8 30.4 30.4 0 
9 45.5 45.4 0.1 
10 36.1 36.0 0.1 
11 74.7 74.5 0.2 
12 44.1 44.0 0.1 
13 44.9 44.7 0.2 
14 69.9 69.8 0.1 
15 14.8 14.7 0 
16 16.6 16.6 0 
17 11.5 11.5 0 
18 26.5 26.3 0.2 
19 138.9 138.8 0.1 
20 117.3 117.4 0.1 
21 172.2 172.1 0.1 
22 61.4 61.3 0.1 
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Preparation of 12-epi crotylation adducts 74 and 75 
 
This procedure was adapted from the work of Szabó and coworkers.10 In a nitrogen-
filled glovebox, a flame-dried, 50 mL Schlenk flask equipped with a stir bar was charged 
with freshly activated 3 Ǻ molecular sieves (pellets) (613 mg), allylboronic acid 73 (11.5 
mL of a 0.15 M solution, 1.68 mmol, 1 equiv), 3,3′-Br2-(R)-BINOL (149 mg, 0.336 mmol, 
20 mol %), freshly distilled tBuOH (483 µL, 5.09 mmol, 3 equiv), and a solution of the 
enal hydrindanone 10 (367 mg, 1.68 mmol, 1 equiv) in dry, degassed PhMe (1.68 mL). 
The resulting heterogeneous mixture was sealed, removed from the glovebox, then placed 
in a pre-equilibrated 0 °C bath and stirred. 
After 40 h, the reaction was quenched with MeOH (5 mL), stirred for 5 min, 
filtered, and concentrated under reduced pressure to afford a viscous residue. Purification 
was achieved via flash column chromatography on SiO2 [100 g SiO2, Acetone/hexanes = 
4%→15%] to afford 74 and a mixture of 75 and residual 3,3′-Br2-(R)-BINOL (fractions 
71–85). The volatiles were concentrated under reduced pressure to afford 74 (566 mg, 1.01 
mmol, 60% yield) as a puffy white solid and the 75/BINOL mixture, respectively. 
The 75/BINOL mixture was subjected to flash column chromatography on SiO2 
[100 g SiO2, Et2O/hexanes = 40%] to afford 3,3′-Br2-(R)-BINOL and 75 (237 mg, 0.423 
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Experimental Note: It is critical that all operations be carried out in a rigorously oxygen-
free environment. Failure to do so will result in rapid decomposition of the allylboronic 
acid. 
 
12-epi crotylation adduct (74) 
TLC (20% acetone/hexanes): Rf = 0.54 (UV, p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 7.43 (dd, J = 8.4, 1.3 Hz, 6H, OCPh3), 7.34 – 7.19 (m, 9H, OCPh3), 
6.15 (dd, J = 17.8, 10.9 Hz, 1H, C19), 5.59 (s, 1H, C17), 5.04 (dd, J = 10.9, 1.2 Hz, 1H, C20), 4.92 
(dd, J = 17.8, 1.3 Hz, 1H, C20), 4.76 (s, 1H, C17), 4.01 (d, J = 6.7 Hz, 1H, C11), 3.21 (dt, J = 10.0, 
6.3 Hz, 1H, C14), 3.11 (ddd, J = 9.9, 7.4, 5.4 Hz, 1H, C14), 2.54 (d, J = 7.0 Hz, 1H, OH), 2.22 – 2.05 
(m, 8H, C1, C2, C6, C8), 1.92 (dd, J = 13.5, 6.2 Hz, 1H, C13), 1.80 (dd, J = 12.9, 6.9 Hz, 1H, C13), 
1.64 (dtd, J = 15.5, 6.1, 5.1, 3.5 Hz, 1H, C7), 1.57 – 1.46 (m, 1H, C1), 1.36 – 1.13 (m, 3H, C7, C8), 
1.05 (d, J = 7.1 Hz, 3H, C16), 0.88 (s, 3H, C18). 
13C NMR (101 MHz, CDCl3): δ 208.0 (C3=O), 152.8 (C10), 152.5 (C5), 143.9 (OCPh3), 142.8 
(C19), 135.7 (C4), 128.6 (OCPh3), 127.8 (OCPh3), 127.0 (OCPh3), 118.4 (C17), 113.9 (C20), 87.4 
(OCPh3), 74.4 (C11), 60.7 (C14), 52.0 (C9), 44.5 (C12), 40.0 (C13), 38.0 (C6), 35.5 (C2), 33.2 (C8), 
32.4 (C1), 28.4 (C7), 19.9 (C18), 19.1 (C16), 17.0 (C15). 
FTIR (thin film, NaCl): 3416, 2930, 1702, 1627, 1448, 1213, 1032, 758, 632 cm–1. 
HRMS (TOF, ES+): calc’d for C39H44O3Na [M+Na]+ 583.3188, found 583.3174. 
[𝜶]𝑫𝟐𝟑: –72.0° (c = 0.41, CHCl3). 
 
11-epi crotylation adduct (75) 
TLC (40% Et2O/hexanes): Rf = 0.14 (UV, p-anisaldehyde). 
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1H NMR (400 MHz, CDCl3): δ 7.46 – 7.39 (m, 6H, OCPh3), 7.33 – 7.20 (m, 9H, OCPh3), 6.15 
(dd, J = 17.8, 10.9 Hz, 1H, C19), 5.62 (s, 1H, C17), 5.04 (dd, J = 10.9, 1.3 Hz, 1H, C20), 4.95 (dd, J 
= 17.8, 1.4 Hz, 1H, C20), 4.77 (s, 1H, C17), 3.95 (d, J = 7.3 Hz, 1H, C11), 3.26 – 3.16 (m, 1H, C14), 
3.15 – 3.05 (m, 1H, C14), 2.62 (d, J = 7.4 Hz, 1H, OH), 2.47 (dd, J = 12.2, 7.9 Hz, 1H, C2), 2.32 – 
2.17 (m, 1H, C8), 2.15 (d, J = 5.9 Hz, 1H, C6), 2.12 (s, 3H, C15), 2.04 (dd, J = 18.4, 7.6 Hz, 1H, C8), 
1.95 (dd, J = 12.5, 7.2 Hz, 1H, C13), 1.89 (d, J = 13.2 Hz, 1H, C1), 1.85 – 1.76 (m, 1H, C13), 1.65 – 
1.56 (m, 1H, C7), 1.42 (td, J = 12.5, 7.9 Hz, 1H, C2), 1.33 – 1.11 (m, 3H, C1, C7), 1.06 (d, J = 7.1 
Hz, 3H, C16), 0.89 (s, 3H, C18). 
13C NMR (101 MHz, CDCl3): δ 208.4 (C3=O), 152.2 (C10), 151.0 (C5), 143.9 (OCPh3), 142.9 
(C19), 136.3 (C4), 128.6 (OCPh3), 127.8 (OCPh3), 127.0 (OCPh3), 118.7 (C17), 113.9 (C20), 87.5 
(OCPh3), 74.7 (C11), 60.7 (C14), 52.0 (C9), 44.3 (C12), 40.2 (C13), 37.5 (C6), 35.8 (C8), 32.7 (C1), 
32.5 (C2), 28.2 (C7), 20.4 (C18), 19.2 (C16), 16.8 (C15). 
FTIR (thin film, NaCl): 3451, 2930, 1702, 1630, 1449, 1214, 1066, 923, 759, 705 cm–1. 
HRMS (TOF, ES+): calc’d for C39H44O3Na [M+Na]+ 583.3188, found 583.3178. 
[𝜶]𝑫𝟐𝟑: –53.4° (c = 0.585, CHCl3). 
 
Preparation of MOM protected crotylation adduct (12-epi) 
 
A flame-dried, 50 mL round-bottom flask equipped with a stir bar was charged with 
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(4.3 mL, 24.7 mmol, 26 equiv). To the homogeneous solution was added chloromethyl 
methyl ether (1.8 mL. 23.8 mmol, 25 equiv) dropwise over 10 min, taking care to vent HCl 
fumes formed via the use of a needle. The reaction was stirred at ambient temperature for 
20 h. The resulting viscous, orange mixture was quenched via addition of sat. aq. NaHCO3 
(20 mL) and stirred at ambient temperature for 30 min. The aqueous layer was extracted 
with CH2Cl2 (3 x 10 mL) and washed with H2O (1 x 10 mL). The combined organic layers 
were washed with brine (1 x 10 mL), dried over Na2SO4, and concentrated via distillation 
to afford a viscous, dark orange residue. 
Purification was achieved via flash column chromatography on SiO2 [50 g SiO2, 
Et2O/hexanes = 20%] to afford MOM ether (455 mg, 0.75 mmol, 79% yield) as a puffy 
white solid. 
 
TLC (40% Et2O/hexanes): Rf = 0.56 (UV, p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 7.42 (m, 6H, OCPh3), 7.32 – 7.17 (m, 9H, OCPh3), 5.88 (dd, J = 
17.7, 10.9 Hz, 1H, C19), 5.49 (s, 1H, C17), 4.93 (dd, J = 10.9, 1.2 Hz, 1H, C20), 4.86 (s, 1H, C17), 
4.79 (dd, J = 17.7, 1.2 Hz, 1H, C20), 4.59 (d, J = 6.7 Hz, 1H, OCH2OCH3), 4.55 (d, J = 6.7 Hz, 1H, 
OCH2OCH3), 3.84 (s, 1H, C11), 3.38 (s, 3H, OCH2OCH3), 3.14 – 3.00 (m, 2H, C14), 2.22 – 2.04 
(m, 8H, C1, C2, C6, C7, C15), 1.98 – 1.81 (m, 2H, C13), 1.67 – 1.57 (m, 1H, C8), 1.56 – 1.40 (m, 1H, 
C1), 1.28 – 1.20 (m, 2H, C7, C8), 1.06 (d, J = 7.1 Hz, 3H, C16), 0.93 (s, 3H, C18). 
13C NMR (101 MHz, CDCl3): δ 208.1 (C3=O), 151.8 (C5), 149.8 (C10), 144.4 (OCPh3), 143.2 
(C19), 136.2 (C4), 128.7 (OCPh3), 127.7 (OCPh3), 126.8 (OCPh3), 121.4 (C17), 113.8 (C20), 96.4 
(OCH2OCH3), 86.8 (OCPh3), 82.1 (C11), 60.7 (C14), 56.4 (OCH2OCH3), 51.0 (C9), 45.3 (C12), 37.7 
(C6), 36.9 (C13), 35.9 (C2), 33.4 (C7), 32.5 (C1), 28.2 (C8), 19.7 (C19), 19.1 (C16), 17.1 (C15). 
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FTIR (thin film, NaCl): 3418, 2931, 2071, 1704, 1628, 1449, 1214, 1036, 920, 760 cm–1. 
HRMS (TOF, ES+): calc’d for C41H48O4Na [M+Na]+ 627.3450, found 627.3444. 
[𝜶]𝑫𝟐𝟑: –52.6° (c = 0.965, CHCl3). 
 
Preparation of alcohol 76 (12-epi) 
 
A flame-dried, 250 mL round-bottom flask equipped with a stir bar was charged 
with MOM ether (332 mg, 0.549 mmol, 1 equiv). Thereafter, a freshly prepared solution 
of formic acid (98%, 3.4 mL) and Et2O (3.4 mL) was rapidly added, and within 5 min, the 
reaction was judged to be complete by TLC analysis. We found it critical to stop this 
reaction immediately after full conversion was achieved. Prolonged times afforded copious 
quantities of formate ester product. The reaction was diluted with Et2O (15 mL) and 
quenched via slow addition of NaHCO3 (100 mL). The aqueous layer was extracted with 
Et2O (4 x 25 mL) and washed with H2O (1 x 10 mL). The combined organic layers were 
washed with brine (1 x 25 mL), dried over Na2SO4, and concentrated under reduced 
pressure to afford a viscous yellow residue. 
Purification was achieved via flash column chromatography on SiO2 [7 g SiO2, 
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TLC (40% Et2O/hexanes): Rf = 0.13 (UV, p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 6.07 (dd, J = 17.8, 10.9 Hz, 1H, C19), 5.58 (s, 1H, C17), 5.11 (dd, 
J = 10.9, 1.1 Hz, 1H, C20), 5.03 (dd, J = 17.8, 1.2 Hz, 1H, C20), 4.92 (s, 1H, C17), 4.65 (d, J = 6.8 
Hz, 1H, OCH2OCH3), 4.59 (d, J = 6.8 Hz, 1H, OCH2OCH3), 3.94 (s, 1H, C11), 3.66 (td, J = 6.9, 
3.0 Hz, 2H, C14), 3.42 (s, 3H, OCH2OCH3), 2.30 – 2.11 (m, 8H, C1, C2, C6, C8, C15), 1.89 (td, J = 
6.8, 4.1 Hz, 2H, C13), 1.66 – 1.54 (m, 2H, C1, C7), 1.31 – 1.23 (m, 2H, C7, C8), 1.11 (s, 3H), 1.07 
(d, J = 7.0 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 207.9 (C3=O), 151.9 (C5), 149.8 (C10), 143.7 (C19), 136.1 (C4), 
121.7 (C17), 114.0 (C20), 96.2 (OCH2OCH3), 82.1 (C11), 59.7 (C14), 56.4 (OCH2OCH3), 50.9 (C9), 
45.4 (C12), 39.9 (C13), 37.7 (C7), 35.8 (C2), 33.4 (C8), 32.5 (C1), 28.1 (C7), 19.8 (C18), 19.0 (C16), 
17.0 (C15). 
FTIR (thin film, NaCl): 3417, 2931, 1704, 1627, 1455, 1212, 1152, 1036, 918, 731 cm–1. 
HRMS (TOF, ES+): calc’d for C22H34O4Na [M+Na]+ 385.2355, found 385.2344. 
[𝜶]𝑫𝟐𝟑: –43.8° (c = 0.230, CHCl3). 
 
Preparation of aldehyde 77 (12-epi) 
 
Stahl Oxidation: 
A flame-dried, 2 dram vial equipped with a stir bar was charged with alcohol 76 
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[Cu]/bpy stock solution, 860 μL of the NMI stock solution, and 860 μL of the ABNO stock 
solution, in that order. The orange reaction was stirred at 960 rpm open to the atmosphere 
for 90 min. Subsequently, the resulting light blue solution was diluted with Et2O (3 mL), 
passed through a short pad of SiO2 using Et2O as the eluent, and concentrated under 
reduced pressure to afford a pale yellow oil. 
Purification was achieved via flash column chromatography on SiO2 [8 g SiO2, 
Et2O/hexanes = 30%→60%] to afford aldehyde 77 (148 mg, 0.411 mmol, 90% yield) as a 
viscous, colorless oil that solidified to a white solid upon standing in the freezer. 
 
Preparation of stock solutions: See page 101. 
 
TLC (70% Et2O/hexanes): Rf = 0.57 (UV, p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 9.73 (dd, J = 4.1, 1.8 Hz, 1H, C14), 6.08 (dd, J = 17.7, 10.9 Hz, 
1H, C19), 5.51 (s, 1H, C17), 5.16 (dd, J = 10.9, 0.7 Hz, 1H, C20), 5.10 (dd, J = 17.7, 0.7 Hz, 1H, 
C20), 4.99 – 4.97 (m, 1H, C17), 4.58 (d, J = 6.9 Hz, 1H, OCH2OCH3), 4.51 (d, J = 6.9 Hz, 1H, 
OCH2OCH3), 4.00 (d, J = 1.2 Hz, 1H, C11), 3.40 (s, 3H, OCH2OCH3), 2.66 (dd, J = 15.1, 4.1 Hz, 
1H, C13), 2.49 (dd, J = 15.1, 1.7 Hz, 1H, C13), 2.29 – 2.05 (m, 8H, C1, C2, C6, C8, C15), 1.68 – 1.49 
(m, 2H, C1, C7), 1.32 (s, 3H, C18), 1.30 – 1.21 (m, 2H, C7, C8), 1.06 (d, J = 7.1 Hz, 3H, C16). 
13C NMR (101 MHz, CDCl3): δ 207.8 (C14=O), 202.6 (C3=O), 141.8 (C5), 122.0 (C10), 114.8 (C19), 95.3 
(OCH2OCH3), 80.4 (C11), 56.5 (OCH2OCH3), 50.7 (C9), 50.2 (C13), 45.7 (C12), 37.6 (C6), 35.9 (C2), 33.4 
(C8), 32.5 (C1), 28.1 (C7), 21.8 (C18), 19.1 (C16), 17.1 (C15). 
FTIR (thin film, NaCl): 2932, 1714, 1628, 1456, 1413, 1373, 1212, 1151, 1035, 921 cm–
1. 
HRMS (TOF, ES+): calc’d for C22H32O4Na [M+Na]+ 383.2198, found 383.2182. 
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[𝜶]𝑫𝟐𝟑: –67.3° (c = 0.095, CHCl3). 
 
Preparation of tricycle 78 (12-epi) 
 
A 25 mL Schlenk tube equipped with a stir bar was charged with a solution of 
aldehyde 77 (75 mg, 0.208 mmol, 1 equiv) in 10.3 mL of THF that had been submitted to 
five freeze-pump-thaw cycles and H2O/THF (1.88 mL). The solution was cooled to 0 ºC 
and stirred at this temperature for 5 min. Thereafter, SmI2/THF (6.3 mL, 0.63 mmol, 3 
equiv) was added dropwise over 8 min. The deep blue color of SmI2 was immediately 
quenched upon addition of each drop. The first drop afforded a yellow solution, fading to 
a pale yellow and almost clear by the time 1.6 equiv SmI2 had been added. When 2.2 equiv 
SmI2 had been added, the blue color became increasingly persistent and upon addition of 
2.6 equiv SmI2, the reaction was dark blue/green. After stirring an additional 10 min at 0 
ºC, TMSCl/THF (1.9 mL, 1.05 mmol, 5 equiv TMSCl) was added dropwise over 2 min, 
and the reaction was stirred an additional 10 min. Throughout this time, the deep blue color 
was quenched to yellow. Thereafter, the reaction was removed from the ice bath and stirred 
open to the atmosphere for 5 min. 
The resulting pale yellow solution was diluted with Et2O (50 mL), and washed with 















THF, 0 ºC, 
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combined organic layers were dried over Na2SO4, filtered, and concentrated under reduced 
pressure to afford a dark orange oil. Purification was achieved via flash column 
chromatography on SiO2 [10 g SiO2, Et2O/hexanes = 30%] to afford tricycle 78 (62 mg, 
0.172 mmol, 77% yield) as a white solid. 
 
Preparation of SmI2: See page 103. 
Stock solution of TMSCl: See page 104. 
Stock solution of H2O/THF: A solution of H2O (60 µL) in THF (5.0 mL) was submitted 
to five freeze-pump-thaw cycles. 
 
TLC (50% Et2O/hexanes): Rf = 0.50 (p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 5.98 (dd, J = 17.5, 10.8 Hz, 1H, C19), 5.42 (d, J = 0.9 Hz, 1H, C17), 
5.32 (t, J = 0.7 Hz, 1H, C17), 5.09 (dd, J = 17.5, 1.0 Hz, 1H, C20), 5.03 (dd, J = 10.8, 1.0 Hz, 1H, 
C20), 4.54 (d, J = 7.1 Hz, 1H, OCH2OCH3), 4.34 (dd, J = 7.1, 0.5 Hz, 1H, OCH2OCH3), 4.12 (d, J 
= 6.2 Hz, 1H, C14), 4.00 (s, 1H, C11), 3.34 (s, 3H, OCH2OCH3), 2.39 – 2.16 (m, 3H, C2, C4), 2.13 – 
1.96 (m, 3H, C1, C8, C13), 1.72 (dtt, J = 15.9, 6.2, 2.9 Hz, 1H, C6), 1.63 (dd, J = 13.1, 3.3 Hz, 1H, 
C7), 1.46 – 1.37 (m, 1H, C7), 1.29 (s, 4H, C1, C15), 1.24 (d, J = 0.8 Hz, 3H, C18), 1.08 (dd, J = 15.8, 
1.2 Hz, 1H, C8), 0.98 (d, J = 6.8 Hz, 3H, C16). 
13C NMR (101 MHz, CDCl3): δ 216.6 (C3=O), 148.1 (C19), 147.9 (C10), 112.8 (C17), 111.3 (C20), 
92.3 (OCH2OCH3), 76.2 (C11), 67.0 (C14), 59.5 (C4), 55.9 (OCH2OCH3), 46.5 (C9), 45.7 (C8), 43.6 
(C12), 42.1 (C5), 37.4 (C6), 34.9 (C2), 31.2 (C13), 29.8 (C1), 26.8 (C7), 18.2 (C16), 15.1 (C18), 13.4 
(C15). 
FTIR (thin film, NaCl): 3521, 2937, 1738, 1456, 1376, 1147, 1095, 1032, 967 cm –1. 
HRMS (FAB+) calc’d for C22H35O4 [M+H]+ 363.2535, found 363.2556. 
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[𝜶]𝑫𝟐𝟑: +161.6° (c = 0.09, CHCl3). 
 
Preparation of silyl enol ether 79 (12-epi) 
 
A flame-dried 1 dram vial equipped with a stir bar was charged with tricycle 78 
(13.1 mg, 0.036 mmol, 1 equiv) and anhydrous THF (720 µL) under an atmosphere of 
argon. The mixture was cooled to –78 °C and stirred for 5 min prior to dropwise addition 
of LiHMDS in THF (108 µL of a 1.0 M solution, 0.108 mmol, 3 equiv) over 5 min. The 
resulting yellow solution was stirred at –78 °C for 5 min and was then placed in an ice bath 
and stirred for 5 min. Subsequently, TIPSOTf (22 µL, 0.072 mmol, 2 equiv) was added 
rapidly. After 3 min, the reaction was quenched at 0 °C via rapid addition of sat. aq. 
NaHCO3 (1 mL) and vigorously stirred at 0 °C for 10 min. Thereafter, the mixture was 
extracted into Et2O (3 x 1 mL) and the combined organic layers were washed with sat. aq. 
NaHCO3 (3 x 1 mL) (note: failure to quench residual TIPSOTf in this manner resulted in 
extensive decomposition of product upon concentration). The combined organic layers 
were dried over Na2SO4, filtered, and concentrated under reduced pressure to afford a pale 
yellow oil. 
Purification was achieved via flash column chromatography on SiO2 [3 g SiO2, 
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as a puffy, viscous, colorless oil that formed a white solid upon standing in the freezer 
overnight. 
 
TLC (30% Et2O/hexanes): Rf = 0.56 (p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 6.02 (dd, J = 17.5, 10.8 Hz, 1H, C19), 5.39 (s, 1H, C17), 5.23 (s, 
1H, C17), 5.09 (dd, J = 17.5, 1.1 Hz, 1H, C20), 5.01 (dd, J = 10.8, 1.1 Hz, 1H, C20), 4.50 (d, J = 6.9 
Hz, 1H, OCH2OCH3), 4.42 (q, J = 2.8 Hz, 2H, C2), 4.33 (d, J = 6.9 Hz, 1H, OCH2OCH3), 4.24 – 
4.15 (m, 2H, C11, C14), 3.33 (s, 3H, OCH2OCH3), 2.81 (s, 1H, C4), 2.33 (ddd, J = 14.2, 3.2, 1.7 Hz, 
1H, C1), 2.21 – 1.95 (m, 3H, C8, C13), 1.77 (ddq, J = 14.3, 7.1, 3.8 Hz, 1H, C6), 1.65 – 1.53 (m, 1H, 
C7), 1.45 – 1.32 (m, 2H, C1, C7), 1.32 – 1.18 (m, 6H, C18, OSi(CH(CH3)2)3), 1.15 (s, 3H, C15), 1.12 (dd, J = 
7.2, 5.1 Hz, 18H, OSi(CH(CH3)2)3), 1.04 – 0.95 (m, 4H, C13, C16). 
13C NMR (101 MHz, CDCl3) δ 157.5 (C3), 149.5 (C10), 148.6 (C19), 112.0 (C17), 110.9 (C20), 98.6 
(C2), 92.7 (OCH2OCH3), 77.2 (C11), 67.7 (C14), 55.9 (OCH2OCH3), 53.2 (C4), 48.9 (C9), 46.3 (C13), 
43.8 (C12), 41.3 (C5), 40.9 (C1), 38.4 (C6), 30.1 (C8), 27.2 (C7), 18.3 (C16), 18.1 (OSi(CH(CH3)2)3), 
17.7 (OSi(CH(CH3)2)3), 15.6 (C18), 15.3 (C15), 12.9 (OSi(CH(CH3)2)3). 
FTIR (thin film, NaCl): 2928, 1636, 1465, 1298, 1140, 1026, 906, 689 cm–1. 
HRMS (FAB+) calc’d for C31H54O4Si [M+H]+ 518.3791, found 518.3798. 
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Preparation of ketone 80 (12-epi) 
 
This procedure was adapted from the work of Shenvi and coworkers.33 To a 1 dram 
vial was added TIPS enol ether 79 (25.6 mg, 0.049 mmol, 1 equiv) and adventitious water 
was removed via azeotropic drying with PhH (3 x 1 mL) under high vacuum (70 mTorr). 
An oven dried stir bar was added, and the atmosphere was exchanged three times with 
argon. Thereafter, 775 µL of a stock solution containing PhSiH3 (9.3 µL, 0.075 mmol, 1.5 
equiv) and TBHP (20 µL, 0.100 mmol, 2 equiv) in iPrOH was added, followed by 175 µL 
of a stock solution containing Mn(dpm)3 (3.0 mg, 0.00506 mmol, 0.1 equiv) in iPrOH. The 
reaction was stirred for 30 min at ambient temperature and another 50 µL of the Mn(dpm)3 
(0.9 mg, 0.00144 mmol, 0.03 equiv) was added. After 1 h, the reaction was passed through 
a plug of SiO2 (eluting with Et2O/hexanes = 10%), and concentrated under reduced 
pressure to afford a dark orange oil. 
Purification was achieved via flash column chromatography on SiO2 [3 g SiO2, 
Et2O/hexanes = 7%→11%] to afford ketone 80 (13.7 mg, 0.0251 mmol, 54% yield) as a 
viscous, colorless oil. 
Experimental Notes: This reaction exhibits a pronounced sensitivity to both residual 
oxygen and water. In addition, we found it critical to perform this reaction at 23 °C, as 
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iPrOH was stored over activated 4 Ǻ molecular sieves (pellets) overnight then was distilled 
from CaH2 (10% w/v) in a flame-dried, argon-filled apparatus immediately prior to use. 
 
Preparation of stock solutions: PhSiH3 (30 µL) and tert-butyl hydroperoxide (65 µL of a 
5.0 M solution in nonane) were dissolved in iPrOH (2.5 mL) and the homogeneous solution 
was submitted to three freeze-pump-thaw cycles. Mn(dpm)3 (17.3 mg) was dissolved in 1 
mL iPrOH and the dark brown homogeneous solution was submitted to three freeze-pump-
thaw cycles.  
 
TLC (30% Et2O/hexanes): Rf = 0.72 (p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 5.96 (dd, J = 17.4, 10.7 Hz, 1H, C19), 5.09 – 4.97 (m, 2H, C20), 
4.55 (d, J = 7.0 Hz, 1H, OCH2OCH3), 4.53 (d, J = 7.0 Hz, 1H, OCH2OCH3), 4.44 (s, 1H, C2), 3.81 
(d, J = 5.8 Hz, 1H, C11), 3.37 (s, 3H, OCH2OCH3), 3.22 (s, 1H, C4), 2.92 (d, J = 12.0 Hz, 1H, C13), 
2.15 (ddd, J = 14.1, 3.2, 1.6 Hz, 1H, C1), 1.95 – 1.66 (m, 4H, C7, C8, C10, C13), 1.66 – 1.50 (m, 3H, 
C1, C6, C7), 1.34 (s, 3H, C15), 1.27 – 1.22 (m, 4H, C8, OSi(CH(CH3)2)3), 1.19 (s, 3H, C18), 1.17 (d, 
J = 7.0 Hz, 3H, C16), 1.13 (d, J = 2.9 Hz, 9H, OSi(CH(CH3)2)3), 1.11 (d, J = 2.9 Hz, 9H, 
OSi(CH(CH3)2)3). 
13C NMR (101 MHz, CDCl3): δ 214.4 (C14=O), 156.8 (C3), 147.7 (C19), 111.4 (C20), 98.6 (C2), 
98.1 (OCH2OCH3), 81.5 (C11), 56.6 (OCH2OCH3), 51.5 (C4), 50.6 (C5), 48.1 (C9), 47.9 (C12), 46.6 
(C13), 37.2 (C6), 34.5 (C1), 34.4 (C10), 32.0 (C7), 26.7 (C8), 23.2 (C15), 18.1 (OSi(CH(CH3)2)3), 16.2 
(C16), 15.0 (C18), 12.9 (OSi(CH(CH3)2)3), 12.0 (C17). 
FTIR (thin film, NaCl): 2946, 2868, 1698, 1634, 1463, 1300, 1129, 1086, 882, 692 cm–1. 
HRMS (FAB+): calc’d for C31H54O4Si [M]+ 518.3791, found 518.3797. 
[𝜶]𝑫𝟐𝟑: –18.5° (c = 0.195, CHCl3). 
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Preparation of alcohol 81 (12-epi) 
 
A 100 mL 3-necked flask equipped with a stir bar was equipped with a cold finger 
connected to a two-way valve, and the entire apparatus was flame-dried under high 
vacuum. After cooling to ambient temperature, the atmosphere was exchanged three times 
for argon, and anhydrous EtOH (7.3 mL) and Et2O (4 mL) were added. The mixture was 
cooled to –78 °C, and ammonia (30 mL) was condensed into the vessel. Subsequently, a 
solution of ketone 80 (23 mg, 0.0443 mmol, 1 equiv) in Et2O (5.3 mL) was added. After 
allowing the system to equilibrate for 5 min, Li0 wire (69 mg, 9.9 mmol, 223 equiv) that 
had been freshly washed with hexanes and cut into ~10 mg pieces was added. Within 3 
min, a deep blue color developed, and after 30 min, the reaction was colorless. 
The apparatus was removed from the cooling bath, and ammonia was boiled off 
over 1 h. The resulting slurry was extracted into Et2O (50 mL), washed with sat. aq. 
NaHCO3 (10 mL), dried over Na2SO4, filtered, and concentrated under reduced pressure to 
afford an oil.  
Purification was achieved via flash column chromatography on SiO2 [3 g SiO2, 
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TLC (15% Et2O/hexanes): Rf = 0.36 (p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 5.76 (dd, J = 17.6, 10.8 Hz, 1H, C19), 4.97 (dd, J = 17.6, 1.2 Hz, 
1H, C20), 4.90 (dd, J = 10.8, 1.2 Hz, 1H, C20), 4.50 (d, J = 6.9 Hz, 1H, OCH2OCH3), 4.47 (d, J = 
6.8 Hz, 1H, OCH2OCH3), 4.20 (t, J = 7.5, 6.7 Hz, 1H, C14), 3.35 (s, 3H, OCH2OCH3), 3.08 (d, J = 
5.6 Hz, 1H, C11), 2.47 – 2.28 (m, 2H, C2), 2.22 – 2.07 (m, 2H, C10, C13), 1.98 (d, J = 15.3 Hz, 2H, 
C1, C7), 1.40 (m, 5H, C6, C7, C15), 1.26 – 1.08 (m, 27H, C1, C8, C13, C18, OSi(CH(CH3)2)3), 1.01 
(d, J = 6.6 Hz, 3H, C16), 0.84 (d, J = 7.2 Hz, 3H, C17). 
13C NMR (101 MHz, CDCl3): δ 149.1 (C19), 147.2 (C3), 120.3 (C4), 110.5 (C20), 99.0 
(OCH2OCH3), 83.5 (C11), 68.2 (C14), 56.5 (OCH2OCH3), 50.6 (C9), 47.1 (C13), 46.2 (C5), 44.9 (C12), 
43.2 (C6), 39.4 (C1), 36.3 (C10), 34.4 (C2), 28.4 (C7), 28.3 (C8), 18.33 (C15), 18.26 
(OSi(CH(CH3)2)3), 18.2 (OSi(CH(CH3)2)3), 17.8 (C16) 14.4 (C18), 13.8 (OSi(CH(CH3)2)3), 11.4 
(C17). 
FTIR (thin film, NaCl): 2921, 2866, 1635, 1463, 1328, 1218, 1030, 1002, 913, 797 cm–1. 
HRMS (FAB+): calc’d for C31H56O4Si [M]+ 520.3948, found 520.3932. 
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Preparation of (+)-12-epi-pleuromutilin 82 (12-epi) 
 
This procedure was adapted from the work of Procter and coworkers.4 A flame-
dried 2 dram vial equipped with a stir bar was charged with alcohol 81 (12.7 mg, 0.0244 
mmol, 1 equiv), EDCI•HCl (28.0 mg, 0.146 mmol, 6 equiv), and DMAP (17.8 mg, 0.146 
mmol, 6 equiv), and the atmosphere was exchanged three times for argon. Subsequently, 
the vessel was charged with anhydrous CH2Cl2 (1.2 mL) and 2-(2,2,2-
trifluoroacetoxy)acetic acid (25.0 mg, 0.146 mmol, 6 equiv), and the reaction was stirred 
at ambient temperature. After 10 min, a light yellow color developed, and after 30 min, the 
reaction was complete by TLC analysis (30% Et2O/hexanes, Rf = 0.77 [p-anisaldehyde], 
Rf (starting material) = 0.70). Thereafter, a solution of anhydrous MeOH (19 μL, 0.480 
mmol, 20 equiv) in freshly distilled Et3N (67 μL, 0.480 mmol, 20 equiv) was added, and 
the reaction immediately turned bright yellow. After 5 min, the reaction was judged was 
complete by TLC analysis (30% Et2O/hexanes, Rf = 0.35 [p-anisaldehyde]). A solution of 
HCl in THF (600 µL of a 2.0 M solution, 1.2 mmol) was added, and the reaction was heated 
to 50 °C. After 30 min, an additional portion of HCl in THF (260 uL) was added. At this 
time, hydrolysis of the methoxymethyl group was judged complete by TLC analysis (70% 
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The reaction was cooled to 0 °C and was cautiously quenched with sat. aq. NaHCO3 
(3 mL). After warming to ambient temperature, the crude mixture was extracted into Et2O 
(3 x 5 mL), dried over Na2SO4, filtered, and concentrated under reduced pressure to afford 
an orange oil. 
Purification was achieved via flash column chromatography on SiO2 [1.5 g SiO2, 
Et2O/hexanes = 50%→70%] to afford (+)-12-epi-pleuromutilin 82 (5.4 mg, 0.0143 mmol, 
60% yield) as a white solid. 
 
TLC (70% Et2O/hexanes): Rf = 0.26 (p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 5.81 – 5.65 (m, 2H, C14, C19), 5.27 – 5.17 (m, 2H, C20), 4.07 (dd, 
J = 17.1, 5.6 Hz, 1H, C22), 4.01 (dd, J = 17.1, 5.2 Hz, 1H, C22), 3.45 (d, J = 6.4 Hz, 1H, C11), 2.45 
– 2.00 (m, 6H, C2, C4, C10, C13, C22OH,), 1.81 (dq, J = 13.9, 2.7 Hz, 1H, C8), 1.73 – 1.58 (m, 2H, 
C1, C6), 1.58 – 1.45 (m, 3H, C1, C7, C11OH), 1.44 (s, 3H, C15), 1.42 – 1.36 (m, 1H, C7), 1.25 (s, 3H, 
C18), 1.18 – 1.04 (m, 2H, C8, C13), 0.97 (d, J = 7.1 Hz, 3H, C17), 0.70 (d, J = 7.0 Hz, 3H, C16). 
13C NMR (101 MHz, CDCl3): δ 217.0 (C3=O), 172.1 (C21), 146.8 (C19), 115.4 (C20), 71.9 (C11), 
70.1 (C14), 61.3 (C22), 58.2 (C4), 45.4 (C9), 45.3 (C12), 43.6 (C13), 41.8 (C5), 36.6 (C6), 34.5 (C2), 
34.4 (C10), 30.1 (C8), 26.9 (C7), 25.0 (C1), 16.7 (C16), 14.8 (C15), 14.1 (C18), 10.8 (C17). 
FTIR (thin film, NaCl): 3437, 2927, 1728, 1603, 1444, 1382, 1232, 1098, 1011, 755 cm 
–1. 
HRMS (FAB+): calc’d for C22H33O5 [M+H]+–H2 377.2328, found 377.2329 
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Preparation of 11,12-bis-epi-Dowd-Beckwith rearrangement tricycle 83 
 
A 2 dram vial equipped with a stir bar was charged with a solution of aldehyde 7 
(35 mg, 0.097 mmol, 1 equiv) in 4.8 mL of THF that had been submitted to five freeze-
pump-thaw cycles and H2O/THF (2.7 mL). The solution was cooled to 0 ºC and stirred at 
this temperature for 5 min. Thereafter, SmI2/THF (2.9 mL, 0.294 mmol, 3 equiv) was added 
dropwise over 8 min. The deep blue color of SmI2 was immediately quenched upon 
addition of each drop. The first drop afforded a yellow solution, fading to a pale yellow 
and almost clear by the time 1.6 equiv SmI2 had been added. When 2.2 equiv SmI2 had 
been added, the blue color became increasingly persistent and upon addition of 2.6 equiv 
SmI2, the reaction was dark blue/green. After stirring an additional 10 min at 0 ºC, 
TMSCl/THF (889 µL, 0.490 mmol, 5 equiv TMSCl) was added dropwise over 2 min, and 
the reaction was stirred an additional 10 min. Throughout this time, the deep blue color 
was quenched to yellow. Thereafter, the reaction was removed from the ice bath and stirred 
open to the atmosphere for 5 min. 
The resulting pale yellow solution was diluted with Et2O (2 mL), and washed with 
H2O (2 x 1 mL). The aqueous layer was back-extracted with Et2O (2 x 1 mL), and the 
combined organic layers were dried over Na2SO4, filtered, and concentrated under reduced 
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Purification was achieved via flash column chromatography on SiO2 [3 g SiO2, 
Et2O/hexanes = 20%] to afford tricycle 83 (7 mg, 0.020 mmol, 21% yield) as a white solid. 
 
Preparation of SmI2: See page 103. 
Stock solution of TMSCl: See page 104. 
Stock solution of H2O/THF: See page 133. 
 
TLC (30% Et2O/hexanes): Rf = 0.33 (p-anisaldehyde). 
1H NMR (400 MHz, CDCl3): δ 6.11 (dd, J = 17.6, 10.9 Hz, 1H, C19), 5.53 (dd, J = 9.0, 5.5 Hz, 
1H, C14), 5.10 (dd, J = 11.0, 1.4 Hz, 1H, C20), 5.07 (d, J = 0.8 Hz, 1H, C17), 5.03 (d, J = 0.8 Hz, 1H, 
C17), 5.00 (dd, J = 17.7, 1.5 Hz, 1H, C20), 4.63 (d, J = 6.8 Hz, 1H, OCH2OCH3), 4.49 (d, J = 6.7 
Hz, 1H, OCH2OCH3), 4.21 (s, 1H, C11), 3.38 (s, 3H, OCH2OCH3), 2.49 – 2.36 (m, 3H, C1, C2), 
2.35 – 2.18 (m, 2H, C8, C13), 2.02 (tq, J = 9.4, 3.6, 2.4 Hz, 1H, C6), 1.92 (ddd, J = 11.7, 9.0, 6.1 Hz, 
1H, C2), 1.81 – 1.65 (m, 1H, C7), 1.61 (dd, J = 13.6, 9.0 Hz, 1H, C13), 1.45 – 1.36 (m, 1H, C7), 1.26 
(d, J = 0.9 Hz, 3H, C18), 1.10 (s, 3H, C15), 1.10 – 1.01 (m, 1H, C8), 0.92 (d, J = 7.0 Hz, 3H, C16). 
13C NMR (101 MHz, CDCl3): δ 219.1 (C3=O), 155.2 (C10), 142.3 (C19), 141.8 (C10), 119.8 
(C17), 112.3 (C20), 106.7 (C14), 93.1 (OCH2OCH3), 79.9 (C11), 56.9 (C5), 55.4 (OCH2OCH3), 45.1 
(C9), 45.0 (C12), 38.7 (C6), 38.5 (C1), 37.1 (C8), 35.6 (C13), 29.6 (C2), 27.8 (C7), 23.1 (C18), 19.8 
(C15), 13.7 (C16). 
FTIR (thin film, NaCl): 2923, 2853, 1711, 1461, 1378, 1261, 1142, 1101, 1040 cm–1. 
HRMS (TOF, ES+): calc’d for C22H33O3 [M+H]+ 345.2430, found 345.2409. 
[𝜶]𝑫𝟐𝟑: –78.7° (c = 0.045, CHCl3). 
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Spectra Relevant to Chapter 2: 













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































240Appendix 1 – Spectra Relevant to Chapter 2









X-Ray Crystallography Reports Relevant to Chapter 2: 
Total Synthesis of (+)-Pleuromutilin and (+)-12-epi-Pleuromutilin 
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Single Crystal X-ray Diffraction Data 
 
Low-temperature diffraction data (φ- and ω-scans) were collected on a Bruker AXS D8 
VENTURE KAPPA diffractometer coupled to a PHOTON 100 CMOS detector with Cu-
Kα radiation (λ = 1.54178 Å) from a IµS HB micro-focus sealed X-ray tube. All 
diffractometer manipulations, including data collection, integration, and scaling were 
carried out using the Bruker APEXII software.1 Absorption corrections were applied using 
SADABS.2 The structure was solved by intrinsic phasing using SHELXT3 and refined 
against F2 on all data by full-matrix least squares with SHELXL-20144 using established 
refinement techniques. 5  All non-hydrogen atoms were refined anisotropically. Unless 
otherwise noted, all hydrogen atoms were included into the model at geometrically 
calculated positions and refined using a riding model. The isotropic displacement 
parameters of all hydrogen atoms were fixed to 1.2 times the U value of the atoms they are 
linked to (1.5 times for methyl and hydroxyl groups). Crystallographic data for 61, 59, and 
83 can be obtained free of charge from The Cambridge Crystallographic Data Centre 
(CCDC) via www.ccdc.cam.ac.uk/data_request/cif under CCDC deposition numbers 
1589653-1589655. Graphical representation of the structure with 50% probability thermal 
ellipsoids was generated using Mercury visualization software.6 
 
Table 1: Crystal and refinement data for compounds 61, 59, and 83. 
 61 59 83 
CCDC Number 1589655 1589654  1589653 
Empirical formula C22H34O6 C22H34O4 C22H32O3 
Formula weight 394.49 362.49 344.47 
T (K) 100 100 100 
Crystal system Orthorhombic Orthorhombic Orthorhombic 
Space group P212121 P212121 P212121 
a, Å 7.2336(4) 8.8601(3) 7.4344(9) 
b, Å 16.5583(8) 11.6560(4) 11.7916(15) 
c, Å 34.6198(18) 37.8871(14) 21.810(3) 
a, ° 90 90 90 
b, ° 90 90 90 
g, ° 90 90 90 
Volume, Å3 4146.6(4) 3912.7(2) 1912.0(4) 
Z 8 8 4 
dcalc, g/cm
3
 1.264 1.231 1.197 
Abs. coeff. (mm
-1) 0.738 0.658 0.609 
q range, ° 2.552 to 79.430 3.968 to 79.461 4.054 to 78.898 
Abs. correction Semi-empirical Semi-empirical Semi-empirical 
GOF 1.066 1.097 1.064 
R1,a wR2,b [I>2s(I)] 0.0345, 0.0897 0.0339, 0.0877 0.0291, 0.0764 
Flack parameter 0.04(3) 0.06(2) 0.00(4) 
Extinction coefficient n/a 0.00096(12) 0.0103(7) 
aR1 = Σ||Fo|-|Fc||/Σ|Fo|. bwR2 = [Σ[w(Fo2-Fc2)2]/Σ[w(Fo2)2]1/2. 
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Figure 1: Structure of 61 with 50% probability anisotropic displacement ellipsoids. The 
second molecule of 16 is omitted for clarity. 
 
Special Refinement Details for 61 
Compound 61 crystallizes in the orthorhombic space group P212121 with two molecules in 
the asymmetric unit. The coordinates for the hydrogen atoms bound to O2A, O4A, O2B, 
and O4B were located in the difference Fourier synthesis and refined using a riding model. 
No hydrogen bond acceptor was found for O2B. Absolute configuration was determined 
by anomalous dispersion (Flack = 0.04(3)).6  
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Figure 2: Structure of 59 with 50% probability anisotropic displacement ellipsoids. The 
second molecule of 17 is omitted for clarity. 
 
Special Refinement Details for 59 
Compound 59 crystallizes in the orthorhombic space group P212121 with two molecules in 
the asymmetric unit. The coordinates for the hydrogen atoms bound to O2A and O2B were 
located in the difference Fourier synthesis and refined using a riding model. Absolute 
configuration was determined by anomalous dispersion (Flack = 0.06(2)).6  
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Figure 3: Structure of 83 with 50% probability anisotropic displacement ellipsoids. 
 
Special Refinement Details for 83 
Compound 83 crystallizes in the orthorhombic space group P212121 with one molecule in 
the asymmetric unit. Absolute configuration was determined by anomalous dispersion 
(Flack = 0.00(4)).6 
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The Illicium family of neurotrophic natural products has received remarkable 
attention from the synthetic community not only for their challenging chemical structures 
but also for their promising biological activities. Since their discovery as small molecules 
that are capable of promoting outgrowth in neuronal cultures, synthetic chemists across the 
field have sought to develop novel synthetic routes to access these natural products.1–25  
Amongst the Illicium natural products, comprehensive biological investigation of 
merrilactone A has been limited, as the Illicium genus only produces it in quantities of 
parts-per-million. Structurally, merrilactone A is a complex cage-shaped pentacyclic 
sesquiterpene that contains a highly strained oxetane moiety. Its lack of natural availability, 
coupled with its densely functionalized and complex architectural framework has attracted 
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considerable attention from the synthetic community. However, the syntheses to date do 
not address the shortage of material needed for biological studies. Recognizing this 
quandary as an opportunity for the development of a concise synthesis with the prospect 
of new reaction development, a synthetic campaign towards (–)-merrilactone A was 
initiated. This chapter will outline the development of a novel Pd-catalyzed asymmetric 
allylic alkylation reaction for the synthesis of vicinal quaternary centers that will enable 
our synthetic studies towards (–)-merrilactone A.  
3.2 NEUROTROPHINS AND CURRENT LIMITATIONS 
Neurodegeneration poses a serious threat to human health and is the hallmark of 
many diseases including Alzheimer’s disease, Parkinson’s disease, motor neuron diseases, 
Huntington’s disease, spinocerebellar ataxia, spinal muscular atrophy, and amyotrophic 
lateral sclerosis. Individuals diagnosed with neurological disorders have few treatment 
options, which leaves them to endure poor quality of life and ultimately results in death. 
The prevalence of neurodegenerative brain disorders increases dramatically with advanced 
age, and with the increasing average life expectancy, the projected financial, societal, and 
emotional costs of treating these disorders are expected to be staggering.26,27 Thus, 
uncovering novel treatments or preventative interventions for brain related 
neurodegenerative disorders is paramount to reducing these growing health threats.  
Neurotrophic factors present a compelling opportunity for treating neurological 
disorders. Studies have demonstrated that under conditions of neurodegeneration, supra-
physiological (i.e., biopharmaceutical) application of neurotrophic factors can activate 
neuronal repair genes.28 Induction of these repair genes by neurotrophins is reported to 
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produce morphological and functional restoration of the degenerating neurons, preventing 
further neurodegeneration while also protecting against cell death.29 Since the discovery of 
the first neurotrophin, NGF (1, Figure 1), neurotrophic factors have become the focus of 
substantial interdisciplinary research due to their therapeutic potential; however efforts to 
translate this potential to the clinic has been unsatisfactory, as in vivo evaluation requires 
direct microinjection of the peptides into the brain.29 Currently, most well-characterized 
neurotrophins are naturally occurring polypeptidic or protein based biomolecules (NGF, 
BDNF, GDNF, NT4/5, NT6) which are too large to cross the blood–brain barrier. These 
suboptimal pharmacological properties are a serious impediment to future development 
and applications as treatment for neurodegeneration in humans.30 In contrast to protein 
neurotrophins such as NGF, small-molecule neurotrophins are of considerable interest 
because of their desirable pharmacokinetic properties and pharmacological advantages: 
low molecular weight, high serum stability, and most importantly, blood–brain barrier 
permeability.  
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3.3 OVERVIEW OF ILLICIUM SESQUITERPENES AND 
PROPOSED BIOSYNTHETIC PATHWAY 
To date, over 100 sesquiterpene lactones have been isolated from the Illicium genus 
of plants. Collectively known as Illicium sesquiterpenes, these natural products share a 
common ring system that have varying oxidation patterns. Initial isolations, for example of 
anisatin (2) and pseudoanisatin (3), were guided by their potent neurotoxic activities 
(Figure 2).31,32 More recently, Fukuyama and coworkers have demonstrated that a number 
of natural products of the same family, such as jiadifenolide (4) and merrilactone A (5), do 
not share this same toxicity profile but instead stimulate neurite outgrowth at low 
nanomolar to low micromolar concentrations in primary cultures of fetal rat cortical 
neurons.33 Such results have drastic implications in the study of neurodegenerative diseases 
such as Alzheimer’s and Parkinson’s28,34 and this difference in activity truly highlights how 
slight oxidation state changes in this family of natural products leads to profoundly 
different biological activities.  
 
Figure 2. Neurotoxic and neurotophic Illicium sesquiterpenes. 
 The Illicium sesquiterpene family member subtypes are ultimately categorized by 
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during the cyclase phase of the biosynthesis and their differing oxidation patterns. (Figure 
3).  
 
Figure 3. Illicium sesquiterpene subtypes based on lactonization pattern.  
 The proposed biosynthesis of this class of natural product commences with 
cyclization of farnesyl pyrophosphate 6 to give bisabolyl cation 7 (Scheme 1). A 
subsequent series of hydride shifts and cyclizations give rise to the polycyclic allo-cedrane 
skeleton 12.33 At this stage, a series of oxidations can lead to the allo-cedrane 
sesquiterpenes, such as 11-O-debenzoyl-tashironin (17). Alternatively, C–C bond 
cleavages would forge the seco-prezizaane 13 or anislactone-type 16 skeletons. Subsequent 
selective enzymatic oxidations can then afford Illicium members such as majucin (14) and 
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Scheme 1. Proposed biosynthesis of Illicium sesquiterpenoids. 
3.4 (–)-MERRILACTONE A 
Merrilactone A (5) is a pentacyclic sesquiterpene dilactone isolated from Illicium 
merrillianum by Fukuyama and coworkers in 2000 (Figure 4). It was identified as a 
nonpeptidal neurotrophic factor that promotes neurite outgrowth in the culture of fetal rat 
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In addition to its interesting bioactivity, the dense triquinane-like carbon skeleton 
has garnered much interest from the synthetic community due to its oxygenation pattern 
and structural complexity. Merrilactone A (5) contains seven contiguous stereocenters, 
three of which are quaternary and two of which are vicinal. It also bears an oxetane linkage 
bridging the b-faces of C7 and C1, making the overall structure highly compact and caged.  
 
Figure 4. Structure and numbering of (–)-merrilactone A (5). 
3.5 PREVIOUS SYNTHESES OF MERRILACTONE A 
Over the past two decades, there have been numerous efforts throughout the 
synthetic community toward developing de novo syntheses of (–)-merrilactone A (5).2–
8,11,12,14,16,17 Because synthetic work in this area is quite extensive, this section will be 
focused on a selection of completed syntheses of merrilactone A (5), highlighting distinct 
strategies used in constructing this natural product as well as common features.  
3.5.1  Fukuyama’s Semisynthesis  
Structurally, merrilactone A (5) is related to anislactone A and B (18), a pair of 
epimeric sesquiterpene dilactones discovered ten years prior by Kouno and coworkers from 
the plant Illicium anistatum.35 Fukuyama was able to convert anislactone B (18) to 
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biogenetic precursors to merrilactone A (5).1 The two-step sequence from Fukuyama’s 
intermediate involves 1) epoxidation and 2) homo-Payne rearrangement, and has been 
adopted by many groups for the construction of the oxetane E ring in order to access 
merrilactone A (5).  
 
Scheme 1. Conversion of anislactone B (18) to merrilactone A (5). 
3.5.2 Danishefsky’s Racemic Synthesis 
Danishefsky and coworkers developed the first racemic synthesis of merrilactone 
A (5) in 2002, and later translated this strategy into an asymmetric synthesis.2,6 Their 
racemic synthesis commenced with a Diels-Alder reaction between 2,3-dimethylmaleic 
anhydride 21 and diene 20 to afford bicycle 22 (Scheme 2). In five steps, they were able to 
elaborate the cyclic anhydride 22 to bicyclic lactone 23, completing the D ring.  
Initial efforts to accomplish this transformation in a single step using conventional 
borohydride reagents led to complex mixtures, where ultimately a five-step protocol was 
developed that involved opening of the anhydride, converting to a diester, reduction, and 
saponification to afford the desired lactone 23. At this stage, conversion to 24 was 
accomplished through a three-step procedure that involved ozonolysis, enamine-promoted 
aldol cyclization, and borohydride reduction to afford the C ring 24. Installation of the C9 
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rearrangement, followed by saponification to produce a mixture of carboxylic acids 25 in 
1.8:1 dr that were inseparable until iodolactonization was performed to forge the A ring 
26. Construction of the final B ring was accomplished in six steps through a radical 
cyclization reaction to afford Fukuyama’s intermediate 19, which was then epoxidized and 
subjected to an acid-promoted homo-Payne rearrangement to afford merrilactone A (5) in 
20 linear steps. 
 
Scheme 2. Danishefsky’s racemic synthesis of merrilactone A (5).  
3.5.3 Frontier’s Racemic Synthesis 
Frontier and coworkers developed a concise racemic synthesis of merrilactone A 
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Their synthesis commenced with conversion of ynol 27 to substituted furan 28 that later 
served as the A ring lactone (Scheme 3). Lithium-halogen exchange of 28 and treatment 
with Weinreb amide 29 afforded coupled product 30, which was poised for their key 
Nazarov cyclization reaction. As planned, Nazarov cyclization of 30 proceeded smoothly 
using a dicationic iridium catalyst to afford a single diastereomer of bicycle 31. Initial 
attempts to cyclize protected alkyne 31 failed to provide tricycle 33. However, desilylation 
to afford 32 allowed smooth radical cyclization to 33.  
To forge the final D ring, a three-step protocol was developed. 33 was subjected to 
fluoride-mediated silyl deprotection conditions, converted to the carbonate, and 
intramolecularly lactonized upon treatment with base to afford tetracycle 34. The C6 
vicinal quaternary center was installed through a-methylation in near quantitative yield 
and complete diastereoselectivity. Reduction of ketone 35 with sodium borohydride 
afforded a 1.2:1 mixture of diastereomers 36 at the resultant alcohol which could be 
reoxidized and resubjected to increase product yield. Exocyclic olefin 19 was isomerized 
under acidic conditions to afford Fukuyama’s intermediate 19. Epoxidation and homo-
Payne rearrangement afforded merrilactone A (5) in 17 linear steps from ynol 27.  
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Scheme 3. Frontier’s racemic synthesis of merrilactone A (5). 
3.5.4 Inoue’s Asymmetric Synthesis 
In 2003, Inoue and coworkers developed a racemic3 synthesis of merrilactone A (5) 
prior to their asymmetric7,12 synthesis in 2006. Lactone 38, which is available in five steps 
from 2,3-dimethylmaleinic anhydride, underwent a [2+2] photocycloaddition with cis-2,3-
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key intermediate 40 where a bis(trifluoromethyl)benzyl (BTB) group was installed as a 
bulky protecting group to differentiate C5 from C6. 40 was then subjected to a ring-closing 
metathesis reaction to produce a bicyclo[4.2.0]octyl system, which was then subjected in 
situ to lead(IV) tetraacetate-promoted oxidative ring expansion to yield the substituted 
eight-membered ring 41. At this stage, the key transannular aldol reaction was performed 
and site-selective deprotonation and diastereoselective C4–C9 bond formation was 
observed to afford bicycle 42. In 13 steps, the A and D rings were installed to afford 
Fukuyama’s intermediate, which could be elaborated to (–)-merrilactone A (5) in two steps 
making their asymmetric synthesis 31 linear steps. 
 
Scheme 4. Inoue’s asymmetric synthesis of (–)-merrilactone A (5). 
In summary, there have been numerous different approaches towards merrilactone 
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studies of this natural product (Table 1). Structurally, the C5 and C6 vicinal quaternary 
centers within such a compact and densely functionalized scaffold also present a unique 
challenge and are an opportunity for the development of new methodologies to access this 
type of structural motif. For the aforementioned reasons, efforts towards an asymmetric 
synthesis were initiated. It was envisioned that our synthesis would allow investigators to 
design analogues through elaboration of key intermediates to address questions 
surrounding the biological target, its ability to cross the blood-brain barrier, and the rational 
design of potent synthetic neurotrophic small molecules. 
 
Table 1. Summary of prior syntheses of merrilactone A (5). 
3.6 RETROSYNTHETIC ANALYSIS 
Retrosynthetically, it was envisioned that (–)-merrilactone A (5) would arise from 
Fukuyama’s intermediate (19) through epoxidation and Payne rearrangements as reported 
by many other prior syntheses (Scheme 5). The A ring of 19 could then be accessed through 
lactonization of acetylated 43, which could be obtained through a selenium(II) oxide 
mediated allylic C–H oxidation36 from tricycle 44. The B ring of tricycle 44 could be forged 
Entry Laboratory (year) C5/C6 Longest LinearSequence Yield (%) Series (±)
1 Danishefsky (2001) [4+2] 20 steps 11 (±)
2 Inoue & Hirama (2006) [2+2] 31 steps 1.1 (–)
3 Inoue (2007) [2+2] 23 steps 1.7 (+)
4 Mehta (2006) [2+2] 21 steps 0.0042 (±)
5 Greaney (2010) [2+2] 25 steps 4 (±)
6 Frontier (2006) Nazarov/Enolate 17 steps 3.7 (±)
7 Zhai (2012) [3,3]/Enolate 18 steps 3.7 (±)
8 Wang (2018) 15 steps 1.5 (±)–
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through an intramolecular Pauson–Khand reaction from enyne 45. Enyne 45 could then be 
synthesized from 46 through a nucleophilic propynyl addition.  
 
Scheme 5. Retrosynthesis of (–)-merrilactone A (5). 
 It was hypothesized that Pauson–Khand reaction could possibly favor the desired 
diastereomer 47 due to conformational analysis shown in Scheme 6. Upon coordination of 
the rhodium catalyst, there are two possible conformations leading to either product, 44 or 
47. Evaluation of these two conformers reveals a steric interaction between the C4–H atom 
and the propargyl hydroxyl group in the conformation leading to diastereomer 47. By 
contrast, coordination of the rhodium catalyst to the desired conformation in which the C4–
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Scheme 6. Pauson–Khand reaction stereochemical rationale. 
 It was then envisioned that the vicinal quaternary centers at C5 and C6 could be 
constructed through a palladium-catalyzed asymmetric allylic alkylation reaction from 
commercially available materials 48 and 49 (Scheme 7).  
 
Scheme 7. Pd-catalyzed asymmetric allylic alkylation to set vicinal quaternary 
centers. 
 Similar reactions employing epoxide 49 under Tsuji-Trost conditions have been 
successfully used to rapidly build complexity in a single step. For example, in Xie’s total 
synthesis of hyperolactone C and (–)-biyouyanagin A,37 malonate derivative 50 was used 
to asymmetrically construct the fully substituted vicinal stereocenters with excellent 
diastereo- and enantioselectivity to furnish the desired branched product 51 (Scheme 8). 
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as a-cyano ester 48 under conditions adapted from Xie’s synthesis, could provide 
enantioselective access to lactone 46.  
 
Scheme 8. Xie’s allylic alkylation en route to hyperolactone C.  
3.7 FORWARD SYNTHETIC EFFORTS 
3.7.1 Development of a Pd-catalyzed Asymmetric Allylic 
Alkylation 
Synthetic efforts towards (–)-merrilactone A (5) began with the development of an 
asymmetric Pd-catalyzed asymmetric allylic alkylation reaction for the synthesis of the D-
ring lactone. It was envisioned that the catalytic cycle would commence with coordination 
of palladium(0) to the alkene of vinyl epoxide 49, resulting in epoxide ionization and 
formation of the intermediate Pd-p-allyl complex (52, Scheme 9). Nucleophile 53 can then 
trap the p-allyl complex, affording the branched product 55. Subsequent lactonization 








[Pd2(dba)3]•CHCl3 (1 mol %)
(R,R)-DACH-phenyl (3 mol %)
CH2Cl2, 23 ºC,
59%
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Scheme 9. Proposed catalytic cycle.  
With this catalytic cycle in mind, investigations of this reaction were initiated 
(Scheme 10). Thus, treatment of vinyl epoxide 49 and a-cyano ester 48 with Pd2(dba)3 (1 
mol %) and (R,R)-DACH-naphthyl ligand 69 (3 mol %, vide infra, Table 2) in anhydrous 
benzene afforded a diastereomeric mixture of lactones 56, branched uncyclized product 55, 
and linear product 57 in 35%, 8%, and 17%, respectively, as a mixture of diastereomers in 
all cases. With these initial results in hand, it was apparent that the primary challenge in 
developing this reaction would be the regioselectivity of nucleophilic addition. Thus, 
various parameters were investigated that would maximize selective formation of branched 
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Scheme 10. Initial result for the formation of lactone 56 and anticipated challenges. 
 Optimization commenced with investigations of alternative nucleophiles. It was 
ultimately found that nucleophiles that did not contain an a-cyano ester component (Table 
2, entries 1 and 2) fared poorly in the reaction and delivered trace product. Variation of the 
alkyl substituent on the ester (entries 4 and 5) led to diminished yields. Interestingly, the 
phenyl variant 66 furnished more linear product than the lactone and branched product 
combined; however, this was not the case with the tert-butyl nucleophile 65. From this 
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regioselectivity of nucleophilic addition?
49
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Table 2. Evaluation of alternative nucleophiles. 
 Next, a ligand evaluation was conducted in an effort to improve the yield and 
diastereoselectivity. Efforts with non-diaminocyclohexyl (DACH) ligands (Table 3, entries 
1 and 2) furnished high yields of the undesired linear products; however, little lactone and 
branched products were observed. Therefore, ligand investigations were continued with 
DACH ligands, where nearly all (entries 4–6) yielded some productive reactivity with the 
exception of (R,R)-DACH-pyridyl 67, which mainly resulted in recovered starting ester 48. 
In summary, most of the ligands employed facilitated successful nucleophilic addition; 
however, the previously established conditions with (R,R)-DACH-naphthyl 69 were still 
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1 2 3 4* 5*
2% 3% 35% 33% 0%
– – 8% 10% 12%
– – 17% 21% 26%
* CH2Cl2 as solvent
4863 64
65 66
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Table 3. Ligand evaluations. 
 Upon establishing the optimal nucleophile and ligand for the reaction, attention was 
turned towards additive investigations. Efforts were focused on tetrabutylammonium salts 
due to their low cost and reasonable solubility in most organic solvents. A survey of 
tetrabutylammonium halides led to a prominent increase in lactone (56, Table 4, entries 1–
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Entry Ligand % SM (ester) (cis:trans)% lactone % branched % linear
1 (R)-BINAP 0% 1:13% 4% 78%
2 (S)-tBu-Bn-PHOX 0% –0% 0% 99%
3 (R,R)-DACH-pyridyl 67 60% 0% – 0% 0%
4 (R,R)-DACH-phenyl 70 0% 0% – 51% 43%
5 (R,R)-DACH-naphthyl 69 0% 30% 1:1 15% 56%
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to higher lactone 56 yields. A notable increase in yield occurred when 15 mol % of 
tetrabutylammonium difluorotriphenylsilicate (TBAT) was used (entries 5–7).  
 
Table 4. Additive investigations. 
The use of TBAT in Pd-catalyzed asymmetric allylic alkylation reactions and its 
effects on regioselectivity have been studied extensively.38–44 It is hypothesized that, in the 
absence of TBAT, the initial ionization of racemic epoxide 49 results in a kinetically 
determined ratio of the two diastereomeric p-allylpalladium species: one that favors the 
formation of the branched product and the other that favors the formation of the linear 
product (Figure 4). If interconversion between the two diastereomers is sluggish, the initial 
diastereomeric ratio dictates the branched-to-linear selectivity. It is proposed that the 
addition of TBAT increases the rate of equilibration of the diastereomeric p-allylpalladium 
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Entry additive (60 mol %) % SM (ester) (cis:trans)% lactone % branched % linear
1 0% 1:1.517% 57% 11%
2 0% 1:1.758% 26% 16%
3 0% 61% 1:1.5 12% 18%
4 48% 5% – – 6%
5 TBAT (30 mol %) 0% 66% 1:1.3 10% 33%
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Figure 4. Cartoon adapted from Trost and coworkers44 rationalizing regioselectivity.  
Further improvement of the yield of the reaction was achieved by changing the 
solvent, where 2-methyltetrahydrofuran at 0.2 M concentration was found to be best (Table 
5, entry 8). At this stage, the enantiomeric excess of each product (cis and trans) was also 
determined. It was found that across all solvents, both diastereomers were formed in high 
enantiomeric excess; however, the diastereoselectivity remained poor (Table 5). It is 
hypothesized that this poor diastereoselectivity arises from poor facial selectivity of the 
enolate nucleophile. It is also possible that reaction though a mixture of enolate geometries 
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Table 5. Solvent evaluation. 
After the reaction parameters were optimized, it was critical that the scalability of 
the reaction be investigated if it were to be used as the first step in total synthesis 
investigations. During the small-scale optimization stage, reactions were performed in a 
nitrogen-filled glovebox in one dram vials. However, this setup was impractical on larger 
scales. Fortunately, this reaction scaled considerably well after slight procedural 
modifications on the benchtop, and the yield increased to 73% (Scheme 11). It was 
determined during optimization that slight variations in the glovebox temperature greatly 
influenced the yield of the reaction mixture. Therefore, it is hypothesized that slow addition 
and more consistent temperatures on the benchtop contributed to the yield increase. 
Although reaction optimization was carried out with (R,R)-DACH-naphthyl (69) 
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Entry solvent (1.0 M) (cis:trans)% lactone %ee (cis) % ee (trans)
1 1:1.651% 87% 84%
2 1:1.340% 93% 95%
3 60% 1:1.5 90% 91%
4 47% 1:1 95% 95%
5 2-Me-THF 62% 1:1 90% 92%














8 2-Me-THF (0.2 M) 69% 1:1 96% 93%
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enantiomers cis-56 and trans-56. This was discovered once semisolid cis-56 was converted 
to crystalline dimethylamide 72. Scale up studies were therefore conducted using the (S,S)-
DACH-naphthyl, allowing a mixture of cis-73 and trans-73 to be prepared in 73% yield on 
94 mmol scale. 
 
Scheme 12. Determination of absolute stereochemistry and successful upscale. 
3.7.2 Proposed Path Forward 
  Although the Pd-catalyzed asymmetric allylic alkylation delivers a 1:1 mixture of 
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b) Synthesis of correct lactone enantiomers using (S,S)-DACH-Np
a) Determination of absolute stereochemistry through x-ray crystallography
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both diastereomers would be useful for these synthetic efforts (Scheme 13). If propynyl 
addition were to occur preferentially into the nitrile, cis-73 would be used to afford ynone 
74. Reduction of the carbonyl would then afford propargyl alcohol 45, the Pauson–Khand 
precursor.  
 If propynyl addition were to occur preferentially into the lactone, the trans-73 
would be used to afford resultant alkoxide 75. Alkoxide 75 could then lactonize onto the 
nitrile, and upon reduction, would afford propargyl alcohol 45. Therefore, both 
diastereomers could potentially be elaborated to the Pauson–Khand precursor.  
 
Scheme 13. PKR precursor 45 is accessible to both diastereomers.  
3.8 CONCLUDING REMARKS 
Herein is described a proposed strategy toward the synthesis of (–)-merrilactone A 
featuring a late-stage allylic C–H oxidation, Pauson–Khand reaction to construct the B and 
C rings, and a Pd-catalyzed asymmetric allylic alkylation reaction for D-ring construction 
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asymmetric allylic alkylation reaction was accomplished and should enable future 
synthetic efforts toward this structurally complex and biologically active natural product.  
3.9 EXPERIMENTAL SECTION 
3.9.1 Materials and Methods 
Unless otherwise stated, reactions were performed under an inert atmosphere (Ar) 
with freshly dried solvents utilizing standard Schlenk techniques. Glassware was oven-
dried at 120 °C for a minimum of four hours, or flame-dried utilizing a Bunsen burner 
under high vacuum. Tetrahydrofuran (THF), methylene chloride (CH2Cl2), diethyl ether 
(Et2O), benzene (PhH), and toluene (PhMe) were dried by passing through activated 
alumina columns. Absolute ethanol (200 Proof) was purchased from Koptec. Methanol 
(HPLC grade) was purchased from Fisher Scientific. Anhydrous ammonia (NH3) was 
purchased from Matheson Tri-Gas. N,N-diisopropylethylamine (iPr2NEt), triethylamine 
(Et3N), methanol (MeOH), isopropanol (iPrOH), tert-butanol (tBuOH), and trimethylsilyl 
chloride (TMSCl) were distilled over calcium hydride prior to use. Unless otherwise stated, 
chemicals and reagents were used as received. All reactions were monitored by thin-layer 
chromatography using EMD/Merck silica gel 60 F254 pre-coated plates (0.25 mm) and 
were visualized by UV (254 nm), p-anisaldehyde, and/or KMnO4 staining. Flash column 
chromatography was performed using silica gel (SiliaFlash® P60, particle size 40-63 
microns [230 to 400 mesh]) purchased from Silicycle. 1H and 13C NMR spectra were 
recorded on a Bruker Avance III HD with Prodigy Cryoprobe (at 400 MHz and 101 MHz, 
respectively) or a Varian Inova 500 (at 500 MHz and 101 MHz respectively) and are 
reported relative to internal CHCl3 (1H, δ = 7.26) and CDCl3 (13C, δ = 77.0). Data for 1H 
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NMR spectra are reported as follows: chemical shift (δ ppm) (multiplicity, coupling 
constant (Hz), integration). Multiplicity and qualifier abbreviations are as follows: s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad, app = apparent. IR 
spectra were recorded on a Perkin Elmer Paragon 1000 spectrometer and are reported in 
frequency of absorption (cm–1).  
3.9.2 Experimental Procedures 
Preparation of lactones cis-73 and trans-73 
 
 To an oven-dried 3-neck round-bottom flask equipped with a stir bar was added 
Pd2dba3 (0.862 g, 0.94 mmol, 1 mol %), (S,S)-DACH-Np (2.61 g, 3.30 mmol, 3.4 mol %), 
and TBAT (7.63 g, 14.1 mmol, 15 mol %) under a steady stream of argon. The flask was 
evacuated and backfilled with Ar three times. 157 mL of 2-Me-THF was added and the 
maroon solution was stirred for 30 min. at ambient temperature. The solution became dark 
orange after 40 minutes. A solution of ethyl 2-cyanopropanoate 48 (11.84 mL, 94 mmol, 1 
equiv) in 157 mL 2-Me-THF was added in one portion (stirring was set to 500 rpm). 
Isoprene monoxide 49 (15.28 mL, 155 mmol, 1.65 equiv) was added in 157 mL 2-Me-THF 
via addition funnel over 30 minutes, where the solution began to turn dark yellow/green 
over the course of epoxide addition. Once two-thirds of the solution had been added, the 
temperature of the solution had risen to 23 ºC and began to steadily decrease back to 
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at ambient temperature for 5 h. Upon completion by TLC analysis, the reaction was filtered 
through 65 g of SiO2 below a pad of celite. 1H NMR analysis of the crude mixture showed 
a 1:1 diastereomeric mixture.  
Purification was achieved via flash column chromatography on SiO2 [0% 
EtOAc/hexanes → 25%] afforded a mixture of the diastereomers cis-73 and trans-73 as a 
white solid (11.3 g, 68.6 mmol, 73%). 
 
1H NMR (500 MHz, CDCl3): δ 6.08 (dd, J = 17.3, 10.8 Hz, 1H), 5.77 (dd, J = 17.5, 10.9 
Hz, 1H), 5.47 (d, J = 10.9 Hz, 1H), 5.40 (d, J = 10.9 Hz, 1H), 5.36 (d, J = 17.3 Hz, 1H), 
5.28 (d, J = 17.5 Hz, 1H), 4.45 – 4.41 (m, 1H), 4.33 (d, J = 9.3 Hz, 1H), 4.21 (d, J = 9.3 
Hz, 1H), 4.08 (d, J = 9.4 Hz, 1H), 1.52 (s, 3H), 1.52 (s, 3H), 1.50 (d, J = 0.4 Hz, 2H), 1.24 
(d, J = 0.6 Hz, 3H). 
 
Preparation of amide 71	
 
 A 150 mL pressure flask was charged with lactone 56 (8.5 g, 51.5 mmol) and 
suspended in EtOH:H2O (5:2, 85 mL, 0.6 M) after which Ghaffar-Parkins catalyst was 
added (100 mg, 0.233 mmol, 0.0045 mol %). The vessel was sealed and placed in a 
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was removed from heating and allowed to cool to ambient temperature. The crude reaction 
mixture was then poured into a 500 mL separatory funnel, diluted with water (100 mL), 
and extracted with 10% DCM in EtOAc (150 mL x 5), dried over Na2SO4, filtered, and 
concentrated under reduced pressure to yield a mixture of diastereomers as a white solid 
(8.76 g, 47.8 mmol, 87% combined yield).  
 1H NMR analysis of the crude mixture shows a 1:1 diastereomeric mixture. The 
diastereomers were separated by flash column chromatography on SiO2 [15% Et2O/15% 
acetone/70% hexanes] to yield the cis-diastereomer 71 (4.5 g, 24.7 mmol, 43% yield) as a 
white solid. 
 
TLC (50% EtOAc/Hexanes): Rf = 0.40 (UV, p-anisaldehyde).  
1H NMR (400 MHz, CDCl3): δ 7.32 (dd, J = 7.7, 0.8 Hz, 1H), 7.19 (d, J = 7.7 Hz, 1H), 
3.77 (s, 3H), 3.20 (ddq, J = 6.7, 4.5, 2.2 Hz, 1H), 2.63 (dd, J = 17.8, 4.5 Hz, 1H), 2.55 (dd, 
J = 17.8, 6.6 Hz, 1H), 2.34 (d, J = 0.7 Hz, 3H), 2.08 (d, J = 2.2 Hz, 3H), 1.69 (s, 3H).  
13C NMR (101 MHz, CDCl3): δ 210.3, 168.8, 155.1, 152.0, 134.7, 133.8, 132.3, 128.1, 
118.8, 75.6, 60.8, 55.7, 35.2, 24.6, 15.9, 9.9.  
FTIR (NaCl, thin film): 3389, 2963, 2919, 1690, 1639, 1320, 1227, 1091, 1018 cm-1.  
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Preparation of dimethylamide 72 
 
 An oven-dried 500 mL round-bottom flask equipped with a stir bar was charged 
with NaH (2.06 g, 86.3 mmol, 3.5 equiv) and THF (100 mL). An oven-dried addition funnel 
was quickly attached to the reaction flask and filled with a solution of cis-amide 71 (4.5 g, 
24.7 mmol, 1.0 equiv) in THF (100 mL). The flask was then cooled to 0 ºC. After cooling 
for 15 min, a solution of the cis-amide 71 was added dropwise over 30 min at 0 ºC. The 
solution was warmed to ambient temperature over 30 min. The flask was cooled to 0 ºC 
and stirred for 15 min before a solution of MeI (6.14 mL, 98.7 mmol, 4.0 equiv) in THF 
(50 mL) was added dropwise over 30 min at 0 ºC, after which the reaction was warmed to 
ambient temperature and stirred for 24 h. The reaction was then cooled to 0 ºC and 1 N 
HCl (10 mL) was slowly added. The solution was diluted with H2O (100 mL). The crude 
reaction mixture was extracted with 10% DCM/EtOAc (120 mL x 5), dried over Na2SO4, 
filtered, and concentrated under reduced pressure.  
Purification was achieved through flash column chromatography on SiO2 [10% 
EtOAc/hexanes → 60%] to afford dimethylamide 72 as an off-white solid (3.4 g, 16.1 
mmol, 65% yield). 
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1H NMR (400 MHz, CDCl3): δ 7.32 (dd, J = 7.7, 0.8 Hz, 1H), 7.19 (d, J = 7.7 Hz, 1H), 
3.77 (s, 3H), 3.20 (ddq, J = 6.7, 4.5, 2.2 Hz, 1H), 2.63 (dd, J = 17.8, 4.5 Hz, 1H), 2.55 (dd, 
J = 17.8, 6.6 Hz, 1H), 2.34 (d, J = 0.7 Hz, 3H), 2.08 (d, J = 2.2 Hz, 3H), 1.69 (s, 3H).  
13C NMR (101 MHz, CDCl3): δ 210.3, 168.8, 155.1, 152.0, 134.7, 133.8, 132.3, 128.1, 
118.8, 75.6, 60.8, 55.7, 35.2, 24.6, 15.9, 9.9.  
FTIR (NaCl, thin film): 3389, 2963, 2919, 1690, 1639, 1320, 1227, 1091, 1018, 921 cm-
HRMS (MM:ESI–APCI): calc’d for [M+Na]+ 259.1334, found 259.1347. 
3.9.3 Proof of Enantiopurity 
Due to COVID-19, this data at the present moment is not obtainable. 
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Spectra Relevant to Chapter 3: 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































288Appendix 3 – Spectra Relevant to Chapter 3












X-Ray Crystallography Reports Relevant to Chapter 3: 
Progress Towards the Total Synthesis of (–)-Merrilactone A 
  




X-Ray Structure Determination  
 
Low-temperature diffraction data (φ- and ω-scans) was collected on a Bruker AXS D8 
VENTURE KAPPA diffractometer coupled to a PHOTON 100 CMOS detector with Cu-
Kα radiation (λ = 1.54178 Å) from a IµS HB micro-focus sealed X-ray tube. All 
diffractometer manipulations, including data collection, integration, and scaling were 
carried out using the Bruker APEXII software.1 Absorption corrections were applied using 
SADABS.2 The structure was solved by intrinsic phasing using SHELXT3 and refined 
against F2 on all data by full-matrix least squares with SHELXL-20143 using established 
refinement techniques.4 All non-hydrogen atoms were refined anisotropically. Unless 
otherwise noted, all hydrogen atoms were included into the model at geometrically 
calculated positions and refined using a riding model. The isotropic displacement 
parameters of all hydrogen atoms were fixed to 1.2 times the U value of the atoms they are 
linked to (1.5 times for methyl groups). Compound 72 crystallizes in the monoclinic space 
group P21 with one molecule in the asymmetric unit. The Flack parameter was determined 
to be 0.11(6); absolute configuration was determined by anomalous dispersion. Graphical 
representation of the structures with 50% probability thermal ellipsoids was generated 
using Mercury visualization software.  




Table 1:  Crystal data and structure refinement for 72. 
Identification code  V18640 
Empirical formula  C11 H17 N O3 
Formula weight  211.25 
Temperature  99.98 K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P 21 
Unit cell dimensions a = 6.7743(13) Å a= 90°. 
 b = 11.832(2) Å b= 109.879(4)°. 
 c = 7.2005(13) Å g = 90°. 
Volume 542.76(18) Å3 
Z 2 
Density (calculated) 1.293 Mg/m3 
Absorption coefficient 0.768 mm-1 
F(000) 228.0 
Crystal size 0.41 x 0.3 x 0.21 mm3 
Theta range for data collection 15.074 to 159.652°. 
Index ranges -8<=h<=8, -15<=k<=14, -7<=l<=9 
Reflections collected 8035 
Independent reflections 2266 [R(int) = 0.0499, R(sigma)=0.0444] 
Completeness to theta = 67.679° 94.4 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7543 and 0.5508 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2266 / 1 / 148 
Goodness-of-fit on F2 1.045 
Final R indices [I>2sigma(I)] R1 = 0.0353, wR2 = 0.0794 
R indices (all data) R1 = 0.0314, wR2 = 0.0795 
Absolute structure parameter 0.11(6) 
Largest diff. peak and hole 0.19 and -0.16 e.Å-3 
  





Compound 72 crystallizes in the monoclinic space group P21 with one molecule in the 
asymmetric unit. Absolute configuration was determined by anomalous dispersion (Flack 




1 APEX2, Version 2 User Manual, M86-E01078, Bruker Analytical X-ray Systems, 
Madison, WI, June 2006. 
2 Sheldrick, G.M. “SADABS (version 2008/1): Program for Absorption Correction for 
Data from Area Detector  Frames”, University of Göttingen, 2008. 
3 Sheldrick, G. Acta Crystallogr., Sect. A: Found. Crystallogr. 2008, 64, 112. 
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